,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),29/128,5.3571954025400176e-11,9.700812600826577e-08,0,0,5.127080864511032,121.25543901793807,ERCC6L;BUB1B;CDCA8;TTK;WDR62;KIF11;CENPA;SKA1;AURKB;AURKA;CDC20;NUF2;BUB1;DLGAP5;PLK1;KNL1;NDC80;SGO1;CENPE;KIF18A;CENPF;ESPL1;KIF4B;CENPI;KIF4A;BIRC5;KIF2C;SPC24;SPC25
1,GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),32/157,1.0459097143748331e-10,9.700812600826577e-08,0,0,4.487051353874883,103.11676510524838,ERCC6L;BUB1B;CDCA8;TTK;WDR62;KIF11;CENPA;SKA1;AURKB;AURKA;CDC20;NUF2;BUB1;MISP;DLGAP5;PLK1;KIF23;KNL1;NDC80;SGO1;TPX2;CENPE;KIF18A;CENPF;KIF4B;KIFC1;CENPI;KIF4A;BIRC5;KIF2C;SPC24;SPC25
2,GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),19/102,2.6819974248961684e-06,0.0016583684077274,0,0,3.9730805139376697,50.97044622637442,SPAG5;CDCA5;PLK1;KIF14;CDCA8;NCAPG;KIF23;NCAPH;NDC80;SGO1;CENPE;KIF18A;KIF18B;ESPL1;KIFC1;CDK1;KIF2C;CEP55;DLGAP5
3,GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),10/34,9.716646811292208e-06,0.0045060949587367,0,0,7.1946477584629465,83.03825003090436,TOP2A;SGO1;KIF18A;KIF18B;SPAG5;ESPL1;KIFC1;PLK1;CDCA8;NDC80
4,GO_Biological_Process_2021,chromosome condensation (GO:0030261),11/45,2.4482660416778112e-05,0.0090830670146246,0,0,5.58858543417367,59.33705973157288,TOP2A;H1-5;H1-4;H1-6;CDCA5;PLK1;CDK1;NCAPG;H1-1;NCAPH;H1-3
5,GO_Biological_Process_2021,kinetochore organization (GO:0051383),6/13,3.4055501018053656e-05,0.0102386129132079,0,0,14.759734340408908,151.8410471866839,CENPE;CENPF;NUF2;CENPA;NDC80;DLGAP5
6,GO_Biological_Process_2021,chromatin assembly (GO:0031497),14/73,3.863627514418084e-05,0.0102386129132079,0,0,4.104714323512474,41.70931144898394,H2BC9;H2BC3;H1-1;H2BC17;H2BC18;H1-3;H1-5;H2BC13;H1-4;H2BC14;H1-6;H3C13;H2BC10;H2BC11
7,GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),7/21,8.93647969591365e-05,0.0165771698359198,0,0,8.614507299270073,80.3111884344407,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1
8,GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),7/21,8.93647969591365e-05,0.0165771698359198,0,0,8.614507299270073,80.3111884344407,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1
9,GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),7/21,8.93647969591365e-05,0.0165771698359198,0,0,8.614507299270073,80.3111884344407,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1
10,GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),7/22,0.00012485247678664885,0.0210546676762939,0,0,8.03978102189781,72.26458847693304,CDC20;CENPF;PLK1;BUB1B;TTK;TRIP13;BUB1
11,GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),13/74,0.0001841838668789951,0.0284717560883779,0,0,3.682779365318093,31.670341127191044,SPAG5;UBE2C;PLK1;CDCA8;KIF11;NDC80;SGO1;TPX2;KIF18A;KIF18B;ESPL1;KIFC1;MISP
12,GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),10/51,0.0004030781064571428,0.051980035751454,0,0,4.20770758485261,32.889042263091,CENPE;KIF18A;KIFC1;CDCA5;NUF2;KIF14;CDCA8;KIF2C;CEP55;NDC80
13,GO_Biological_Process_2021,negative regulation of chromatin organization (GO:1905268),5/13,0.0004483453218454261,0.051980035751454,0,0,10.75193533697632,82.89684960402266,H1-5;H1-4;H1-6;H1-1;H1-3
14,GO_Biological_Process_2021,negative regulation of chromatin silencing (GO:0031936),5/13,0.0004483453218454261,0.051980035751454,0,0,10.75193533697632,82.89684960402266,H1-5;H1-4;H1-6;H1-1;H1-3
15,GO_Biological_Process_2021,negative regulation of gene silencing (GO:0060969),5/13,0.0004483453218454261,0.051980035751454,0,0,10.75193533697632,82.89684960402266,H1-5;H1-4;H1-6;H1-1;H1-3
16,GO_Biological_Process_2021,meiotic sister chromatid cohesion (GO:0051177),4/8,0.0005384526455455215,0.0525699819729969,0,0,17.191082802547772,129.39403119067265,SGO1;BUB1B;HORMAD1;BUB1
17,GO_Biological_Process_2021,mitotic spindle elongation (GO:0000022),4/8,0.0005384526455455215,0.0525699819729969,0,0,17.191082802547772,129.39403119067265,KIF4B;KIF4A;KIF23;AURKB
18,GO_Biological_Process_2021,mitotic spindle midzone assembly (GO:0051256),4/8,0.0005384526455455215,0.0525699819729969,0,0,17.191082802547772,129.39403119067265,KIF4B;KIF4A;KIF23;AURKB
19,GO_Biological_Process_2021,nucleosome organization (GO:0034728),14/94,0.0006206423151391022,0.0575645747291517,0,0,3.023852157943067,22.3304092296199,H2BC9;H2BC3;H1-1;H2BC17;H2BC18;H1-3;H1-5;H2BC13;H1-4;H2BC14;H1-6;H3C13;H2BC10;H2BC11
20,GO_Biological_Process_2021,kinetochore assembly (GO:0051382),4/9,0.000926927379614605,0.0804108671166149,0,0,13.75213830755232,96.03991901106492,CENPE;CENPF;CENPA;DLGAP5
21,GO_Biological_Process_2021,nucleosome positioning (GO:0016584),5/15,0.0009536598795501504,0.0804108671166149,0,0,8.60063752276867,59.81918394663385,H1-5;H1-4;H1-6;H1-1;H1-3
22,GO_Biological_Process_2021,nucleosome assembly (GO:0006334),10/58,0.0011607180260693,0.0936144321025471,0,0,3.5927493138151876,24.28237398633213,H2BC9;H2BC13;H2BC14;H3C13;H2BC10;H2BC3;H2BC11;H2BC17;H2BC18;ASF1B
23,GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),9/49,0.0012739752982538,0.0982814820585026,0,0,3.8782678244972577,25.851032859504045,ANLN;ESPL1;KIF4B;KIF4A;PLK1;KIF23;KIF20A;CENPA;CEP55
24,GO_Biological_Process_2021,regulation of chromatin silencing (GO:0031935),5/16,0.001324548275721,0.0982814820585026,0,0,7.818347408511343,51.80971612770012,H1-5;H1-4;H1-6;H1-1;H1-3
25,GO_Biological_Process_2021,"protein localization to chromosome, centromeric region (GO:0071459)",5/17,0.0017918961337811,0.1278448972370776,0,0,7.16643897996357,45.32400664449889,CDK1;TTK;KNL1;CENPA;AURKB
26,GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),14/106,0.00204243233634,0.1403226660707707,0,0,2.6277598115542777,16.27532958865214,SPAG5;PLK1;KIF11;MKI67;CDC25C;PKMYT1;AURKB;AURKA;SIX3;NEK2;KIF20A;HORMAD1;FSD1;BUB1
27,GO_Biological_Process_2021,regulation of chromosome segregation (GO:0051983),5/18,0.0023694636343719,0.1569769657771419,0,0,6.614824155807763,39.9872183634903,KIF2C;HORMAD1;MKI67;BUB1;AURKB
28,GO_Biological_Process_2021,mitotic spindle assembly (GO:0090307),8/44,0.0025081492492762,0.1604350640485302,0,0,3.8277016742770167,22.921082012106524,TPX2;KIF4B;KIFC1;KIF4A;KIF23;KIF11;MISP;AURKB
29,GO_Biological_Process_2021,centromeric sister chromatid cohesion (GO:0070601),3/6,0.0029499106313213,0.1689145510444993,0,0,17.176363636363636,100.0691579498174,SGO1;BUB1B;BUB1
30,GO_Biological_Process_2021,negative regulation of cytokinesis (GO:0032466),3/6,0.0029499106313213,0.1689145510444993,0,0,17.176363636363636,100.0691579498174,AURKB;E2F7;E2F8
31,GO_Biological_Process_2021,piRNA metabolic process (GO:0034587),5/19,0.0030712465654416,0.1689145510444993,0,0,6.142011449388499,35.53566214578461,TDRD1;ASZ1;MAEL;TDRD12;TEX15
32,GO_Biological_Process_2021,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),4/12,0.0031870670008396,0.1689145510444993,0,0,8.593721565059145,49.4023337456292,CENPE;NUF2;KIF2C;NDC80
33,GO_Biological_Process_2021,negative regulation of cell division (GO:0051782),4/12,0.0031870670008396,0.1689145510444993,0,0,8.593721565059145,49.4023337456292,ORC6;AURKB;E2F7;E2F8
34,GO_Biological_Process_2021,protein localization to condensed chromosome (GO:1903083),4/12,0.0031870670008396,0.1689145510444993,0,0,8.593721565059145,49.4023337456292,CDK1;TTK;KNL1;AURKB
35,GO_Biological_Process_2021,centromere complex assembly (GO:0034508),7/37,0.0036563199946515,0.18840204416885,0,0,4.016697080291971,22.538884708297623,CENPE;CENPF;CENPI;HJURP;KNL1;CENPA;DLGAP5
36,GO_Biological_Process_2021,negative regulation of meiotic nuclear division (GO:0045835),3/7,0.0049512029351657,0.2482292282360105,0,0,12.881590909090908,68.37709106946104,DMRT1;HORMAD1;TRIP13
37,GO_Biological_Process_2021,protein localization to kinetochore (GO:0034501),4/14,0.0058996535288991,0.2833918147113833,0,0,6.87424931756142,35.28457072015436,CDK1;TTK;KNL1;AURKB
38,GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),10/72,0.0059581028429886,0.2833918147113833,0,0,2.779417406959242,14.238964168574242,ANLN;ESPL1;KIF4B;KIF4A;PLK1;KIF23;KIF20A;CENPA;CEP55;AURKB
39,GO_Biological_Process_2021,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),3/8,0.0075988634398786,0.3482967124452531,0,0,10.304727272727272,50.28456081989774,CENPE;UBE2C;PLK1
40,GO_Biological_Process_2021,placenta development (GO:0001890),4/15,0.0076982022696794,0.3482967124452531,0,0,6.248986682107701,30.4123712217744,PLAC1;E2F7;TEX19;E2F8
41,GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),9/64,0.0081797300075397,0.3612714086663384,0,0,2.81831477480472,13.545091747319551,PGLYRP4;CXCL10;CXCL9;PGLYRP3;CXCL11;H2BC10;H2BC11;CXCL13;S100A7
42,GO_Biological_Process_2021,extracellular structure organization (GO:0043062),21/216,0.0084603270949574,0.3649745758406063,0,0,1.8614247120716625,8.883402692378665,FBN2;POSTN;MMP1;COL11A1;COL22A1;FN1;DMP1;MMP10;HAPLN1;DSPP;ADAMTS20;COMP;MMP11;ACAN;ADAMTS14;MMP13;IBSP;ADAMTS19;COL9A1;COL10A1;MATN3
43,GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),21/217,0.0088961380920669,0.3681647586894148,0,0,1.851828624240824,8.74459035056156,FBN2;POSTN;MMP1;COL11A1;COL22A1;FN1;DMP1;MMP10;HAPLN1;DSPP;ADAMTS20;COMP;MMP11;ACAN;ADAMTS14;MMP13;IBSP;ADAMTS19;COL9A1;COL10A1;MATN3
44,GO_Biological_Process_2021,DNA packaging (GO:0006323),5/24,0.0089312205611987,0.3681647586894148,0,0,4.524494295848912,21.347478996884607,H1-5;H1-4;H1-6;H1-1;H1-3
45,GO_Biological_Process_2021,regulation of mitotic sister chromatid separation (GO:0010965),4/16,0.0098227595797667,0.3961134569666796,0,0,5.727934485896269,26.480545738845812,CENPE;PTTG1;UBE2C;PLK1
46,GO_Biological_Process_2021,positive regulation of synapse maturation (GO:0090129),3/9,0.01093484250717,0.4315772946978829,0,0,8.586818181818181,38.776362369214006,CDC20;NEUROD2;NEURL1
47,GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),5/26,0.012620349062447,0.4877239064758187,0,0,4.093156388238356,17.89710021301966,CENPE;ESPL1;UBE2C;PLK1;DLGAP5
48,GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),5/27,0.0148016725622751,0.5397098344605047,0,0,3.906896837224706,16.45981534449389,CDCA5;PLK1;CDK1;NCAPG;NCAPH
49,GO_Biological_Process_2021,epithelial structure maintenance (GO:0010669),4/18,0.0151293322867634,0.5397098344605047,0,0,4.909138177564019,20.57478662878344,MUC2;CRACD;TFF3;TFF1
50,GO_Biological_Process_2021,maintenance of gastrointestinal epithelium (GO:0030277),4/18,0.0151293322867634,0.5397098344605047,0,0,4.909138177564019,20.57478662878344,MUC2;CRACD;TFF3;TFF1
51,GO_Biological_Process_2021,microtubule depolymerization (GO:0007019),4/18,0.0151293322867634,0.5397098344605047,0,0,4.909138177564019,20.57478662878344,KIF18A;KIF18B;KIF14;KIF2C
52,GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),26/300,0.0154291994349022,0.5400219802215789,0,0,1.6408040718676506,6.84460351667677,FBN2;PRSS1;COL11A1;KLK4;DMP1;HAPLN1;COMP;SCUBE3;ACAN;ADAMTS14;IBSP;ADAMTS19;COL10A1;PRSS2;POSTN;MMP1;COL22A1;FN1;MMP10;DSPP;ADAMTS20;MMP11;MMP13;P4HA3;COL9A1;MATN3
53,GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),10/84,0.0170112173119496,0.5843668169197505,0,0,2.327217427857867,9.48080991237834,PLK1;KIF14;KIF23;KIF20A;FSD1;AURKB;E2F7;RXFP3;AURKA;E2F8
54,GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),6/39,0.0190199028988138,0.636124508503709,0,0,3.12654346565012,12.388207273767758,CDC20;ANLN;UBE2C;CDCA5;BUB1B;NEK2
55,GO_Biological_Process_2021,columnar/cuboidal epithelial cell differentiation (GO:0002065),3/11,0.0197755591381756,0.636124508503709,0,0,6.439431818181818,25.26387752772124,GATA5;GATA4;SOX11
56,GO_Biological_Process_2021,regulation of synapse maturation (GO:0090128),3/11,0.0197755591381756,0.636124508503709,0,0,6.439431818181818,25.26387752772124,CDC20;NEUROD2;NEURL1
57,GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),5/29,0.0198896072739704,0.636124508503709,0,0,3.5809426229508197,14.028550173747528,ESPL1;PLK1;CENPA;MISP;NDC80
58,GO_Biological_Process_2021,regulation of nuclear division (GO:0051783),4/20,0.021953211705093,0.6902238595414838,0,0,4.295040946314832,16.40208203175625,NEK2;CDC25C;MKI67;PKMYT1
59,GO_Biological_Process_2021,regulation of sister chromatid cohesion (GO:0007063),3/12,0.0253050684275088,0.7466371667912131,0,0,5.723636363636364,21.04438326367208,ESPL1;CDCA5;BUB1
60,GO_Biological_Process_2021,mitotic nuclear membrane disassembly (GO:0007077),3/12,0.0253050684275088,0.7466371667912131,0,0,5.723636363636364,21.04438326367208,CCNB2;PLK1;CDK1
61,GO_Biological_Process_2021,positive regulation of ubiquitin protein ligase activity (GO:1904668),3/12,0.0253050684275088,0.7466371667912131,0,0,5.723636363636364,21.04438326367208,CDC20;UBE2C;PLK1
62,GO_Biological_Process_2021,gastro-intestinal system smooth muscle contraction (GO:0014831),2/5,0.0271788182951392,0.7466371667912131,0,0,11.440508628519527,41.24666423068267,HTR1D;SULF1
63,GO_Biological_Process_2021,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),2/5,0.0271788182951392,0.7466371667912131,0,0,11.440508628519527,41.24666423068267,RET;SULF1
64,GO_Biological_Process_2021,meiotic sister chromatid segregation (GO:0045144),2/5,0.0271788182951392,0.7466371667912131,0,0,11.440508628519527,41.24666423068267,SGO1;HORMAD1
65,GO_Biological_Process_2021,melanin biosynthetic process (GO:0042438),2/5,0.0271788182951392,0.7466371667912131,0,0,11.440508628519527,41.24666423068267,TYRP1;TYR
66,GO_Biological_Process_2021,trophoblast giant cell differentiation (GO:0060707),2/5,0.0271788182951392,0.7466371667912131,0,0,11.440508628519527,41.24666423068267,E2F7;E2F8
67,GO_Biological_Process_2021,regulation of cyclin-dependent protein kinase activity (GO:1904029),7/54,0.028084600955495,0.7466371667912131,0,0,2.5615390588600713,9.15118502547418,CCNA2;CCNB2;CCNE1;CDC25C;PKMYT1;CCNP;CDKN3
68,GO_Biological_Process_2021,cellular component disassembly (GO:0022411),8/66,0.0281749874260835,0.7466371667912131,0,0,2.373043615178712,8.470153615400072,MMP11;SCUBE3;PRSS1;MMP13;MMP1;KLK4;PRSS2;MMP10
69,GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),8/66,0.0281749874260835,0.7466371667912131,0,0,2.373043615178712,8.470153615400072,MMP11;SCUBE3;PRSS1;MMP13;MMP1;KLK4;PRSS2;MMP10
70,GO_Biological_Process_2021,negative regulation of lymphocyte activation (GO:0051250),4/22,0.0303876788673444,0.7939316098440006,0,0,3.817409766454353,13.336953417304729,IL4I1;FOXJ1;SOX11;TIGIT
71,GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),9/82,0.036407485102325,0.9256329279743452,0,0,2.1213593448699006,7.02802297207419,CCNA2;CCNB2;CCNE1;CDKN2A;PLK1;CDC25C;PKMYT1;CCNP;CDKN3
72,GO_Biological_Process_2021,negative regulation of DNA recombination (GO:0045910),7/57,0.0364265249283704,0.9256329279743452,0,0,2.4074635036496352,7.974621893787227,H1-5;POLQ;H1-4;H1-6;ZSCAN4;H1-1;H1-3
73,GO_Biological_Process_2021,nuclear membrane disassembly (GO:0051081),3/14,0.0385777815817819,0.9524093975429972,0,0,4.682479338842975,15.241839109897615,CCNB2;PLK1;CDK1
74,GO_Biological_Process_2021,hepatocyte differentiation (GO:0070365),2/6,0.0392932992460053,0.9524093975429972,0,0,8.579927338782925,27.770661776496876,E2F7;E2F8
75,GO_Biological_Process_2021,neuroepithelial cell differentiation (GO:0060563),2/6,0.0392932992460053,0.9524093975429972,0,0,8.579927338782925,27.770661776496876,SOX11;DSPP
76,GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),7/58,0.0395339749923508,0.9524093975429972,0,0,2.360133104336626,7.624633853088721,ESPL1;UBE2C;CDCA5;CDK1;CDC25C;DTL;DLGAP5
77,GO_Biological_Process_2021,establishment of mitotic spindle orientation (GO:0000132),4/24,0.0404863021917341,0.9628473149444456,0,0,3.435304822565969,11.01630657824745,PLK1;CENPA;MISP;NDC80
78,GO_Biological_Process_2021,regulation of cell cycle G2/M phase transition (GO:1902749),9/85,0.0442969426625527,0.9999959186369975,0,0,2.037296738189166,6.349927188640305,TPX2;CENPF;PLK1;KIF14;CDK1;NEK2;HMMR;GTSE1;AURKA
79,GO_Biological_Process_2021,negative regulation of DNA metabolic process (GO:0051053),5/36,0.0461161809859831,0.9999959186369975,0,0,2.7713144133027794,8.526202071369502,H1-5;H1-4;H1-6;H1-1;H1-3
80,GO_Biological_Process_2021,regulation of T cell chemotaxis (GO:0010819),3/15,0.0462976877542246,0.9999959186369975,0,0,4.2920454545454545,13.18801037693185,CXCL10;CXCL13;S100A7
81,GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),10/101,0.0518195471976931,0.9999959186369975,0,0,1.890753345465148,5.596606914551649,DMRT1;SPAG5;KIF14;KIF23;NDC80;AURKB;E2F7;RXFP3;AURKA;E2F8
82,GO_Biological_Process_2021,adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,HTR1E;HTR1D
83,GO_Biological_Process_2021,glandular epithelial cell development (GO:0002068),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,CDH2;PAX6
84,GO_Biological_Process_2021,type B pancreatic cell development (GO:0003323),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,CDH2;NKX6-1
85,GO_Biological_Process_2021,negative regulation of lymphocyte differentiation (GO:0045620),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,IFNL1;INHBA
86,GO_Biological_Process_2021,noradrenergic neuron differentiation (GO:0003357),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,SOX11;ASCL1
87,GO_Biological_Process_2021,pituitary gland development (GO:0021983),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,SOX2;SIX3
88,GO_Biological_Process_2021,positive regulation of synaptic plasticity (GO:0031915),2/7,0.0530301622261317,0.9999959186369975,0,0,6.863578564940963,20.15760564831268,CDC20;NEUROD2
89,GO_Biological_Process_2021,oogenesis (GO:0048477),3/16,0.0547149898082294,0.9999959186369975,0,0,3.961678321678322,11.511122139669553,STRA8;HORMAD1;TRIP13
90,GO_Biological_Process_2021,microtubule polymerization or depolymerization (GO:0031109),4/27,0.0587808002973111,0.9999959186369975,0,0,2.986746844957867,8.464261362624438,KIF18A;KIF18B;KIF14;KIF2C
91,GO_Biological_Process_2021,positive regulation of calcium ion transmembrane transport (GO:1904427),4/27,0.0587808002973111,0.9999959186369975,0,0,2.986746844957867,8.464261362624438,CXCL10;CEMIP;CXCL9;CXCL11
92,GO_Biological_Process_2021,DNA replication-independent nucleosome assembly (GO:0006336),5/39,0.0616346378567443,0.9999959186369975,0,0,2.526384870888246,7.0398504266324595,CENPI;HJURP;KNL1;CENPA;ASF1B
93,GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),7/64,0.0617788621824362,0.9999959186369975,0,0,2.11102573953131,5.877505216655795,RRM2;ESPL1;DMRT1;NEK2;AURKB;E2F7;E2F8
94,GO_Biological_Process_2021,positive regulation of stem cell proliferation (GO:2000648),3/17,0.0638052550458572,0.9999959186369975,0,0,3.6785064935064935,10.12295457630502,TERT;CCNE1;SOX11
95,GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),4/28,0.065707342515711,0.9999959186369975,0,0,2.862147406733394,7.792323970916565,RET;TERT;IFI6;INHBA
96,GO_Biological_Process_2021,positive regulation of cell communication (GO:0010647),4/28,0.065707342515711,0.9999959186369975,0,0,2.862147406733394,7.792323970916565,SYT1;CD80;NMU;SOX11
97,GO_Biological_Process_2021,protein depolymerization (GO:0051261),4/28,0.065707342515711,0.9999959186369975,0,0,2.862147406733394,7.792323970916565,KIF18A;KIF18B;KIF14;KIF2C
98,GO_Biological_Process_2021,proximal/distal pattern formation (GO:0009954),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,HOXB9;SIX3
99,GO_Biological_Process_2021,cellular response to interleukin-21 (GO:0098757),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,IL21;IL21R
100,GO_Biological_Process_2021,regulation of protein localization to cell cortex (GO:1904776),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,PLK1;MISP
101,GO_Biological_Process_2021,interleukin-21-mediated signaling pathway (GO:0038114),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,IL21;IL21R
102,GO_Biological_Process_2021,tyrosine phosphorylation of STAT protein (GO:0007260),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,IL21;IFNL4
103,GO_Biological_Process_2021,negative regulation of chromosome organization (GO:2001251),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,TOP2A;ESPL1
104,GO_Biological_Process_2021,neuron fate specification (GO:0048665),2/8,0.0681739502655982,0.9999959186369975,0,0,5.7193460490463215,15.360406207302534,ASCL1;MNX1
105,GO_Biological_Process_2021,regulation of DNA recombination (GO:0000018),5/42,0.0797534581906915,0.9999959186369975,0,0,2.3211736326490424,5.869819106899171,H1-5;H1-4;H1-6;H1-1;H1-3
106,GO_Biological_Process_2021,CENP-A containing chromatin organization (GO:0061641),4/30,0.0807649356977681,0.9999959186369975,0,0,2.641702246797788,6.6470838759550706,CENPI;HJURP;KNL1;CENPA
107,GO_Biological_Process_2021,CENP-A containing nucleosome assembly (GO:0034080),4/30,0.0807649356977681,0.9999959186369975,0,0,2.641702246797788,6.6470838759550706,CENPI;HJURP;KNL1;CENPA
108,GO_Biological_Process_2021,establishment of spindle orientation (GO:0051294),4/30,0.0807649356977681,0.9999959186369975,0,0,2.641702246797788,6.6470838759550706,PLK1;CENPA;MISP;NDC80
109,GO_Biological_Process_2021,positive regulation of monocyte chemotaxis (GO:0090026),3/19,0.0838896376688888,0.9999959186369975,0,0,3.2183522727272726,7.975891758285179,CXCL10;S100A14;S100A7
110,GO_Biological_Process_2021,adult heart development (GO:0007512),2/9,0.0845280002165119,0.9999959186369975,0,0,4.9020371091215775,12.111327965749702,MYH6;MYH7
111,GO_Biological_Process_2021,regulation of mitotic centrosome separation (GO:0046602),2/9,0.0845280002165119,0.9999959186369975,0,0,4.9020371091215775,12.111327965749702,NEK2;KIF11
112,GO_Biological_Process_2021,intestinal epithelial cell differentiation (GO:0060575),2/9,0.0845280002165119,0.9999959186369975,0,0,4.9020371091215775,12.111327965749702,GATA5;GATA4
113,GO_Biological_Process_2021,phenol-containing compound biosynthetic process (GO:0046189),2/9,0.0845280002165119,0.9999959186369975,0,0,4.9020371091215775,12.111327965749702,TYRP1;TYR
114,GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",6/56,0.0869721987401356,0.9999959186369975,0,0,2.061659070191431,5.034915264264827,CDK1;CDC25C;GTSE1;E2F7;AURKA;E2F8
115,GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),4/31,0.0888777442444515,0.9999959186369975,0,0,2.5437266201597413,6.1570737848771655,CDC20;UBE2C;PLK1;MAGEC2
116,GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),8/84,0.0915016824700677,0.9999959186369975,0,0,1.8092766161980296,4.326700335267016,CDC20;PTTG1;UBE2C;PLK1;CDK1;BUB1B;AURKB;AURKA
117,GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),6/57,0.0929187518366771,0.9999959186369975,0,0,2.021127138184353,4.802258317668042,DMRT1;NEK2;MKI67;CDC25C;PKMYT1;AURKA
118,GO_Biological_Process_2021,skeletal muscle contraction (GO:0003009),3/20,0.0948196038120817,0.9999959186369975,0,0,3.0288770053475935,7.135365145162148,CCDC78;TNNT1;MYH7
119,GO_Biological_Process_2021,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/20,0.0948196038120817,0.9999959186369975,0,0,3.0288770053475935,7.135365145162148,CDK1;CDC25C;DTL
120,GO_Biological_Process_2021,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",8/85,0.0964060732380702,0.9999959186369975,0,0,1.7856846349997035,4.177048639595431,CENPE;KIF18A;KIF4B;KIF4A;KIF23;KIF2C;KIF11;KIF15
121,GO_Biological_Process_2021,chromatin remodeling at centromere (GO:0031055),4/32,0.0973654543023006,0.9999959186369975,0,0,2.452749252567269,5.713149123671096,CENPI;HJURP;KNL1;CENPA
122,GO_Biological_Process_2021,mitotic G2/M transition checkpoint (GO:0044818),5/45,0.1003984759867819,0.9999959186369975,0,0,2.1467440801457194,4.934523655954141,PLK1;CDK1;HUS1B;CLSPN;DTL
123,GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),5/45,0.1003984759867819,0.9999959186369975,0,0,2.1467440801457194,4.934523655954141,IL4I1;IFNL1;CD80;TIGIT;FOXP3
124,GO_Biological_Process_2021,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,SPAG5;NEK2
125,GO_Biological_Process_2021,cellular response to acetylcholine (GO:1905145),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,LYPD1;LY6H
126,GO_Biological_Process_2021,G protein-coupled serotonin receptor signaling pathway (GO:0098664),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,HTR1E;HTR1D
127,GO_Biological_Process_2021,granulocyte migration (GO:0097530),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,CD177;UMODL1
128,GO_Biological_Process_2021,indolalkylamine catabolic process (GO:0046218),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,IL4I1;TDO2
129,GO_Biological_Process_2021,L-glutamate transmembrane transport (GO:0015813),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,SLC1A1;SLC1A6
130,GO_Biological_Process_2021,lung epithelium development (GO:0060428),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,FOXJ1;ASCL1
131,GO_Biological_Process_2021,mitotic DNA replication checkpoint signaling (GO:0033314),2/10,0.1019130281078252,0.9999959186369975,0,0,4.28905540417802,9.79463916114625,HUS1B;CLSPN
132,GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),6/59,0.1054486208817084,0.9999959186369975,0,0,1.9446517947747717,4.374555372719155,EME1;PLK1;CDK1;HUS1B;CLSPN;DTL
133,GO_Biological_Process_2021,mitotic G2 DNA damage checkpoint signaling (GO:0007095),4/33,0.1062157318213872,0.9999959186369975,0,0,2.368046186188071,5.30982981835587,PLK1;CDK1;CLSPN;DTL
134,GO_Biological_Process_2021,autonomic nervous system development (GO:0048483),3/21,0.1062954015166313,0.9999959186369975,0,0,2.860454545454546,6.411803985352055,FN1;SOX11;ASCL1
135,GO_Biological_Process_2021,regulation of transposition (GO:0010528),3/21,0.1062954015166313,0.9999959186369975,0,0,2.860454545454546,6.411803985352055,TEX15;TEX19;APOBEC3B
136,GO_Biological_Process_2021,regulation of ubiquitin protein ligase activity (GO:1904666),3/21,0.1062954015166313,0.9999959186369975,0,0,2.860454545454546,6.411803985352055,CDC20;UBE2C;PLK1
137,GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",7/74,0.1129407952604103,0.9999959186369975,0,0,1.7949940080618805,3.9146872345434938,CDK1;FOXM1;CDC25C;GTSE1;E2F7;AURKA;E2F8
138,GO_Biological_Process_2021,positive regulation of calcium ion transport into cytosol (GO:0010524),4/34,0.1154151990430617,0.9999959186369975,0,0,2.288989990900819,4.942431196707942,CXCL10;CEMIP;CXCL9;CXCL11
139,GO_Biological_Process_2021,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),4/34,0.1154151990430617,0.9999959186369975,0,0,2.288989990900819,4.942431196707942,CXCL10;CEMIP;CXCL9;CXCL11
140,GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),16/209,0.1159217550544062,0.9999959186369975,0,0,1.4264863602347098,3.07384964148201,CDKN2A;UBE2C;PLK1;INHBA;CDC25C;PKMYT1;FOXM1;AURKA;CCNA2;CCNB2;MELK;CCNE1;CDK1;NEK2;CCNP;CDKN3
141,GO_Biological_Process_2021,cell proliferation in forebrain (GO:0021846),2/11,0.1201658132162587,0.9999959186369975,0,0,3.8122918558885863,8.077799311012534,SIX3;KIF14
142,GO_Biological_Process_2021,cellular response to UV-A (GO:0071492),2/11,0.1201658132162587,0.9999959186369975,0,0,3.8122918558885863,8.077799311012534,MMP1;OPN5
143,GO_Biological_Process_2021,T cell chemotaxis (GO:0010818),2/11,0.1201658132162587,0.9999959186369975,0,0,3.8122918558885863,8.077799311012534,CXCL10;CXCL11
144,GO_Biological_Process_2021,tryptophan catabolic process (GO:0006569),2/11,0.1201658132162587,0.9999959186369975,0,0,3.8122918558885863,8.077799311012534,IL4I1;TDO2
145,GO_Biological_Process_2021,tryptophan metabolic process (GO:0006568),2/11,0.1201658132162587,0.9999959186369975,0,0,3.8122918558885863,8.077799311012534,IL4I1;TDO2
146,GO_Biological_Process_2021,positive regulation of DNA-dependent DNA replication (GO:2000105),2/11,0.1201658132162587,0.9999959186369975,0,0,3.8122918558885863,8.077799311012534,E2F7;E2F8
147,GO_Biological_Process_2021,regulation of cell division (GO:0051302),7/76,0.1252370951740849,0.9999959186369975,0,0,1.742780069819105,3.620706768285786,ORC6;KIF18B;PLK1;KIF20A;FSD1;AURKB;AURKA
148,GO_Biological_Process_2021,mitotic cell cycle checkpoint signaling (GO:0007093),3/23,0.1307389035811518,0.9999959186369975,0,0,2.574136363636363,5.237216982253092,BUB1B;BUB1;AURKB
149,GO_Biological_Process_2021,positive regulation of cell cycle G2/M phase transition (GO:1902751),3/23,0.1307389035811518,0.9999959186369975,0,0,2.574136363636363,5.237216982253092,CDK1;CDC25C;DTL
150,GO_Biological_Process_2021,neutrophil migration (GO:1990266),7/77,0.1316295733837327,0.9999959186369975,0,0,1.7177919708029197,3.483275968197888,CXCL10;CXCL9;CXCL11;CCL11;CXCL13;CD177;UMODL1
151,GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),4/36,0.1348037399271047,0.9999959186369975,0,0,2.145700636942675,4.299845328182704,DMRT1;ESPL1;DLGAP5;AURKA
152,GO_Biological_Process_2021,cell cycle checkpoint signaling (GO:0000075),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,BUB1B;BUB1
153,GO_Biological_Process_2021,ganglion development (GO:0061548),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,TUBB3;ASCL1
154,GO_Biological_Process_2021,replicative senescence (GO:0090399),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,TERT;CDKN2A
155,GO_Biological_Process_2021,tyrosine metabolic process (GO:0006570),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,IL4I1;TYR
156,GO_Biological_Process_2021,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,LIN28B;TERT
157,GO_Biological_Process_2021,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,ESPL1;DLGAP5
158,GO_Biological_Process_2021,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,ESPL1;DLGAP5
159,GO_Biological_Process_2021,positive regulation of mitotic sister chromatid separation (GO:1901970),2/12,0.1391379741645733,0.9999959186369975,0,0,3.430881017257039,6.766689639550565,ESPL1;DLGAP5
160,GO_Biological_Process_2021,negative regulation of neuron differentiation (GO:0045665),3/24,0.1436321381606894,0.9999959186369975,0,0,2.4514285714285715,4.756996760583398,SOX2;SIX3;ASCL1
161,GO_Biological_Process_2021,ncRNA metabolic process (GO:0034660),4/37,0.1449619736646871,0.9999959186369975,0,0,2.080569112416246,4.018169466412878,TDRD1;ASZ1;MAEL;TDRD12
162,GO_Biological_Process_2021,positive regulation of cytokinesis (GO:0032467),4/37,0.1449619736646871,0.9999959186369975,0,0,2.080569112416246,4.018169466412878,KIF14;KIF23;AURKB;RXFP3
163,GO_Biological_Process_2021,mitotic G1 DNA damage checkpoint signaling (GO:0031571),6/65,0.1478702875449389,0.9999959186369975,0,0,1.746334378814332,3.337978152778559,CDK1;CDC25C;GTSE1;E2F7;AURKA;E2F8
164,GO_Biological_Process_2021,histone exchange (GO:0043486),4/38,0.1554079497049833,0.9999959186369975,0,0,2.0192688540384305,3.759276229958373,CENPI;HJURP;KNL1;CENPA
165,GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),4/38,0.1554079497049833,0.9999959186369975,0,0,2.0192688540384305,3.759276229958373,SYT1;CD80;NMU;SOX11
166,GO_Biological_Process_2021,positive regulation of T cell migration (GO:2000406),3/25,0.1569229627425196,0.9999959186369975,0,0,2.3398760330578514,4.33345106189966,CXCL10;CXCL13;S100A7
167,GO_Biological_Process_2021,establishment of protein localization to chromosome (GO:0070199),2/13,0.1586948308866987,0.9999959186369975,0,0,3.1188176038312276,5.741032815553097,H1-5;TERT
168,GO_Biological_Process_2021,mitotic DNA integrity checkpoint signaling (GO:0044774),2/13,0.1586948308866987,0.9999959186369975,0,0,3.1188176038312276,5.741032815553097,HUS1B;CLSPN
169,GO_Biological_Process_2021,skeletal system development (GO:0001501),12/158,0.1633438023295106,0.9999959186369975,0,0,1.4126288562711098,2.5595395162509087,COMP;ACAN;CLEC3A;COL10A1;SOX11;SULF1;PITX1;HAPLN1;NKX3-2;MATN3;PAX1;DSPP
170,GO_Biological_Process_2021,protein monoubiquitination (GO:0006513),4/39,0.1661249026301055,0.9999959186369975,0,0,1.9614714675679188,3.5208713890920196,UHRF1;UBE2T;NEURL1;DTL
171,GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),4/39,0.1661249026301055,0.9999959186369975,0,0,1.9614714675679188,3.5208713890920196,IL4I1;CD80;SOX11;FOXP3
172,GO_Biological_Process_2021,regulation of monocyte chemotaxis (GO:0090025),3/26,0.1705739577391994,0.9999959186369975,0,0,2.23802371541502,3.95813809688001,CXCL10;S100A14;S100A7
173,GO_Biological_Process_2021,negative regulation of transposition (GO:0010529),3/26,0.1705739577391994,0.9999959186369975,0,0,2.23802371541502,3.95813809688001,TEX15;TEX19;APOBEC3B
174,GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),8/98,0.1728876284258603,0.9999959186369975,0,0,1.5266971080669711,2.6795266165400533,CENPE;KIF18A;KIF4B;KIF4A;KIF23;KIF2C;KIF11;KIF15
175,GO_Biological_Process_2021,striated muscle contraction (GO:0006941),5/54,0.1758774911992762,0.9999959186369975,0,0,1.7516077469239062,3.0442375103925423,CCDC78;SMPX;TNNT1;MYH6;MYH7
176,GO_Biological_Process_2021,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),4/40,0.1770957179684966,0.9999959186369975,0,0,1.9068850470124352,3.3009417981864613,CST2;CST1;TAS2R30;CST4
177,GO_Biological_Process_2021,C4-dicarboxylate transport (GO:0015740),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,SLC1A1;SLC1A6
178,GO_Biological_Process_2021,regulation of cell projection organization (GO:0031344),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,NTNG1;ERMN
179,GO_Biological_Process_2021,cell junction maintenance (GO:0034331),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,CBLN2;CD177
180,GO_Biological_Process_2021,detection of bacterium (GO:0016045),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,PGLYRP4;PGLYRP3
181,GO_Biological_Process_2021,response to UV-A (GO:0070141),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,MMP1;OPN5
182,GO_Biological_Process_2021,negative regulation of T cell differentiation (GO:0045581),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,IFNL1;FOXJ1
183,GO_Biological_Process_2021,negative regulation of T cell mediated immunity (GO:0002710),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,IL4I1;FOXP3
184,GO_Biological_Process_2021,neuron fate commitment (GO:0048663),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,PAX6;ASCL1
185,GO_Biological_Process_2021,positive regulation of regulatory T cell differentiation (GO:0045591),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,IL4I1;FOXP3
186,GO_Biological_Process_2021,positive regulation of T cell chemotaxis (GO:0010820),2/14,0.1787143470054946,0.9999959186369975,0,0,2.8587647593097185,4.9226973602163255,CXCL13;S100A7
187,GO_Biological_Process_2021,G2/M transition of mitotic cell cycle (GO:0000086),10/130,0.1808448178675022,0.9999959186369975,0,0,1.4316102470265324,2.448219553854028,CCNA2;CCNB2;MELK;PLK1;CDK1;NEK2;CDC25C;PKMYT1;FOXM1;AURKA
188,GO_Biological_Process_2021,positive regulation of BMP signaling pathway (GO:0030513),3/27,0.1845481061136127,0.9999959186369975,0,0,2.144659090909091,3.62414168113129,FOXD1;SOX11;SULF1
189,GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),8/100,0.186571950692479,0.9999959186369975,0,0,1.4933492158030577,2.507241223105885,CENPE;KIF18A;KIF4B;KIF4A;KIF23;KIF2C;KIF11;KIF15
190,GO_Biological_Process_2021,cell cycle G2/M phase transition (GO:0044839),10/131,0.1868350027426146,0.9999959186369975,0,0,1.4197031447301762,2.381593750206794,CCNA2;CCNB2;MELK;PLK1;CDK1;NEK2;CDC25C;PKMYT1;FOXM1;AURKA
191,GO_Biological_Process_2021,sensory perception of bitter taste (GO:0050913),4/41,0.1883030277564728,0.9999959186369975,0,0,1.8552492437842756,3.0977147902914046,CST2;CST1;TAS2R30;CST4
192,GO_Biological_Process_2021,chemokine-mediated signaling pathway (GO:0070098),5/56,0.1949851168760968,0.9999959186369975,0,0,1.6827386692381872,2.750995103269949,CXCL10;CXCL9;CXCL11;CCL11;CXCL13
193,GO_Biological_Process_2021,sarcomere organization (GO:0045214),3/28,0.1988090007617774,0.9999959186369975,0,0,2.0587636363636364,3.3257488282051573,SYNPO2L;TNNT1;MYH6
194,GO_Biological_Process_2021,regulation of integrin activation (GO:0033623),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,KIF14;CXCL13
195,GO_Biological_Process_2021,detection of mechanical stimulus involved in sensory perception (GO:0050974),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,COL11A1;SCN1A
196,GO_Biological_Process_2021,endoderm development (GO:0007492),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,GATA4;HOXC11
197,GO_Biological_Process_2021,G protein-coupled glutamate receptor signaling pathway (GO:0007216),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,GRM4;GRM8
198,GO_Biological_Process_2021,synaptonemal complex assembly (GO:0007130),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,HORMAD1;TRIP13
199,GO_Biological_Process_2021,synaptonemal complex organization (GO:0070193),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,HORMAD1;TRIP13
200,GO_Biological_Process_2021,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),2/15,0.1990861468378354,0.9999959186369975,0,0,2.6387200447145953,4.258940723595559,EME1;HUS1B
201,GO_Biological_Process_2021,skeletal system morphogenesis (GO:0048705),4/42,0.1997293001002153,0.9999959186369975,0,0,1.8063311144102296,2.909624302257872,FBN2;HOXB9;MMP13;SOX11
202,GO_Biological_Process_2021,"positive regulation of gene expression, epigenetic (GO:0045815)",5/57,0.2047991916217154,0.9999959186369975,0,0,1.6502907384054926,2.6169078306787363,H1-5;H1-4;H1-6;H1-1;H1-3
203,GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),8/103,0.2079225248060388,0.9999959186369975,0,0,1.4459601057438116,2.271010114572415,CENPE;KIF18A;KIF4B;KIF4A;KIF23;KIF2C;KIF11;KIF15
204,GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),4/43,0.2113569224699474,0.9999959186369975,0,0,1.759921607055365,2.7352824792392756,ZFP42;GATA4;INHBA;TEX19
205,GO_Biological_Process_2021,signal release from synapse (GO:0099643),4/43,0.2113569224699474,0.9999959186369975,0,0,1.759921607055365,2.7352824792392756,GRM4;HRH3;SYT1;GAD1
206,GO_Biological_Process_2021,male gonad development (GO:0008584),4/43,0.2113569224699474,0.9999959186369975,0,0,1.759921607055365,2.7352824792392756,ZFP42;GATA4;INHBA;TEX19
207,GO_Biological_Process_2021,positive regulation of neuron differentiation (GO:0045666),4/43,0.2113569224699474,0.9999959186369975,0,0,1.759921607055365,2.7352824792392756,NEUROD2;SOX11;ASCL1;BRINP3
208,GO_Biological_Process_2021,glial cell differentiation (GO:0010001),3/29,0.2133210201405847,0.9999959186369975,0,0,1.9794755244755244,3.0582047876944047,SOX2;CDH2;SOX11
209,GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),6/73,0.2141863503495359,0.9999959186369975,0,0,1.537163770935659,2.3686292537033093,GRM4;HRH3;SYT1;GAD1;SLC1A1;SLC1A6
210,GO_Biological_Process_2021,aromatic amino acid family catabolic process (GO:0009074),2/16,0.2197106022490427,0.9999959186369975,0,0,2.4501102893473465,3.7130050424607135,IL4I1;TDO2
211,GO_Biological_Process_2021,digestive tract morphogenesis (GO:0048546),2/16,0.2197106022490427,0.9999959186369975,0,0,2.4501102893473465,3.7130050424607135,PERCC1;SOX11
212,GO_Biological_Process_2021,resolution of meiotic recombination intermediates (GO:0000712),2/16,0.2197106022490427,0.9999959186369975,0,0,2.4501102893473465,3.7130050424607135,TOP2A;EME1
213,GO_Biological_Process_2021,sympathetic nervous system development (GO:0048485),2/16,0.2197106022490427,0.9999959186369975,0,0,2.4501102893473465,3.7130050424607135,SOX11;ASCL1
214,GO_Biological_Process_2021,mitotic sister chromatid cohesion (GO:0007064),2/16,0.2197106022490427,0.9999959186369975,0,0,2.4501102893473465,3.7130050424607135,SGO1;CDCA5
215,GO_Biological_Process_2021,negative regulation of anoikis (GO:2000811),2/16,0.2197106022490427,0.9999959186369975,0,0,2.4501102893473465,3.7130050424607135,CEACAM6;CEACAM5
216,GO_Biological_Process_2021,cardiac ventricle morphogenesis (GO:0003208),4/44,0.2231682789381404,0.9999959186369975,0,0,1.715832575068244,2.5734557606977275,GATA4;SOX11;MYH6;MYH7
217,GO_Biological_Process_2021,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),4/44,0.2231682789381404,0.9999959186369975,0,0,1.715832575068244,2.5734557606977275,CST2;CST1;TAS2R30;CST4
218,GO_Biological_Process_2021,lymphocyte chemotaxis (GO:0048247),4/44,0.2231682789381404,0.9999959186369975,0,0,1.715832575068244,2.5734557606977275,CXCL10;CXCL11;CCL11;CXCL13
219,GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),4/44,0.2231682789381404,0.9999959186369975,0,0,1.715832575068244,2.5734557606977275,GRM4;HRH3;SYT1;GAD1
220,GO_Biological_Process_2021,positive regulation of cell division (GO:0051781),4/44,0.2231682789381404,0.9999959186369975,0,0,1.715832575068244,2.5734557606977275,KIF14;KIF23;AURKB;RXFP3
221,GO_Biological_Process_2021,regulation of catecholamine secretion (GO:0050433),3/30,0.2280494756339386,0.9999959186369975,0,0,1.906060606060606,2.817524826316455,HRH3;SYT1;SYT13
222,GO_Biological_Process_2021,potassium ion transport (GO:0006813),9/122,0.2311298438112624,0.9999959186369975,0,0,1.3675235799453171,2.003115216028026,KCNG1;SLC24A2;KCNF1;KCNG3;SLC9A4;KCNJ6;LRRC52;KCNH1;KCNJ3
223,GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),5/60,0.2351563445739398,0.9999959186369975,0,0,1.560026494452724,2.2581456672289364,GRM4;HRH3;HTR1E;GRM8;HTR1D
224,GO_Biological_Process_2021,cellular response to chemokine (GO:1990869),5/60,0.2351563445739398,0.9999959186369975,0,0,1.560026494452724,2.2581456672289364,CXCL10;CXCL9;CXCL11;CCL11;CXCL13
225,GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),13/188,0.2389686380977032,0.9999959186369975,0,0,1.2759423328964614,1.8264131471281535,UBE2C;PLK1;KIF14;BUB1B;HMMR;AURKA;CDC20;ANLN;TPX2;CENPE;CENPF;CDK1;NEK2
226,GO_Biological_Process_2021,DNA replication checkpoint signaling (GO:0000076),2/17,0.2404979847671061,0.9999959186369975,0,0,2.286648501362398,3.2585737410142146,HUS1B;CLSPN
227,GO_Biological_Process_2021,regulation of stem cell proliferation (GO:0072091),2/17,0.2404979847671061,0.9999959186369975,0,0,2.286648501362398,3.2585737410142146,TERT;SOX11
228,GO_Biological_Process_2021,stem cell development (GO:0048864),2/17,0.2404979847671061,0.9999959186369975,0,0,2.286648501362398,3.2585737410142146,CDH2;SOX11
229,GO_Biological_Process_2021,midbody abscission (GO:0061952),2/17,0.2404979847671061,0.9999959186369975,0,0,2.286648501362398,3.2585737410142146,KIF20A;CEP55
230,GO_Biological_Process_2021,negative regulation of cell aging (GO:0090344),2/17,0.2404979847671061,0.9999959186369975,0,0,2.286648501362398,3.2585737410142146,TERT;FOXM1
231,GO_Biological_Process_2021,positive regulation of telomere capping (GO:1904355),2/17,0.2404979847671061,0.9999959186369975,0,0,2.286648501362398,3.2585737410142146,NEK2;AURKB
232,GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),3/31,0.2429607336276587,0.9999959186369975,0,0,1.8378896103896103,2.6003481110052107,CXCL10;S100A14;S100A7
233,GO_Biological_Process_2021,DNA replication (GO:0006260),8/108,0.2454571720670477,0.9999959186369975,0,0,1.373296803652968,1.928977732941345,FAM111B;BRIP1;ORC6;EXO1;PCLAF;CDK1;MCM10;CLSPN
234,GO_Biological_Process_2021,response to light stimulus (GO:0009416),5/61,0.2455447811391215,0.9999959186369975,0,0,1.5320875618006766,2.1514737017502545,PCLAF;GPR52;TYR;DTL;OPN5
235,GO_Biological_Process_2021,receptor-mediated virion attachment to host cell (GO:0046813),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,LRRC15
236,GO_Biological_Process_2021,antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CD1A
237,GO_Biological_Process_2021,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)",1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CD1A
238,GO_Biological_Process_2021,"antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)",1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CD1A
239,GO_Biological_Process_2021,apoptotic chromosome condensation (GO:0030263),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,TOP2A
240,GO_Biological_Process_2021,atrial cardiac muscle cell membrane repolarization (GO:0099624),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,KCNJ3
241,GO_Biological_Process_2021,atrial cardiac muscle tissue morphogenesis (GO:0055009),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,MYH6
242,GO_Biological_Process_2021,regulation of barbed-end actin filament capping (GO:2000812),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CRACD
243,GO_Biological_Process_2021,regulation of cardioblast differentiation (GO:0051890),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,GATA4
244,GO_Biological_Process_2021,regulation of circadian sleep/wake cycle (GO:0042749),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,HCRTR2
245,GO_Biological_Process_2021,regulation of core promoter binding (GO:1904796),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,PAX6
246,GO_Biological_Process_2021,regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,UHRF1
247,GO_Biological_Process_2021,regulation of endothelial tube morphogenesis (GO:1901509),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CXCL10
248,GO_Biological_Process_2021,cellular response to erythropoietin (GO:0036018),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,EPO
249,GO_Biological_Process_2021,cellular response to heparin (GO:0071504),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,AOC1
250,GO_Biological_Process_2021,regulation of germinal center formation (GO:0002634),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,FOXJ1
251,GO_Biological_Process_2021,cellular response to vitamin (GO:0071295),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,POSTN
252,GO_Biological_Process_2021,cerebral cortex neuron differentiation (GO:0021895),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,ASCL1
253,GO_Biological_Process_2021,regulation of kidney development (GO:0090183),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,FOXD1
254,GO_Biological_Process_2021,chronic inflammatory response (GO:0002544),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CXCL13
255,GO_Biological_Process_2021,regulation of metaphase plate congression (GO:0090235),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SPAG5
256,GO_Biological_Process_2021,de novo centriole assembly (GO:0097742),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CCDC78
257,GO_Biological_Process_2021,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CCDC78
258,GO_Biological_Process_2021,regulation of miRNA catabolic process (GO:2000625),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,LIN28B
259,GO_Biological_Process_2021,deoxyribonucleotide metabolic process (GO:0009262),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,RRM2
260,GO_Biological_Process_2021,regulation of neutrophil degranulation (GO:0043313),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CD177
261,GO_Biological_Process_2021,endodermal cell fate specification (GO:0001714),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SOX2
262,GO_Biological_Process_2021,regulation of protein kinase C activity (GO:1900019),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CEMIP
263,GO_Biological_Process_2021,enteroendocrine cell differentiation (GO:0035883),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,PERCC1
264,GO_Biological_Process_2021,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,IL4I1
265,GO_Biological_Process_2021,establishment of monopolar cell polarity (GO:0061162),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,FOXJ1
266,GO_Biological_Process_2021,establishment of protein localization to telomere (GO:0070200),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,TERT
267,GO_Biological_Process_2021,regulation of sequestering of zinc ion (GO:0061088),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SLC30A8
268,GO_Biological_Process_2021,forebrain regionalization (GO:0021871),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SIX3
269,GO_Biological_Process_2021,gamma-aminobutyric acid metabolic process (GO:0009448),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,GAD1
270,GO_Biological_Process_2021,glomerular visceral epithelial cell migration (GO:0090521),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,ANLN
271,GO_Biological_Process_2021,glutamate catabolic process (GO:0006538),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,GAD1
272,GO_Biological_Process_2021,hemoglobin metabolic process (GO:0020027),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,INHBA
273,GO_Biological_Process_2021,L-aspartate transmembrane transport (GO:0070778),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SLC1A1
274,GO_Biological_Process_2021,L-phenylalanine catabolic process (GO:0006559),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,IL4I1
275,GO_Biological_Process_2021,lung morphogenesis (GO:0060425),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SOX11
276,GO_Biological_Process_2021,membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,KCNJ3
277,GO_Biological_Process_2021,tryptophan catabolic process to kynurenine (GO:0019441),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,TDO2
278,GO_Biological_Process_2021,negative regulation of B cell differentiation (GO:0045578),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,INHBA
279,GO_Biological_Process_2021,negative regulation of calcium ion transport into cytosol (GO:0010523),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,EPO
280,GO_Biological_Process_2021,negative regulation of CREB transcription factor activity (GO:0032792),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,FOXP3
281,GO_Biological_Process_2021,negative regulation of gonadotropin secretion (GO:0032277),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,INHBA
282,GO_Biological_Process_2021,negative regulation of histone deacetylation (GO:0031064),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,FOXP3
283,GO_Biological_Process_2021,negative regulation of interleukin-13 production (GO:0032696),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,IFNL1
284,GO_Biological_Process_2021,negative regulation of interleukin-5 production (GO:0032714),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,IFNL1
285,GO_Biological_Process_2021,negative regulation of macrophage differentiation (GO:0045650),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,INHBA
286,GO_Biological_Process_2021,negative regulation of synapse organization (GO:1905809),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,NEUROD2
287,GO_Biological_Process_2021,positive regulation of cardioblast differentiation (GO:0051891),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,GATA4
288,GO_Biological_Process_2021,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,FOXP3
289,GO_Biological_Process_2021,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,UHRF1
290,GO_Biological_Process_2021,positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CEACAM6
291,GO_Biological_Process_2021,positive regulation of hippo signaling (GO:0035332),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,SOX11
292,GO_Biological_Process_2021,positive regulation of MHC class I biosynthetic process (GO:0045345),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,IFNL1
293,GO_Biological_Process_2021,positive regulation of protein kinase C activity (GO:1900020),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CEMIP
294,GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,GATA5
295,GO_Biological_Process_2021,protein localization to axon (GO:0099612),1/5,0.2469879735685025,0.9999959186369975,0,0,4.286070780399274,5.993708385793417,CNTNAP2
296,GO_Biological_Process_2021,"regulation of synaptic transmission, glutamatergic (GO:0051966)",4/46,0.2472721350874814,0.9999959186369975,0,0,1.633952944235019,2.2830665471359555,GRM4;CDH2;SYT1;GRM8
297,GO_Biological_Process_2021,endodermal cell differentiation (GO:0035987),3/32,0.2580223147048313,0.9999959186369975,0,0,1.7744200626959248,2.403823195481438,COL11A1;FN1;INHBA
298,GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/32,0.2580223147048313,0.9999959186369975,0,0,1.7744200626959248,2.403823195481438,RRM2;CCNE1;E2F7
299,GO_Biological_Process_2021,liver development (GO:0001889),3/32,0.2580223147048313,0.9999959186369975,0,0,1.7744200626959248,2.403823195481438,E2F7;AURKA;E2F8
300,GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),4/47,0.2595299978732721,0.9999959186369975,0,0,1.595869395010263,2.15264107212046,PLK1;CDK1;SUMO4;GTSE1
301,GO_Biological_Process_2021,acidic amino acid transport (GO:0015800),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,SLC1A1;SLC1A6
302,GO_Biological_Process_2021,regulation of B cell differentiation (GO:0045577),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,IL4I1;INHBA
303,GO_Biological_Process_2021,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,TOP2A;APOBEC3B
304,GO_Biological_Process_2021,regulation of spindle organization (GO:0090224),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,TPX2;FSD1
305,GO_Biological_Process_2021,glycoprotein catabolic process (GO:0006516),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,NEU4;NCCRP1
306,GO_Biological_Process_2021,hyaluronan catabolic process (GO:0030214),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,CEMIP;HMMR
307,GO_Biological_Process_2021,T cell migration (GO:0072678),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,CXCL10;CXCL11
308,GO_Biological_Process_2021,negative regulation of leukocyte cell-cell adhesion (GO:1903038),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,IL4I1;TIGIT
309,GO_Biological_Process_2021,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,H2BC11;PYDC1
310,GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,RET;CXCL13
311,GO_Biological_Process_2021,positive regulation of lymphocyte chemotaxis (GO:0140131),2/18,0.2613676781670573,0.9999959186369975,0,0,2.143619436875568,2.876366726178177,CXCL13;S100A7
312,GO_Biological_Process_2021,protein-DNA complex assembly (GO:0065004),10/143,0.2649187623265198,0.9999959186369975,0,0,1.290784142423763,1.714589955374806,H2BC9;H2BC13;H2BC14;ORC6;H3C13;H2BC10;H2BC3;H2BC11;H2BC17;H2BC18
313,GO_Biological_Process_2021,cell cycle G1/S phase transition (GO:0044843),5/63,0.2666613204065625,0.9999959186369975,0,0,1.4790999309088626,1.9550386255920589,CCNA2;CCNE1;CDKN2A;INHBA;CDKN3
314,GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),8/111,0.2689731295992168,0.9999959186369975,0,0,1.3330850733696855,1.7505323914165138,CCNA2;CCNB2;TCL1A;CCNE1;CDC25C;PKMYT1;CCNP;CDKN3
315,GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),6/79,0.2694389824829527,0.9999959186369975,0,0,1.410371998351669,1.8495806309278453,SOX2;NEUROD2;SIX3;SOX11;ASCL1;BRINP3
316,GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),7/95,0.269887154973823,0.9999959186369975,0,0,1.3651190278699403,1.787966492241125,CDC20;UBE2C;SIX3;PLK1;CDK1;BUB1B;GTSE1
317,GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),16/244,0.2729723020050351,0.9999959186369975,0,0,1.205248632159977,1.5648766811494772,GABRQ;GABBR2;GRIA2;HTR1E;SYT1;GABRA5;GAD1;CHRNA6;SLC1A1;HTR1D;SLC1A6;HCRTR2;CHRND;GRM4;HRH3;GABRD
318,GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),12/178,0.27812300499875,0.9999959186369975,0,0,1.2411074177553476,1.58823498433542,CDC20;UBE2C;PLK1;CDK1;CKS2;BUB1B;NEK2;MKI67;CDC25C;PKMYT1;BRINP3;DLGAP5
319,GO_Biological_Process_2021,carbohydrate derivative catabolic process (GO:1901136),2/19,0.2822474477793805,0.9999959186369975,0,0,2.017417321151894,2.5519746450264345,NEU4;NCCRP1
320,GO_Biological_Process_2021,cardiac atrium morphogenesis (GO:0003209),2/19,0.2822474477793805,0.9999959186369975,0,0,2.017417321151894,2.5519746450264345,GATA4;MYH6
321,GO_Biological_Process_2021,mesenchymal cell development (GO:0014031),2/19,0.2822474477793805,0.9999959186369975,0,0,2.017417321151894,2.5519746450264345,CDH2;SOX11
322,GO_Biological_Process_2021,negative regulation of nervous system development (GO:0051961),2/19,0.2822474477793805,0.9999959186369975,0,0,2.017417321151894,2.5519746450264345,CCL11;PAX6
323,GO_Biological_Process_2021,neural crest cell differentiation (GO:0014033),2/19,0.2822474477793805,0.9999959186369975,0,0,2.017417321151894,2.5519746450264345,CDH2;SOX11
324,GO_Biological_Process_2021,female gamete generation (GO:0007292),3/34,0.2884727566831411,0.9999959186369975,0,0,1.659765395894428,2.0633450339651764,STRA8;HORMAD1;TRIP13
325,GO_Biological_Process_2021,B cell chemotaxis (GO:0035754),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CXCL13
326,GO_Biological_Process_2021,cardiac ventricle formation (GO:0003211),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SOX11
327,GO_Biological_Process_2021,cellular hyperosmotic response (GO:0071474),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,EPO
328,GO_Biological_Process_2021,regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CEACAM6
329,GO_Biological_Process_2021,cellular water homeostasis (GO:0009992),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SCT
330,GO_Biological_Process_2021,choline transport (GO:0015871),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SLC44A4
331,GO_Biological_Process_2021,chondrocyte development (GO:0002063),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SULF1
332,GO_Biological_Process_2021,regulation of macrophage apoptotic process (GO:2000109),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CDKN2A
333,GO_Biological_Process_2021,embryonic camera-type eye morphogenesis (GO:0048596),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SIX3
334,GO_Biological_Process_2021,equilibrioception (GO:0050957),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CLRN1
335,GO_Biological_Process_2021,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,IL4I1
336,GO_Biological_Process_2021,free ubiquitin chain polymerization (GO:0010994),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,UBE2C
337,GO_Biological_Process_2021,glandular epithelial cell differentiation (GO:0002067),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,PERCC1
338,GO_Biological_Process_2021,regulation of type 2 immune response (GO:0002828),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,IFNL1
339,GO_Biological_Process_2021,response to DNA damage checkpoint signaling (GO:0072423),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,EME1
340,GO_Biological_Process_2021,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,HS6ST3
341,GO_Biological_Process_2021,response to heparin (GO:0071503),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,AOC1
342,GO_Biological_Process_2021,histone-serine phosphorylation (GO:0035404),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,AURKB
343,GO_Biological_Process_2021,imitative learning (GO:0098596),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CNTNAP2
344,GO_Biological_Process_2021,ISG15-protein conjugation (GO:0032020),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,ISG15
345,GO_Biological_Process_2021,spinal cord dorsal/ventral patterning (GO:0021513),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,ASCL1
346,GO_Biological_Process_2021,spinal cord motor neuron differentiation (GO:0021522),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,MNX1
347,GO_Biological_Process_2021,maintenance of DNA methylation (GO:0010216),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,UHRF1
348,GO_Biological_Process_2021,meiotic DNA double-strand break formation (GO:0042138),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,HORMAD1
349,GO_Biological_Process_2021,type B pancreatic cell proliferation (GO:0044342),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,NKX6-1
350,GO_Biological_Process_2021,tyrosine catabolic process (GO:0006572),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,IL4I1
351,GO_Biological_Process_2021,vocal learning (GO:0042297),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CNTNAP2
352,GO_Biological_Process_2021,negative regulation of amino acid transport (GO:0051956),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,HRH3
353,GO_Biological_Process_2021,negative regulation of anion transport (GO:1903792),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,HRH3
354,GO_Biological_Process_2021,negative regulation of cardiac muscle cell apoptotic process (GO:0010667),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,GATA4
355,GO_Biological_Process_2021,negative regulation of glial cell proliferation (GO:0060253),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SOX11
356,GO_Biological_Process_2021,negative regulation of meiotic cell cycle (GO:0051447),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,DMRT1
357,GO_Biological_Process_2021,negative regulation of morphogenesis of an epithelium (GO:1905331),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,SULF1
358,GO_Biological_Process_2021,negative regulation of myeloid cell apoptotic process (GO:0033033),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,EPO
359,GO_Biological_Process_2021,negative regulation of T cell differentiation in thymus (GO:0033085),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,FOXJ1
360,GO_Biological_Process_2021,neuroblast proliferation (GO:0007405),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,ARTN
361,GO_Biological_Process_2021,neutrophil extravasation (GO:0072672),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CD177
362,GO_Biological_Process_2021,piRNA biosynthetic process (GO:1990511),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,TEX15
363,GO_Biological_Process_2021,positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CXCL13
364,GO_Biological_Process_2021,positive regulation of endothelial cell development (GO:1901552),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,PROC
365,GO_Biological_Process_2021,positive regulation of establishment of endothelial barrier (GO:1903142),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,PROC
366,GO_Biological_Process_2021,positive regulation of gap junction assembly (GO:1903598),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,CNTNAP2
367,GO_Biological_Process_2021,positive regulation of kidney development (GO:0090184),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,FOXD1
368,GO_Biological_Process_2021,protein K27-linked ubiquitination (GO:0044314),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,UBE2T
369,GO_Biological_Process_2021,protein K29-linked ubiquitination (GO:0035519),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,UBE2T
370,GO_Biological_Process_2021,protein localization to nuclear envelope (GO:0090435),1/6,0.2885269132392572,0.9999959186369975,0,0,3.4286751361161523,4.26172974136786,PLK1
371,GO_Biological_Process_2021,chloride transmembrane transport (GO:1902476),4/50,0.2969246543763925,0.9999959186369975,0,0,1.4915535862641929,1.8111590072378236,GABRQ;GABRA5;SLC1A1;GABRD
372,GO_Biological_Process_2021,regulation of granulocyte chemotaxis (GO:0071622),2/20,0.303072762758947,0.9999959186369975,0,0,1.9052376627308507,2.274439115630366,S100A14;S100A7
373,GO_Biological_Process_2021,regulation of protein localization to cell periphery (GO:1904375),2/20,0.303072762758947,0.9999959186369975,0,0,1.9052376627308507,2.274439115630366,PLK1;MISP
374,GO_Biological_Process_2021,insulin secretion (GO:0030073),2/20,0.303072762758947,0.9999959186369975,0,0,1.9052376627308507,2.274439115630366,SLC30A8;MAFA
375,GO_Biological_Process_2021,mitotic cytokinetic process (GO:1902410),2/20,0.303072762758947,0.9999959186369975,0,0,1.9052376627308507,2.274439115630366,KIF20A;CEP55
376,GO_Biological_Process_2021,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/20,0.303072762758947,0.9999959186369975,0,0,1.9052376627308507,2.274439115630366,CDKN2A;PLK1
377,GO_Biological_Process_2021,positive regulation of epithelial cell differentiation (GO:0030858),2/20,0.303072762758947,0.9999959186369975,0,0,1.9052376627308507,2.274439115630366,FOXJ1;NKX6-1
378,GO_Biological_Process_2021,cellular response to virus (GO:0098586),3/35,0.3038030548102466,0.9999959186369975,0,0,1.6078125,1.9155086357974167,IL21;CXCL10;IFI6
379,GO_Biological_Process_2021,regulation of mitotic spindle organization (GO:0060236),3/35,0.3038030548102466,0.9999959186369975,0,0,1.6078125,1.9155086357974167,TPX2;PLK1;FSD1
380,GO_Biological_Process_2021,embryonic skeletal system development (GO:0048706),3/35,0.3038030548102466,0.9999959186369975,0,0,1.6078125,1.9155086357974167,HOXB9;SOX11;SULF1
381,GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),3/35,0.3038030548102466,0.9999959186369975,0,0,1.6078125,1.9155086357974167,IL4I1;CD80;FOXP3
382,GO_Biological_Process_2021,regulation of G2/M transition of mitotic cell cycle (GO:0010389),10/149,0.3073763710411904,0.9999959186369975,0,0,1.234671914801187,1.4565206263875743,TPX2;CENPF;PLK1;CDK1;KIF14;NEK2;HMMR;CDC25C;DTL;AURKA
383,GO_Biological_Process_2021,gonad development (GO:0008406),4/51,0.3095421361386256,0.9999959186369975,0,0,1.4597409637387957,1.711781376391634,ZFP42;GATA4;INHBA;TEX19
384,GO_Biological_Process_2021,endoderm formation (GO:0001706),3/36,0.3191666270677826,0.9999959186369975,0,0,1.5590082644628098,1.7804528706302285,COL11A1;FN1;INHBA
385,GO_Biological_Process_2021,retina homeostasis (GO:0001895),3/36,0.3191666270677826,0.9999959186369975,0,0,1.5590082644628098,1.7804528706302285,POTEI;POTEJ;CST4
386,GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol (GO:0051279),4/52,0.3222096636417457,0.9999959186369975,0,0,1.4292538671519563,1.6187054920336428,CXCL10;CXCL9;CEMIP;CXCL11
387,GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),7/101,0.3228184323221953,0.9999959186369975,0,0,1.2775760987731015,1.4445108899744163,KRT3;SIX3;CDK1;ASCL1;ACTL8;E2F7;E2F8
388,GO_Biological_Process_2021,acetylcholine receptor signaling pathway (GO:0095500),2/21,0.3237861670942821,0.9999959186369975,0,0,1.8048663894067591,2.03529721739196,LYPD1;LY6H
389,GO_Biological_Process_2021,regulation of anoikis (GO:2000209),2/21,0.3237861670942821,0.9999959186369975,0,0,1.8048663894067591,2.03529721739196,CEACAM6;CEACAM5
390,GO_Biological_Process_2021,regulation of dendritic spine development (GO:0060998),2/21,0.3237861670942821,0.9999959186369975,0,0,1.8048663894067591,2.03529721739196,NEURL1;KIF1A
391,GO_Biological_Process_2021,heparan sulfate proteoglycan metabolic process (GO:0030201),2/21,0.3237861670942821,0.9999959186369975,0,0,1.8048663894067591,2.03529721739196,SULF1;HS6ST3
392,GO_Biological_Process_2021,innate immune response in mucosa (GO:0002227),2/21,0.3237861670942821,0.9999959186369975,0,0,1.8048663894067591,2.03529721739196,H2BC10;H2BC11
393,GO_Biological_Process_2021,protein localization to chromatin (GO:0071168),2/21,0.3237861670942821,0.9999959186369975,0,0,1.8048663894067591,2.03529721739196,H1-5;PLK1
394,GO_Biological_Process_2021,aldehyde catabolic process (GO:0046185),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,AGXT
395,GO_Biological_Process_2021,aspartate transmembrane transport (GO:0015810),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,SLC1A6
396,GO_Biological_Process_2021,atrioventricular valve formation (GO:0003190),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,GATA4
397,GO_Biological_Process_2021,cellular amino acid biosynthetic process (GO:0008652),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,GAD1
398,GO_Biological_Process_2021,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CXCL13
399,GO_Biological_Process_2021,cellular response to histamine (GO:0071420),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,AOC1
400,GO_Biological_Process_2021,regulation of glial cell differentiation (GO:0045685),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CDK1
401,GO_Biological_Process_2021,cleavage furrow formation (GO:0036089),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,AURKB
402,GO_Biological_Process_2021,regulation of MHC class I biosynthetic process (GO:0045343),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,IFNL1
403,GO_Biological_Process_2021,dense core granule cytoskeletal transport (GO:0099519),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,KIF1A
404,GO_Biological_Process_2021,regulation of morphogenesis of an epithelium (GO:1905330),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CXCL10
405,GO_Biological_Process_2021,regulation of muscle organ development (GO:0048634),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CENPF
406,GO_Biological_Process_2021,detection of muscle stretch (GO:0035995),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CDH2
407,GO_Biological_Process_2021,detection of stimulus involved in sensory perception of pain (GO:0062149),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,SCN1A
408,GO_Biological_Process_2021,DNA ligation (GO:0006266),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,TOP2A
409,GO_Biological_Process_2021,regulation of norepinephrine secretion (GO:0014061),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,HRH3
410,GO_Biological_Process_2021,endothelial cell morphogenesis (GO:0001886),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,COL22A1
411,GO_Biological_Process_2021,establishment of centrosome localization (GO:0051660),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,MISP
412,GO_Biological_Process_2021,regulation of T cell mediated immune response to tumor cell (GO:0002840),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,IL4I1
413,GO_Biological_Process_2021,regulation of T cell tolerance induction (GO:0002664),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,FOXP3
414,GO_Biological_Process_2021,regulation of T-helper 1 cell differentiation (GO:0045625),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CD80
415,GO_Biological_Process_2021,ganglioside catabolic process (GO:0006689),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,NEU4
416,GO_Biological_Process_2021,gap junction assembly (GO:0016264),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,GJB2
417,GO_Biological_Process_2021,glomerular epithelial cell development (GO:0072310),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,FOXJ1
418,GO_Biological_Process_2021,Golgi disassembly (GO:0090166),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CDK1
419,GO_Biological_Process_2021,hyaluronan biosynthetic process (GO:0030213),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CEMIP
420,GO_Biological_Process_2021,hyperosmotic response (GO:0006972),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,EPO
421,GO_Biological_Process_2021,long-term synaptic depression (GO:0060292),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,SLC24A2
422,GO_Biological_Process_2021,maintenance of protein location in extracellular region (GO:0071694),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,FBN2
423,GO_Biological_Process_2021,maintenance of synapse structure (GO:0099558),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,CBLN2
424,GO_Biological_Process_2021,miRNA catabolic process (GO:0010587),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,LIN28B
425,GO_Biological_Process_2021,vitamin A metabolic process (GO:0006776),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,RLBP1
426,GO_Biological_Process_2021,negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,AUNIP
427,GO_Biological_Process_2021,negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,PYDC1
428,GO_Biological_Process_2021,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,PRAME
429,GO_Biological_Process_2021,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,FOXM1
430,GO_Biological_Process_2021,negative regulation of T-helper 17 type immune response (GO:2000317),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,FOXP3
431,GO_Biological_Process_2021,negative regulation of type 2 immune response (GO:0002829),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,IFNL1
432,GO_Biological_Process_2021,positive regulation of histone H3-K9 methylation (GO:0051574),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,H1-5
433,GO_Biological_Process_2021,positive regulation of miRNA metabolic process (GO:2000630),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,LIN28B
434,GO_Biological_Process_2021,positive regulation of mitochondrial membrane potential (GO:0010918),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,TCL1A
435,GO_Biological_Process_2021,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,NDC80
436,GO_Biological_Process_2021,positive regulation of spindle checkpoint (GO:0090232),1/7,0.3277763707261986,0.9999959186369975,0,0,2.8570780399274045,3.1868525576087,NDC80
437,GO_Biological_Process_2021,glutamate receptor signaling pathway (GO:0007215),3/37,0.3345376235992171,0.9999959186369975,0,0,1.5130748663101603,1.656825949042266,GRIA2;GRM4;GRM8
438,GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),5/70,0.343025780012527,0.9999959186369975,0,0,1.3193218439120078,1.411607977130131,CXCL10;CXCL9;CXCL11;CCL11;CXCL13
439,GO_Biological_Process_2021,female gonad development (GO:0008585),2/22,0.344336696800359,0.9999959186369975,0,0,1.7145322434150772,1.8279234000257796,ZFP42;INHBA
440,GO_Biological_Process_2021,homologous chromosome segregation (GO:0045143),2/22,0.344336696800359,0.9999959186369975,0,0,1.7145322434150772,1.8279234000257796,SGO1;PTTG1
441,GO_Biological_Process_2021,negative regulation of B cell activation (GO:0050869),2/22,0.344336696800359,0.9999959186369975,0,0,1.7145322434150772,1.8279234000257796,FOXJ1;INHBA
442,GO_Biological_Process_2021,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/22,0.344336696800359,0.9999959186369975,0,0,1.7145322434150772,1.8279234000257796,CDKN2A;PLK1
443,GO_Biological_Process_2021,negative regulation of phosphate metabolic process (GO:0045936),2/22,0.344336696800359,0.9999959186369975,0,0,1.7145322434150772,1.8279234000257796,CDKN2A;INHBA
444,GO_Biological_Process_2021,positive regulation of granulocyte chemotaxis (GO:0071624),2/22,0.344336696800359,0.9999959186369975,0,0,1.7145322434150772,1.8279234000257796,S100A14;S100A7
445,GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),4/54,0.3476348996651771,0.9999959186369975,0,0,1.3719381255686989,1.4495932379997667,F7;CXCL10;S100A14;S100A7
446,GO_Biological_Process_2021,actin-myosin filament sliding (GO:0033275),3/38,0.3498915928436572,0.9999959186369975,0,0,1.4697662337662338,1.5434484182160226,TNNT1;MYH6;MYH7
447,GO_Biological_Process_2021,muscle filament sliding (GO:0030049),3/38,0.3498915928436572,0.9999959186369975,0,0,1.4697662337662338,1.5434484182160226,TNNT1;MYH6;MYH7
448,GO_Biological_Process_2021,positive regulation of potassium ion transport (GO:0043268),3/38,0.3498915928436572,0.9999959186369975,0,0,1.4697662337662338,1.5434484182160226,GABBR2;KCNJ6;KCNJ3
449,GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),9/139,0.3593537933885108,0.9999959186369975,0,0,1.1876177752777388,1.2154648930201084,KCNG1;SLC24A2;KCNF1;KCNG3;SLC9A4;KCNJ6;LRRC52;KCNH1;KCNJ3
450,GO_Biological_Process_2021,regulation of telomere capping (GO:1904353),2/23,0.3646793397850501,0.9999959186369975,0,0,1.6328013494226028,1.64706686158337,NEK2;AURKB
451,GO_Biological_Process_2021,hyaluronan metabolic process (GO:0030212),2/23,0.3646793397850501,0.9999959186369975,0,0,1.6328013494226028,1.64706686158337,CEMIP;HMMR
452,GO_Biological_Process_2021,triglyceride catabolic process (GO:0019433),2/23,0.3646793397850501,0.9999959186369975,0,0,1.6328013494226028,1.64706686158337,PNLIPRP2;FABP6
453,GO_Biological_Process_2021,vesicle transport along microtubule (GO:0047496),2/23,0.3646793397850501,0.9999959186369975,0,0,1.6328013494226028,1.64706686158337,BICDL1;KIF1A
454,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),2/23,0.3646793397850501,0.9999959186369975,0,0,1.6328013494226028,1.64706686158337,TERT;IFI6
455,GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),2/23,0.3646793397850501,0.9999959186369975,0,0,1.6328013494226028,1.64706686158337,TERT;IFI6
456,GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,HRH3
457,GO_Biological_Process_2021,amine metabolic process (GO:0009308),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,AOC1
458,GO_Biological_Process_2021,regulation of chaperone-mediated autophagy (GO:1904714),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,EEF1A2
459,GO_Biological_Process_2021,cell-cell adhesion mediated by cadherin (GO:0044331),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,CDH2
460,GO_Biological_Process_2021,regulation of meiotic nuclear division (GO:0040020),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,DMRT1
461,GO_Biological_Process_2021,regulation of positive chemotaxis (GO:0050926),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,F7
462,GO_Biological_Process_2021,regulation of protein localization to chromatin (GO:1905634),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,CDCA5
463,GO_Biological_Process_2021,regulation of protein localization to nucleolus (GO:1904749),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,TERT
464,GO_Biological_Process_2021,establishment of protein localization to chromatin (GO:0071169),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,H1-5
465,GO_Biological_Process_2021,regulation of striated muscle tissue development (GO:0016202),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,CENPF
466,GO_Biological_Process_2021,forebrain neuron differentiation (GO:0021879),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,INHBA
467,GO_Biological_Process_2021,glyoxylate metabolic process (GO:0046487),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,AGXT
468,GO_Biological_Process_2021,integrin activation (GO:0033622),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,FN1
469,GO_Biological_Process_2021,somatic hypermutation of immunoglobulin genes (GO:0016446),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,POLQ
470,GO_Biological_Process_2021,lens fiber cell differentiation (GO:0070306),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,SIX3
471,GO_Biological_Process_2021,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,KCNJ3
472,GO_Biological_Process_2021,water homeostasis (GO:0030104),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,SCT
473,GO_Biological_Process_2021,multi-ciliated epithelial cell differentiation (GO:1903251),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,CCDC78
474,GO_Biological_Process_2021,negative regulation of B cell apoptotic process (GO:0002903),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,AURKB
475,GO_Biological_Process_2021,negative regulation of striated muscle cell apoptotic process (GO:0010664),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,GATA4
476,GO_Biological_Process_2021,negative regulation of T-helper 17 cell differentiation (GO:2000320),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,FOXP3
477,GO_Biological_Process_2021,osteoblast development (GO:0002076),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,CLEC5A
478,GO_Biological_Process_2021,peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,P4HA3
479,GO_Biological_Process_2021,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,FOXP3
480,GO_Biological_Process_2021,positive regulation of isomerase activity (GO:0010912),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,UHRF1
481,GO_Biological_Process_2021,positive regulation of meiotic nuclear division (GO:0045836),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,STRA8
482,GO_Biological_Process_2021,positive regulation of melanin biosynthetic process (GO:0048023),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,TYRP1
483,GO_Biological_Process_2021,positive regulation of muscle contraction (GO:0045933),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,NMU
484,GO_Biological_Process_2021,positive regulation of myeloid cell apoptotic process (GO:0033034),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,CDKN2A
485,GO_Biological_Process_2021,positive regulation of secondary metabolite biosynthetic process (GO:1900378),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,TYRP1
486,GO_Biological_Process_2021,protein localization to microtubule cytoskeleton (GO:0072698),1/8,0.3648624256257259,0.9999959186369975,0,0,2.4487943997925847,2.46896000751378,FAM83D
487,GO_Biological_Process_2021,DNA integrity checkpoint signaling (GO:0031570),3/39,0.3652054804346593,0.9999959186369975,0,0,1.4288636363636364,1.4392873733517375,BRIP1;HUS1B;CLSPN
488,GO_Biological_Process_2021,collagen fibril organization (GO:0030199),6/89,0.3673915318689962,0.9999959186369975,0,0,1.2397886898551362,1.2414340819508782,ADAMTS14;COL11A1;COL22A1;P4HA3;COL9A1;COL10A1
489,GO_Biological_Process_2021,chromosome organization (GO:0051276),7/106,0.3681134770535251,0.9999959186369975,0,0,1.212729484627295,1.2119582211621154,SOX2;H1-5;TOP2A;H3C13;NUF2;CDCA8;NDC80
490,GO_Biological_Process_2021,sensory organ development (GO:0007423),4/56,0.3730852580153136,0.9999959186369975,0,0,1.3190312871841534,1.300496670665145,SOX2;SIX3;PAX6;ASCL1
491,GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),5/73,0.3763144186107089,0.9999959186369975,0,0,1.2609155684131577,1.2323309470231243,CXCL10;CXCL9;CXCL11;CCL11;CXCL13
492,GO_Biological_Process_2021,digestive tract development (GO:0048565),3/40,0.3804576196264641,0.9999959186369975,0,0,1.3901719901719902,1.3434350871405611,PERCC1;GATA5;GATA4
493,GO_Biological_Process_2021,positive regulation of ossification (GO:0045778),3/40,0.3804576196264641,0.9999959186369975,0,0,1.3901719901719902,1.3434350871405611,FBN2;ISG15;SOX11
494,GO_Biological_Process_2021,amino acid import across plasma membrane (GO:0089718),2/24,0.3847745350301595,0.9999959186369975,0,0,1.5585005367021716,1.4885203396713522,SLC1A1;SLC1A6
495,GO_Biological_Process_2021,endocrine system development (GO:0035270),2/24,0.3847745350301595,0.9999959186369975,0,0,1.5585005367021716,1.4885203396713522,SOX2;SIX3
496,GO_Biological_Process_2021,heterochromatin assembly (GO:0031507),2/24,0.3847745350301595,0.9999959186369975,0,0,1.5585005367021716,1.4885203396713522,H3C13;CDKN2A
497,GO_Biological_Process_2021,visual system development (GO:0150063),3/41,0.3956277148485366,0.9999959186369975,0,0,1.3535167464114832,1.2550912066300342,SOX2;SIX3;PAX6
498,GO_Biological_Process_2021,positive regulation of cation transmembrane transport (GO:1904064),3/41,0.3956277148485366,0.9999959186369975,0,0,1.3535167464114832,1.2550912066300342,GABBR2;KCNJ6;KCNJ3
499,GO_Biological_Process_2021,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),6/92,0.3973187416483812,0.9999959186369975,0,0,1.1963494519938098,1.1042502178443043,FOXD1;BMP8A;SOX11;TTK;INHBA;SULF1
500,GO_Biological_Process_2021,regulation of neurotransmitter receptor activity (GO:0099601),4/58,0.398453734669658,0.9999959186369975,0,0,1.2700434738651298,1.168648138539201,GRIA2;PSCA;PATE4;CNIH2
501,GO_Biological_Process_2021,eye development (GO:0001654),4/58,0.398453734669658,0.9999959186369975,0,0,1.2700434738651298,1.168648138539201,SOX2;FBN2;SIX3;PAX6
502,GO_Biological_Process_2021,androgen biosynthetic process (GO:0006702),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,HSD17B6
503,GO_Biological_Process_2021,basement membrane assembly (GO:0070831),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,NTNG1
504,GO_Biological_Process_2021,regulation of gap junction assembly (GO:1903596),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CNTNAP2
505,GO_Biological_Process_2021,cellular response to interleukin-17 (GO:0097398),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,IL17C
506,GO_Biological_Process_2021,regulation of glial cell proliferation (GO:0060251),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,SOX11
507,GO_Biological_Process_2021,detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,COL11A1
508,GO_Biological_Process_2021,development of primary female sexual characteristics (GO:0046545),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,ZFP42
509,GO_Biological_Process_2021,DNA cytosine deamination (GO:0070383),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,APOBEC3B
510,GO_Biological_Process_2021,DNA topological change (GO:0006265),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,TOP2A
511,GO_Biological_Process_2021,embryonic digestive tract morphogenesis (GO:0048557),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,SOX11
512,GO_Biological_Process_2021,endothelial cell chemotaxis (GO:0035767),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CXCL13
513,GO_Biological_Process_2021,epithelial cell apoptotic process (GO:1904019),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,SIX3
514,GO_Biological_Process_2021,regulation of smooth muscle cell apoptotic process (GO:0034391),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CDKN2A
515,GO_Biological_Process_2021,glomerular filtration (GO:0003094),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,SULF1
516,GO_Biological_Process_2021,response to type I interferon (GO:0034340),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,ISG15
517,GO_Biological_Process_2021,histone phosphorylation (GO:0016572),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CCNA2
518,GO_Biological_Process_2021,interleukin-17-mediated signaling pathway (GO:0097400),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,IL17C
519,GO_Biological_Process_2021,kynurenine metabolic process (GO:0070189),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,TDO2
520,GO_Biological_Process_2021,L-phenylalanine metabolic process (GO:0006558),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,IL4I1
521,GO_Biological_Process_2021,sympathetic ganglion development (GO:0061549),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,ASCL1
522,GO_Biological_Process_2021,type B pancreatic cell differentiation (GO:0003309),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CDH2
523,GO_Biological_Process_2021,negative regulation of protein activation cascade (GO:2000258),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,F7
524,GO_Biological_Process_2021,negative regulation of T cell cytokine production (GO:0002725),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,FOXP3
525,GO_Biological_Process_2021,neuronal ion channel clustering (GO:0045161),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CNTNAP2
526,GO_Biological_Process_2021,oligosaccharide catabolic process (GO:0009313),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,NEU4
527,GO_Biological_Process_2021,positive regulation of membrane potential (GO:0045838),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,TCL1A
528,GO_Biological_Process_2021,positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,CDKN2A
529,GO_Biological_Process_2021,positive regulation of smooth muscle contraction (GO:0045987),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,NMU
530,GO_Biological_Process_2021,protein K6-linked ubiquitination (GO:0085020),1/9,0.399904220522853,0.9999959186369975,0,0,2.14258166969147,1.9637408260349072,UBE2T
531,GO_Biological_Process_2021,regulation of dopamine secretion (GO:0014059),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,SYT1;SYT13
532,GO_Biological_Process_2021,regulation of spindle assembly (GO:0090169),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,SPAG5;PLK1
533,GO_Biological_Process_2021,response to hexose (GO:0009746),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,SLC30A8;MAFA
534,GO_Biological_Process_2021,in utero embryonic development (GO:0001701),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,FOXD3;MYH6
535,GO_Biological_Process_2021,ventricular cardiac muscle tissue development (GO:0003229),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,MYH6;MYH7
536,GO_Biological_Process_2021,positive regulation of lipid metabolic process (GO:0045834),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,SCT;EEF1A2
537,GO_Biological_Process_2021,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,CEMIP;PLK1
538,GO_Biological_Process_2021,positive regulation of vascular endothelial growth factor production (GO:0010575),2/25,0.4045877095662135,0.9999959186369975,0,0,1.4906606642182996,1.3488790561630166,GATA4;SULF1
539,GO_Biological_Process_2021,regulation of nervous system development (GO:0051960),3/42,0.4106968191143357,0.9999959186369975,0,0,1.3187412587412588,1.173547850220983,GBX2;KIF14;ASCL1
540,GO_Biological_Process_2021,translesion synthesis (GO:0019985),3/42,0.4106968191143357,0.9999959186369975,0,0,1.3187412587412588,1.173547850220983,PCLAF;ISG15;DTL
541,GO_Biological_Process_2021,regulation of regulatory T cell differentiation (GO:0045589),2/26,0.4240888491972795,0.9999959186369975,0,0,1.4284741144414168,1.2253626594700562,IL4I1;FOXP3
542,GO_Biological_Process_2021,meiosis I (GO:0007127),2/26,0.4240888491972795,0.9999959186369975,0,0,1.4284741144414168,1.2253626594700562,SGO1;PTTG1
543,GO_Biological_Process_2021,negative regulation of cell development (GO:0010721),2/26,0.4240888491972795,0.9999959186369975,0,0,1.4284741144414168,1.2253626594700562,CCL11;PAX6
544,GO_Biological_Process_2021,positive regulation of filopodium assembly (GO:0051491),2/26,0.4240888491972795,0.9999959186369975,0,0,1.4284741144414168,1.2253626594700562,PLPPR5;NEURL1
545,GO_Biological_Process_2021,cellular response to retinoic acid (GO:0071300),3/43,0.4256473063973229,0.9999959186369975,0,0,1.2857045454545457,1.0981770738337953,RET;STRA8;BRINP3
546,GO_Biological_Process_2021,DNA synthesis involved in DNA repair (GO:0000731),3/43,0.4256473063973229,0.9999959186369975,0,0,1.2857045454545457,1.0981770738337953,PCLAF;ISG15;DTL
547,GO_Biological_Process_2021,myofibril assembly (GO:0030239),3/43,0.4256473063973229,0.9999959186369975,0,0,1.2857045454545457,1.0981770738337953,SYNPO2L;TNNT1;MYH6
548,GO_Biological_Process_2021,sensory perception of light stimulus (GO:0050953),6/95,0.4271751301791016,0.9999959186369975,0,0,1.1558387020781908,0.983111563737253,COL11A1;GRM8;SIX3;PAX6;TYR;CLRN1
549,GO_Biological_Process_2021,aromatic amino acid family metabolic process (GO:0009072),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,IL4I1
550,GO_Biological_Process_2021,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,CXCL13
551,GO_Biological_Process_2021,regulation of hair cycle (GO:0042634),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,TERT
552,GO_Biological_Process_2021,regulation of memory T cell differentiation (GO:0043380),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,IFNL1
553,GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,FOXM1
554,GO_Biological_Process_2021,DNA replication-dependent nucleosome assembly (GO:0006335),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,ASF1B
555,GO_Biological_Process_2021,DNA replication-dependent nucleosome organization (GO:0034723),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,ASF1B
556,GO_Biological_Process_2021,ectoderm development (GO:0007398),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,AMER2
557,GO_Biological_Process_2021,endodermal cell fate commitment (GO:0001711),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,SOX2
558,GO_Biological_Process_2021,regulation of T-helper 17 cell differentiation (GO:2000319),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,FOXP3
559,GO_Biological_Process_2021,regulation of type B pancreatic cell development (GO:2000074),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,NKX6-1
560,GO_Biological_Process_2021,renal filtration (GO:0097205),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,SULF1
561,GO_Biological_Process_2021,glycosphingolipid catabolic process (GO:0046479),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,NEU4
562,GO_Biological_Process_2021,response to histamine (GO:0034776),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,AOC1
563,GO_Biological_Process_2021,ionotropic glutamate receptor signaling pathway (GO:0035235),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,GRIA2
564,GO_Biological_Process_2021,modification-dependent macromolecule catabolic process (GO:0043632),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,ISG15
565,GO_Biological_Process_2021,morphogenesis of an epithelial sheet (GO:0002011),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,SOX11
566,GO_Biological_Process_2021,negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,FOXJ1
567,GO_Biological_Process_2021,negative regulation of lymphocyte apoptotic process (GO:0070229),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,AURKB
568,GO_Biological_Process_2021,negative regulation of transforming growth factor beta production (GO:0071635),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,FN1
569,GO_Biological_Process_2021,neuron remodeling (GO:0016322),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,EPHA8
570,GO_Biological_Process_2021,phosphatidylcholine catabolic process (GO:0034638),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,PNLIPRP2
571,GO_Biological_Process_2021,positive regulation of tissue remodeling (GO:0034105),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,IL21
572,GO_Biological_Process_2021,production of siRNA involved in RNA interference (GO:0030422),1/10,0.4330143424497985,0.9999959186369975,0,0,1.9044162129461584,1.5939667148334422,TERT
573,GO_Biological_Process_2021,cation transmembrane transport (GO:0098655),3/44,0.440462839674298,0.9999959186369975,0,0,1.254279379157428,1.0284202836482728,SLC44A4;TRPM8;TRPM5
574,GO_Biological_Process_2021,embryonic organ morphogenesis (GO:0048562),3/44,0.440462839674298,0.9999959186369975,0,0,1.254279379157428,1.0284202836482728,FBN2;HOXB9;SOX11
575,GO_Biological_Process_2021,positive regulation of osteoblast differentiation (GO:0045669),3/44,0.440462839674298,0.9999959186369975,0,0,1.254279379157428,1.0284202836482728,FBN2;CCN4;SOX11
576,GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transport (GO:1901381),3/44,0.440462839674298,0.9999959186369975,0,0,1.254279379157428,1.0284202836482728,GABBR2;KCNJ6;KCNJ3
577,GO_Biological_Process_2021,regulation of ion transport (GO:0043269),5/79,0.4425710980920831,0.9999959186369975,0,0,1.1583099492935558,0.9442011665387064,NKAIN1;KCNJ6;SYT1;SYT13;KCNJ3
578,GO_Biological_Process_2021,calcium-ion regulated exocytosis (GO:0017156),2/27,0.4432521016409895,0.9999959186369975,0,0,1.3712624886466849,1.1156819135787093,SYT1;SYT13
579,GO_Biological_Process_2021,regulation of vascular endothelial growth factor production (GO:0010574),2/27,0.4432521016409895,0.9999959186369975,0,0,1.3712624886466849,1.1156819135787093,GATA4;SULF1
580,GO_Biological_Process_2021,L-alpha-amino acid transmembrane transport (GO:1902475),2/27,0.4432521016409895,0.9999959186369975,0,0,1.3712624886466849,1.1156819135787093,SLC1A1;SLC1A6
581,GO_Biological_Process_2021,peptide hormone secretion (GO:0030072),2/27,0.4432521016409895,0.9999959186369975,0,0,1.3712624886466849,1.1156819135787093,SLC30A8;MAFA
582,GO_Biological_Process_2021,positive regulation of nuclear division (GO:0051785),2/27,0.4432521016409895,0.9999959186369975,0,0,1.3712624886466849,1.1156819135787093,DMRT1;AURKA
583,GO_Biological_Process_2021,presynaptic endocytosis (GO:0140238),2/27,0.4432521016409895,0.9999959186369975,0,0,1.3712624886466849,1.1156819135787093,SYT1;PACSIN1
584,GO_Biological_Process_2021,regulation of neurogenesis (GO:0050767),4/62,0.4485598696467592,0.9999959186369975,0,0,1.1822032568792946,0.9477878589112128,CCL11;PAX6;SOX11;ASCL1
585,GO_Biological_Process_2021,response to retinoic acid (GO:0032526),4/62,0.4485598696467592,0.9999959186369975,0,0,1.1822032568792946,0.9477878589112128,RET;STRA8;ASCL1;BRINP3
586,GO_Biological_Process_2021,defense response to virus (GO:0051607),8/133,0.4525914562526928,0.9999959186369975,0,0,1.0971762557077624,0.8698033984602624,IL21;CXCL10;IFNL1;IFI6;ISG15;IFNL4;IFNL3;APOBEC3B
587,GO_Biological_Process_2021,microtubule bundle formation (GO:0001578),3/45,0.4551283352904945,0.9999959186369975,0,0,1.2243506493506493,0.9637792560213072,PLK1;FOXJ1;KIF20A
588,GO_Biological_Process_2021,regulation of B cell activation (GO:0050864),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,IL4I1;FOXJ1
589,GO_Biological_Process_2021,carbohydrate derivative biosynthetic process (GO:1901137),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,RRM2;GAL3ST2
590,GO_Biological_Process_2021,regulation of microtubule polymerization or depolymerization (GO:0031110),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,SKA3;SKA1
591,GO_Biological_Process_2021,regulation of multicellular organismal development (GO:2000026),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,GBX2;CDK1
592,GO_Biological_Process_2021,regulation of plasma membrane bounded cell projection organization (GO:0120035),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,NTNG1;ZNF804A
593,GO_Biological_Process_2021,L-amino acid transport (GO:0015807),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,SLC1A1;SLC1A6
594,GO_Biological_Process_2021,mucosal immune response (GO:0002385),2/28,0.4620554094669387,0.9999959186369975,0,0,1.3184517571438552,1.0179376561826556,H2BC10;H2BC11
595,GO_Biological_Process_2021,rDNA heterochromatin assembly (GO:0000183),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,H3C13
596,GO_Biological_Process_2021,atrial septum morphogenesis (GO:0060413),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,GATA4
597,GO_Biological_Process_2021,regulation of cardiac muscle cell apoptotic process (GO:0010665),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,GATA4
598,GO_Biological_Process_2021,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,KCNJ3
599,GO_Biological_Process_2021,regulation of coagulation (GO:0050818),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,PROC
600,GO_Biological_Process_2021,cell-cell junction maintenance (GO:0045217),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,CD177
601,GO_Biological_Process_2021,regulation of lipid kinase activity (GO:0043550),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,EEF1A2
602,GO_Biological_Process_2021,regulation of long-term neuronal synaptic plasticity (GO:0048169),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,NEURL1
603,GO_Biological_Process_2021,regulation of melanin biosynthetic process (GO:0048021),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,TYRP1
604,GO_Biological_Process_2021,cytidine to uridine editing (GO:0016554),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,APOBEC3B
605,GO_Biological_Process_2021,regulation of mitochondrial depolarization (GO:0051900),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,IFI6
606,GO_Biological_Process_2021,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,FOXM1
607,GO_Biological_Process_2021,embryonic eye morphogenesis (GO:0048048),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,FBN2
608,GO_Biological_Process_2021,formation of extrachromosomal circular DNA (GO:0001325),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,EXO1
609,GO_Biological_Process_2021,Golgi inheritance (GO:0048313),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,CDK1
610,GO_Biological_Process_2021,inositol phosphate biosynthetic process (GO:0032958),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,ITPKA
611,GO_Biological_Process_2021,somite development (GO:0061053),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,SOX11
612,GO_Biological_Process_2021,"synaptic transmission, GABAergic (GO:0051932)",1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,GABRA5
613,GO_Biological_Process_2021,T cell homeostasis (GO:0043029),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,FOXP3
614,GO_Biological_Process_2021,t-circle formation (GO:0090656),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,EXO1
615,GO_Biological_Process_2021,telomere maintenance via telomere trimming (GO:0090737),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,EXO1
616,GO_Biological_Process_2021,negative regulation of activated T cell proliferation (GO:0046007),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,FOXP3
617,GO_Biological_Process_2021,negative regulation of interleukin-17 production (GO:0032700),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,FOXP3
618,GO_Biological_Process_2021,negative regulation of nuclear division (GO:0051784),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,DMRT1
619,GO_Biological_Process_2021,negative regulation of protein maturation (GO:1903318),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,MAGEA3
620,GO_Biological_Process_2021,negative regulation of T-helper cell differentiation (GO:0045623),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,FOXP3
621,GO_Biological_Process_2021,organophosphate catabolic process (GO:0046434),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,PNLIPRP2
622,GO_Biological_Process_2021,peptidyl-proline hydroxylation (GO:0019511),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,P4HA3
623,GO_Biological_Process_2021,positive regulation of dendrite development (GO:1900006),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,PACSIN1
624,GO_Biological_Process_2021,positive regulation of integrin activation (GO:0033625),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,CXCL13
625,GO_Biological_Process_2021,positive regulation of leukocyte apoptotic process (GO:2000108),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,CDKN2A
626,GO_Biological_Process_2021,positive regulation of voltage-gated potassium channel activity (GO:1903818),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,LRRC52
627,GO_Biological_Process_2021,protein kinase C signaling (GO:0070528),1/11,0.4642991830993185,0.9999959186369975,0,0,1.7138838475499092,1.3149364945605293,PRSS33
628,GO_Biological_Process_2021,positive regulation of response to stimulus (GO:0048584),3/46,0.4696299246478028,0.9999959186369975,0,0,1.195813953488372,0.9038084895397178,IFNL1;CDKN2A;CD80
629,GO_Biological_Process_2021,postreplication repair (GO:0006301),3/46,0.4696299246478028,0.9999959186369975,0,0,1.195813953488372,0.9038084895397178,PCLAF;ISG15;DTL
630,GO_Biological_Process_2021,dicarboxylic acid transport (GO:0006835),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,SLC1A1;SLC1A6
631,GO_Biological_Process_2021,regulation of ubiquitin-protein transferase activity (GO:0051438),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,PLK1;MAGEC2
632,GO_Biological_Process_2021,homologous chromosome pairing at meiosis (GO:0007129),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,HORMAD1;TRIP13
633,GO_Biological_Process_2021,limb development (GO:0060173),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,COMP;KREMEN2
634,GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,INHBA;FOXP3
635,GO_Biological_Process_2021,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,RET;INHBA
636,GO_Biological_Process_2021,protein K11-linked ubiquitination (GO:0070979),2/29,0.4804801708432711,0.9999959186369975,0,0,1.2695529316782723,0.9305433479942652,UBE2C;UBE2T
637,GO_Biological_Process_2021,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),3/47,0.4839549132793215,0.9999959186369975,0,0,1.1685743801652893,0.8481086683687836,BMP8A;TTK;INHBA
638,GO_Biological_Process_2021,inorganic anion transmembrane transport (GO:0098661),4/65,0.4852559001541721,0.9999959186369975,0,0,1.1238831128149287,0.8126561627041636,GABRQ;GABRA5;SLC1A1;GABRD
639,GO_Biological_Process_2021,epidermis development (GO:0008544),5/83,0.4858156623655698,0.9999959186369975,0,0,1.0986759142496847,0.7931627328748609,CASP14;FLG2;CALML5;HOXB13;S100A7
640,GO_Biological_Process_2021,regulation of B cell apoptotic process (GO:0002902),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,AURKB
641,GO_Biological_Process_2021,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,SYT1
642,GO_Biological_Process_2021,carboxylic acid catabolic process (GO:0046395),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,IL4I1
643,GO_Biological_Process_2021,regulation of histone H3-K9 methylation (GO:0051570),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,H1-5
644,GO_Biological_Process_2021,depurination (GO:0045007),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,NEIL3
645,GO_Biological_Process_2021,regulation of oxidative stress-induced cell death (GO:1903201),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,GATA4
646,GO_Biological_Process_2021,exit from mitosis (GO:0010458),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,UBE2C
647,GO_Biological_Process_2021,keratan sulfate catabolic process (GO:0042340),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,ACAN
648,GO_Biological_Process_2021,melanocyte differentiation (GO:0030318),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,TYRP1
649,GO_Biological_Process_2021,urogenital system development (GO:0001655),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,AMH
650,GO_Biological_Process_2021,negative regulation of gene silencing by miRNA (GO:0060965),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,TERT
651,GO_Biological_Process_2021,negative regulation of hemostasis (GO:1900047),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,PROC
652,GO_Biological_Process_2021,neurotransmitter uptake (GO:0001504),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,SLC1A6
653,GO_Biological_Process_2021,organic hydroxy compound catabolic process (GO:1901616),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,HSD17B6
654,GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,HTR1D
655,GO_Biological_Process_2021,positive regulation of actin filament depolymerization (GO:0030836),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,CRACD
656,GO_Biological_Process_2021,positive regulation of cardiocyte differentiation (GO:1905209),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,GATA4
657,GO_Biological_Process_2021,positive regulation of cellular senescence (GO:2000774),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,CDKN2A
658,GO_Biological_Process_2021,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/12,0.4938592792945523,0.9999959186369975,0,0,1.5579937304075235,1.0991718403283195,CD177
659,GO_Biological_Process_2021,spindle assembly (GO:0051225),5/84,0.4964473687016124,0.9999959186369975,0,0,1.0847109819925758,0.7595990263372402,TPX2;KIFC1;NEK2;KIF11;MISP
660,GO_Biological_Process_2021,regulation of interleukin-10 production (GO:0032653),3/48,0.4980917384999101,0.9999959186369975,0,0,1.1425454545454543,0.7963210537898854,ISG15;TIGIT;FOXP3
661,GO_Biological_Process_2021,substrate adhesion-dependent cell spreading (GO:0034446),3/48,0.4980917384999101,0.9999959186369975,0,0,1.1425454545454543,0.7963210537898854,NTNG1;KIF14;FN1
662,GO_Biological_Process_2021,negative regulation of mitotic cell cycle (GO:0045930),3/48,0.4980917384999101,0.9999959186369975,0,0,1.1425454545454543,0.7963210537898854,BUB1B;BRINP3;BUB1
663,GO_Biological_Process_2021,alpha-amino acid catabolic process (GO:1901606),2/30,0.4985109260539437,0.9999959186369975,0,0,1.224146879460231,0.8521650880429291,IL4I1;TDO2
664,GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),2/30,0.4985109260539437,0.9999959186369975,0,0,1.224146879460231,0.8521650880429291,NEURL1;MAGEA1
665,GO_Biological_Process_2021,positive regulation of lipid kinase activity (GO:0090218),2/30,0.4985109260539437,0.9999959186369975,0,0,1.224146879460231,0.8521650880429291,EPHA8;EEF1A2
666,GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),5/85,0.5069952106405062,0.9999959186369975,0,0,1.0710951730418945,0.7275453828021173,RRM2;CCNE1;CDKN2A;INHBA;CDKN3
667,GO_Biological_Process_2021,response to glucose (GO:0009749),3/49,0.5120299253694699,0.9999959186369975,0,0,1.1176482213438734,0.7481226573120214,SLC30A8;NKX6-1;MAFA
668,GO_Biological_Process_2021,receptor signaling pathway via JAK-STAT (GO:0007259),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,IL21;IFNL4
669,GO_Biological_Process_2021,regulation of calcium ion-dependent exocytosis (GO:0017158),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,SYT1;SYT13
670,GO_Biological_Process_2021,regulation of cellular senescence (GO:2000772),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,TERT;CDKN2A
671,GO_Biological_Process_2021,embryonic skeletal system morphogenesis (GO:0048704),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,HOXB9;SOX11
672,GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,SUMO4;SOX11
673,GO_Biological_Process_2021,negative regulation of interleukin-6 production (GO:0032715),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,ORM1;FOXJ1
674,GO_Biological_Process_2021,peptide cross-linking (GO:0018149),2/31,0.516135068082939,0.9999959186369975,0,0,1.181872279119296,0.7816747103983679,FN1;IVL
675,GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),5/86,0.5174536670545631,0.9999959186369975,0,0,1.05781555690481,0.6969262193189797,IL21;IFNL1;ISG15;INHBA;FOXP3
676,GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),4/68,0.5209279372120663,0.9999959186369975,0,0,1.0710304822565968,0.6984656348735727,TERT;PLK1;CDK1;GTSE1
677,GO_Biological_Process_2021,atrial cardiac muscle cell action potential (GO:0086014),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,KCNJ3
678,GO_Biological_Process_2021,regulation of cell aging (GO:0090342),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,FOXM1
679,GO_Biological_Process_2021,cardiac cell development (GO:0055006),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,MYH6
680,GO_Biological_Process_2021,cardiac right ventricle morphogenesis (GO:0003215),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,GATA4
681,GO_Biological_Process_2021,regulation of interleukin-5 production (GO:0032674),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,IFNL1
682,GO_Biological_Process_2021,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,NDC80
683,GO_Biological_Process_2021,detection of calcium ion (GO:0005513),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,SYT1
684,GO_Biological_Process_2021,DNA deamination (GO:0045006),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,APOBEC3B
685,GO_Biological_Process_2021,DNA replication-independent nucleosome organization (GO:0034724),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,ASF1B
686,GO_Biological_Process_2021,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,F7
687,GO_Biological_Process_2021,regulation of T cell differentiation in thymus (GO:0033081),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,FOXJ1
688,GO_Biological_Process_2021,response to UV-B (GO:0010224),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,IVL
689,GO_Biological_Process_2021,spinal cord development (GO:0021510),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,SOX11
690,GO_Biological_Process_2021,synaptic vesicle localization (GO:0097479),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,SYNDIG1
691,GO_Biological_Process_2021,mature B cell differentiation involved in immune response (GO:0002313),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,IL21
692,GO_Biological_Process_2021,negative regulation of adenylate cyclase activity (GO:0007194),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,GABBR2
693,GO_Biological_Process_2021,negative regulation of cellular senescence (GO:2000773),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,TERT
694,GO_Biological_Process_2021,negative regulation of myotube differentiation (GO:0010832),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,CEACAM5
695,GO_Biological_Process_2021,plasma membrane tubulation (GO:0097320),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,PACSIN1
696,GO_Biological_Process_2021,polyamine metabolic process (GO:0006595),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,AOC1
697,GO_Biological_Process_2021,positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,SYT1
698,GO_Biological_Process_2021,positive regulation of calcium-mediated signaling (GO:0050850),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,NEUROD2
699,GO_Biological_Process_2021,positive regulation of cell aging (GO:0090343),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,CDKN2A
700,GO_Biological_Process_2021,positive regulation of transporter activity (GO:0032411),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,SYNGR3
701,GO_Biological_Process_2021,protein localization to mitochondrion (GO:0070585),1/13,0.5217896351623155,0.9999959186369975,0,0,1.4280852994555353,0.9289563062088442,ISG15
702,GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),17/306,0.5233167614501092,0.9999959186369975,0,0,1.0079081356299426,0.6526893940575571,GABRQ;GABBR2;GRIA2;HTR1E;SYT1;GABRA5;GAD1;CHRNA6;SLC1A1;HTR1D;SLC1A6;HCRTR2;CHRND;GRM4;HRH3;GABRD;CBLN2
703,GO_Biological_Process_2021,defense response to symbiont (GO:0140546),7/124,0.5299835527534081,0.9999959186369975,0,0,1.0251731237132695,0.6508919559512343,IL21;IFNL1;IFI6;ISG15;IFNL4;IFNL3;APOBEC3B
704,GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),4/69,0.5325564111670429,0.9999959186369975,0,0,1.0544970952614263,0.6644032419219044,NEUROD2;SYT1;SYT13;KCNH1
705,GO_Biological_Process_2021,aortic valve morphogenesis (GO:0003180),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,GATA5;GATA4
706,GO_Biological_Process_2021,cardiac muscle tissue morphogenesis (GO:0055008),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,MYH6;MYH7
707,GO_Biological_Process_2021,DNA damage checkpoint signaling (GO:0000077),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,BRIP1;CLSPN
708,GO_Biological_Process_2021,hematopoietic progenitor cell differentiation (GO:0002244),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,TMEM190;INHBA
709,GO_Biological_Process_2021,negative regulation of double-strand break repair (GO:2000780),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,POLQ;AUNIP
710,GO_Biological_Process_2021,positive regulation of interleukin-10 production (GO:0032733),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,ISG15;TIGIT
711,GO_Biological_Process_2021,positive regulation of telomere maintenance (GO:0032206),2/32,0.5333425753852282,0.9999959186369975,0,0,1.1424159854677567,0.718112784546934,NEK2;AURKB
712,GO_Biological_Process_2021,sensory perception of mechanical stimulus (GO:0050954),5/88,0.538081821577859,0.9999959186369975,0,0,1.0322162968815152,0.6397105231623834,CEMIP;COL11A1;BIRC5;OTOR;CLRN1
713,GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),4/70,0.5440431097651776,0.9999959186369975,0,0,1.0384647199933823,0.6321412948798597,PGLYRP4;PGLYRP3;H2BC10;H2BC11
714,GO_Biological_Process_2021,antiviral innate immune response (GO:0140374),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CXCL10
715,GO_Biological_Process_2021,atrial septum development (GO:0003283),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,GATA4
716,GO_Biological_Process_2021,bone morphogenesis (GO:0060349),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,MMP13
717,GO_Biological_Process_2021,calcium ion import across plasma membrane (GO:0098703),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,SLC24A2
718,GO_Biological_Process_2021,regulation of chromatin organization (GO:1902275),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,MKI67
719,GO_Biological_Process_2021,regulation of histone deacetylation (GO:0031063),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,FOXP3
720,GO_Biological_Process_2021,regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CD177
721,GO_Biological_Process_2021,covalent chromatin modification (GO:0016569),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,AURKB
722,GO_Biological_Process_2021,dicarboxylic acid catabolic process (GO:0043649),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,GAD1
723,GO_Biological_Process_2021,regulation of retinoic acid receptor signaling pathway (GO:0048385),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,PRAME
724,GO_Biological_Process_2021,sequestering of extracellular ligand from receptor (GO:0035581),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,FBN2
725,GO_Biological_Process_2021,sodium-independent organic anion transport (GO:0043252),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,SLCO5A1
726,GO_Biological_Process_2021,steroid catabolic process (GO:0006706),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,HSD17B6
727,GO_Biological_Process_2021,striated muscle cell development (GO:0055002),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,MYH6
728,GO_Biological_Process_2021,substrate-dependent cell migration (GO:0006929),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,EPHA8
729,GO_Biological_Process_2021,synaptic membrane adhesion (GO:0099560),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,NTNG1
730,GO_Biological_Process_2021,T-helper cell differentiation (GO:0042093),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,IL21
731,GO_Biological_Process_2021,negative regulation of cartilage development (GO:0061037),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,NKX3-2
732,GO_Biological_Process_2021,negative regulation of coagulation (GO:0050819),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,PROC
733,GO_Biological_Process_2021,negative regulation of cyclase activity (GO:0031280),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,GABBR2
734,GO_Biological_Process_2021,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,SULF1
735,GO_Biological_Process_2021,negative regulation of interleukin-12 production (GO:0032695),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,TIGIT
736,GO_Biological_Process_2021,neuromuscular process controlling balance (GO:0050885),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CLRN1
737,GO_Biological_Process_2021,neurotransmitter biosynthetic process (GO:0042136),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,SLC44A4
738,GO_Biological_Process_2021,ovarian follicle development (GO:0001541),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,INHBA
739,GO_Biological_Process_2021,pancreas development (GO:0031016),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,NKX6-1
740,GO_Biological_Process_2021,peptidyl-serine dephosphorylation (GO:0070262),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,PPP2R2C
741,GO_Biological_Process_2021,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CD80
742,GO_Biological_Process_2021,positive regulation of leukocyte degranulation (GO:0043302),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CD177
743,GO_Biological_Process_2021,positive regulation of lymphocyte migration (GO:2000403),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CXCL10
744,GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,LRRC52
745,GO_Biological_Process_2021,positive regulation of superoxide anion generation (GO:0032930),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CD177
746,GO_Biological_Process_2021,positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,CD80
747,GO_Biological_Process_2021,pre-miRNA processing (GO:0031054),1/14,0.5481800262382279,0.9999959186369975,0,0,1.3181627809576992,0.7924155738141718,LIN28B
748,GO_Biological_Process_2021,regulation of interleukin-17 production (GO:0032660),2/33,0.5501257654833872,0.9999959186369975,0,0,1.1055052591485746,0.660659187522386,IL21;FOXP3
749,GO_Biological_Process_2021,positive regulation of telomere maintenance via telomerase (GO:0032212),2/33,0.5501257654833872,0.9999959186369975,0,0,1.1055052591485746,0.660659187522386,NEK2;AURKB
750,GO_Biological_Process_2021,signal transduction in response to DNA damage (GO:0042770),3/52,0.5525632776054734,0.9999959186369975,0,0,1.0490538033395176,0.6222854168092223,BRIP1;CLSPN;E2F7
751,GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),3/52,0.5525632776054734,0.9999959186369975,0,0,1.0490538033395176,0.6222854168092223,ESM1;E2F7;E2F8
752,GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),3/52,0.5525632776054734,0.9999959186369975,0,0,1.0490538033395176,0.6222854168092223,CNTNAP2;MNX1;PACSIN1
753,GO_Biological_Process_2021,positive regulation of cellular protein localization (GO:1903829),4/71,0.5553823652395882,0.9999959186369975,0,0,1.0229109230915483,0.6015723345700155,PLK1;CDK1;GTSE1;NDC80
754,GO_Biological_Process_2021,cellular macromolecule catabolic process (GO:0044265),3/53,0.5656223384152236,0.9999959186369975,0,0,1.0280181818181815,0.5857942333874292,NEU4;MAGEC2;NCCRP1
755,GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,RET;EPHA8
756,GO_Biological_Process_2021,cardiac muscle contraction (GO:0060048),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,MYH6;MYH7
757,GO_Biological_Process_2021,regulation of transmembrane transport (GO:0034762),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,KCNJ6;KCNJ3
758,GO_Biological_Process_2021,synaptic vesicle recycling (GO:0036465),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,SYT1;PACSIN1
759,GO_Biological_Process_2021,ventricular cardiac muscle tissue morphogenesis (GO:0055010),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,MYH6;MYH7
760,GO_Biological_Process_2021,positive regulation of telomerase activity (GO:0051973),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,NEK2;AURKB
761,GO_Biological_Process_2021,protein localization to chromosome (GO:0034502),2/34,0.5664790681377226,0.9999959186369975,0,0,1.0709014532243415,0.6086095185730146,PLK1;CENPA
762,GO_Biological_Process_2021,sensory perception of sound (GO:0007605),5/91,0.5682325658090331,0.9999959186369975,0,0,0.9960499004532554,0.5629918041843265,CEMIP;COL11A1;BIRC5;OTOR;CLRN1
763,GO_Biological_Process_2021,acetyl-CoA metabolic process (GO:0006084),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,TDO2
764,GO_Biological_Process_2021,calcium ion import into cytosol (GO:1902656),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,SLC24A2
765,GO_Biological_Process_2021,clathrin coat assembly (GO:0048268),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,CALY
766,GO_Biological_Process_2021,regulation of macrophage differentiation (GO:0045649),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,INHBA
767,GO_Biological_Process_2021,regulation of neuron projection arborization (GO:0150011),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,NTNG1
768,GO_Biological_Process_2021,establishment of apical/basal cell polarity (GO:0035089),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,FOXJ1
769,GO_Biological_Process_2021,establishment of spindle localization (GO:0051293),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,ESPL1
770,GO_Biological_Process_2021,regulation of superoxide anion generation (GO:0032928),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,CD177
771,GO_Biological_Process_2021,response to muscle stretch (GO:0035994),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,CDH2
772,GO_Biological_Process_2021,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,KCNJ3
773,GO_Biological_Process_2021,myoblast fusion (GO:0007520),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,KCNH1
774,GO_Biological_Process_2021,negative regulation of chondrocyte differentiation (GO:0032331),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,NKX3-2
775,GO_Biological_Process_2021,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,MAGEA3
776,GO_Biological_Process_2021,negative regulation of protein processing (GO:0010955),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,MAGEA3
777,GO_Biological_Process_2021,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,APOBEC3B
778,GO_Biological_Process_2021,positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,CEACAM6
779,GO_Biological_Process_2021,positive regulation of keratinocyte differentiation (GO:0045618),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,ZBED2
780,GO_Biological_Process_2021,positive regulation of protein export from nucleus (GO:0046827),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,GTSE1
781,GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,SCT
782,GO_Biological_Process_2021,"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.57311528692086,0.9999959186369975,0,0,1.2239434793881254,0.6813306383993923,TERT
783,GO_Biological_Process_2021,regulation of potassium ion transmembrane transport (GO:1901379),3/54,0.5784451206719013,0.9999959186369975,0,0,1.007807486631016,0.5516855104818414,GABBR2;KCNJ6;KCNJ3
784,GO_Biological_Process_2021,negative regulation of viral genome replication (GO:0045071),3/54,0.5784451206719013,0.9999959186369975,0,0,1.007807486631016,0.5516855104818414,ISG15;IFNL3;APOBEC3B
785,GO_Biological_Process_2021,acylglycerol catabolic process (GO:0046464),2/35,0.5823988157408472,0.9999959186369975,0,0,1.038394847659153,0.5613560630749512,PNLIPRP2;FABP6
786,GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),2/35,0.5823988157408472,0.9999959186369975,0,0,1.038394847659153,0.5613560630749512,KCNJ6;KCNJ3
787,GO_Biological_Process_2021,regulation of regulated secretory pathway (GO:1903305),2/35,0.5823988157408472,0.9999959186369975,0,0,1.038394847659153,0.5613560630749512,SYT1;SYT13
788,GO_Biological_Process_2021,lung development (GO:0030324),2/35,0.5823988157408472,0.9999959186369975,0,0,1.038394847659153,0.5613560630749512,FOXJ1;SOX11
789,GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),2/35,0.5823988157408472,0.9999959186369975,0,0,1.038394847659153,0.5613560630749512,CDKN2A;E2F7
790,GO_Biological_Process_2021,negative regulation of neurogenesis (GO:0050768),2/35,0.5823988157408472,0.9999959186369975,0,0,1.038394847659153,0.5613560630749512,CCL11;PAX6
791,GO_Biological_Process_2021,visual perception (GO:0007601),5/93,0.587757924488728,0.9999959186369975,0,0,0.9733089087597284,0.5172553924633838,COL11A1;GRM8;SIX3;PAX6;TYR
792,GO_Biological_Process_2021,brain development (GO:0007420),8/150,0.5898897819714143,0.9999959186369975,0,0,0.9649495144382276,0.5093192375427196,DMBX1;CNTNAP2;CENPF;CDH2;SCT;SIX3;FOXJ1;NKX2-2
793,GO_Biological_Process_2021,glycoprotein metabolic process (GO:0009100),3/55,0.5910267255365785,0.9999959186369975,0,0,0.988374125874126,0.5197800637917613,NEU4;GAL3ST2;NCCRP1
794,GO_Biological_Process_2021,interstrand cross-link repair (GO:0036297),3/55,0.5910267255365785,0.9999959186369975,0,0,0.988374125874126,0.5197800637917613,NEIL3;EME1;UBE2T
795,GO_Biological_Process_2021,negative regulation of cytokine-mediated signaling pathway (GO:0001960),3/55,0.5910267255365785,0.9999959186369975,0,0,0.988374125874126,0.5197800637917613,H2BC11;PYDC1;ISG15
796,GO_Biological_Process_2021,basement membrane organization (GO:0071711),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,NTNG1
797,GO_Biological_Process_2021,regulation of ERBB signaling pathway (GO:1901184),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,IFI6
798,GO_Biological_Process_2021,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,CD80
799,GO_Biological_Process_2021,regulation of hormone secretion (GO:0046883),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,SOX11
800,GO_Biological_Process_2021,ceramide catabolic process (GO:0046514),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,NEU4
801,GO_Biological_Process_2021,regulation of interleukin-1 production (GO:0032652),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,ORM1
802,GO_Biological_Process_2021,regulation of interleukin-13 production (GO:0032656),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,IFNL1
803,GO_Biological_Process_2021,eosinophil chemotaxis (GO:0048245),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,CCL11
804,GO_Biological_Process_2021,eosinophil migration (GO:0072677),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,CCL11
805,GO_Biological_Process_2021,regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,CORIN
806,GO_Biological_Process_2021,glutamine family amino acid catabolic process (GO:0009065),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,GAD1
807,GO_Biological_Process_2021,retrograde axonal transport (GO:0008090),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,KIF1A
808,GO_Biological_Process_2021,mesenchyme development (GO:0060485),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,GATA4
809,GO_Biological_Process_2021,transepithelial transport (GO:0070633),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,SLC1A1
810,GO_Biological_Process_2021,negative regulation of histone modification (GO:0031057),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,FOXP3
811,GO_Biological_Process_2021,negative regulation of immune effector process (GO:0002698),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,IFNL1
812,GO_Biological_Process_2021,negative regulation of lyase activity (GO:0051350),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,GABBR2
813,GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,SOX11
814,GO_Biological_Process_2021,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,ISG15
815,GO_Biological_Process_2021,neural tube development (GO:0021915),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,SOX11
816,GO_Biological_Process_2021,neuron cell-cell adhesion (GO:0007158),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,RET
817,GO_Biological_Process_2021,polyol biosynthetic process (GO:0046173),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,ITPKA
818,GO_Biological_Process_2021,protein localization to microtubule organizing center (GO:1905508),1/16,0.5966755821764589,0.9999959186369975,0,0,1.1422867513611614,0.5898560050908457,SPAG5
819,GO_Biological_Process_2021,aortic valve development (GO:0003176),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,GATA5;GATA4
820,GO_Biological_Process_2021,axonal transport (GO:0098930),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,KIF4A;KIF1A
821,GO_Biological_Process_2021,regulation of cell cycle G1/S phase transition (GO:1902806),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,KIF14;FAM83D
822,GO_Biological_Process_2021,regulation of ossification (GO:0030278),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,SOX11;KREMEN2
823,GO_Biological_Process_2021,telomere maintenance via telomere lengthening (GO:0010833),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,TERT;ZSCAN4
824,GO_Biological_Process_2021,positive regulation of bone mineralization (GO:0030501),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,FBN2;ISG15
825,GO_Biological_Process_2021,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),2/36,0.597883051014121,0.9999959186369975,0,0,1.0078003953625048,0.5183723232478998,NEK2;AURKB
826,GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),3/56,0.6033630263321236,0.9999959186369975,0,0,0.9696740994854204,0.4899144860484404,ACAN;CEMIP;HMMR
827,GO_Biological_Process_2021,telomere maintenance (GO:0000723),3/56,0.6033630263321236,0.9999959186369975,0,0,0.9696740994854204,0.4899144860484404,TERT;ZSCAN4;HUS1B
828,GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),6/114,0.6053953188609147,0.9999959186369975,0,0,0.9515344879975692,0.4775500530336164,CDC20;NEUROD2;TCL1A;CALY;MMP1;NEURL1
829,GO_Biological_Process_2021,chloride transport (GO:0006821),4/76,0.60970094457555,0.9999959186369975,0,0,0.9516226872914773,0.4708502460669042,GABRQ;GABRA5;SLC1A1;GABRD
830,GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),4/76,0.60970094457555,0.9999959186369975,0,0,0.9516226872914773,0.4708502460669042,IL21;IL4I1;CD80;FOXP3
831,GO_Biological_Process_2021,anterograde axonal transport (GO:0008089),2/37,0.6129313497279363,0.9999959186369975,0,0,0.978954197482808,0.4792003703944622,KIF4A;KIF1A
832,GO_Biological_Process_2021,regulation of microtubule cytoskeleton organization (GO:0070507),2/37,0.6129313497279363,0.9999959186369975,0,0,0.978954197482808,0.4792003703944622,SKA3;SKA1
833,GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2/37,0.6129313497279363,0.9999959186369975,0,0,0.978954197482808,0.4792003703944622,CDKN2A;E2F7
834,GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),3/57,0.6154506249550273,0.9999959186369975,0,0,0.9516666666666668,0.4619395291098406,IL21;IFNL1;ISG15
835,GO_Biological_Process_2021,regulation of cellular response to growth factor stimulus (GO:0090287),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,SULF1
836,GO_Biological_Process_2021,regulation of establishment of endothelial barrier (GO:1903140),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,PROC
837,GO_Biological_Process_2021,regulation of neuroblast proliferation (GO:1902692),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,SIX3
838,GO_Biological_Process_2021,DNA biosynthetic process (GO:0071897),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,TERT
839,GO_Biological_Process_2021,regulation of NLRP3 inflammasome complex assembly (GO:1900225),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,PYDC1
840,GO_Biological_Process_2021,epithelial cell morphogenesis (GO:0003382),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,COL22A1
841,GO_Biological_Process_2021,gliogenesis (GO:0042063),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,CDH2
842,GO_Biological_Process_2021,RNA interference (GO:0016246),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,TERT
843,GO_Biological_Process_2021,negative regulation of cytokine production involved in immune response (GO:0002719),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,FOXP3
844,GO_Biological_Process_2021,negative regulation of insulin secretion (GO:0046676),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,BMP8A
845,GO_Biological_Process_2021,negative regulation of interleukin-10 production (GO:0032693),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,FOXP3
846,GO_Biological_Process_2021,positive regulation of dendrite extension (GO:1903861),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,SYT1
847,GO_Biological_Process_2021,positive regulation of positive chemotaxis (GO:0050927),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,F7
848,GO_Biological_Process_2021,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,CCN4
849,GO_Biological_Process_2021,positive regulation of stem cell differentiation (GO:2000738),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,GATA4
850,GO_Biological_Process_2021,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.6189366644544897,0.9999959186369975,0,0,1.070837114337568,0.5137366013703448,DLGAP5
851,GO_Biological_Process_2021,inorganic cation import across plasma membrane (GO:0098659),4/77,0.6200620190885736,0.9999959186369975,0,0,0.938536901541875,0.448560361552544,SLC24A2;SLC9A4;KCNJ6;KCNJ3
852,GO_Biological_Process_2021,negative regulation of developmental process (GO:0051093),4/77,0.6200620190885736,0.9999959186369975,0,0,0.938536901541875,0.448560361552544,NEUROD2;FOXJ1;PRAME;FOXM1
853,GO_Biological_Process_2021,cation transport (GO:0006812),9/174,0.6262728890873072,0.9999959186369975,0,0,0.9339537975735416,0.4370614973677938,KCNG1;KCNF1;KCNJ6;SLC1A1;TRPM8;TRPM5;KCNH1;SCN1A;KCNJ3
854,GO_Biological_Process_2021,chordate embryonic development (GO:0043009),3/58,0.6272868098639613,0.9999959186369975,0,0,0.9343140495867768,0.4357186752852991,FOXD3;SULF1;MYH6
855,GO_Biological_Process_2021,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/58,0.6272868098639613,0.9999959186369975,0,0,0.9343140495867768,0.4357186752852991,BMP8A;TTK;INHBA
856,GO_Biological_Process_2021,DNA replication initiation (GO:0006270),2/38,0.6275446578608165,0.9999959186369975,0,0,0.951710566151983,0.4434404424226446,ORC6;MCM10
857,GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),2/38,0.6275446578608165,0.9999959186369975,0,0,0.951710566151983,0.4434404424226446,SYT1;PACSIN1
858,GO_Biological_Process_2021,ventricular septum development (GO:0003281),2/38,0.6275446578608165,0.9999959186369975,0,0,0.951710566151983,0.4434404424226446,GATA4;SOX11
859,GO_Biological_Process_2021,positive regulation of cell development (GO:0010720),2/38,0.6275446578608165,0.9999959186369975,0,0,0.951710566151983,0.4434404424226446,SOX11;NKX6-1
860,GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),3/59,0.6388695144392796,0.9999959186369975,0,0,0.9175811688311688,0.4111268748393062,IL21;IFNL1;EPO
861,GO_Biological_Process_2021,regulation of adaptive immune response (GO:0002819),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,IL4I1
862,GO_Biological_Process_2021,base conversion or substitution editing (GO:0016553),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,APOBEC3B
863,GO_Biological_Process_2021,regulation of catabolic process (GO:0009894),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,FAM83D
864,GO_Biological_Process_2021,regulation of delayed rectifier potassium channel activity (GO:1902259),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,KCNG1
865,GO_Biological_Process_2021,regulation of dendrite extension (GO:1903859),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,SYT1
866,GO_Biological_Process_2021,DNA conformation change (GO:0071103),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,TOP2A
867,GO_Biological_Process_2021,DNA strand elongation (GO:0022616),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,TERT
868,GO_Biological_Process_2021,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,TERT
869,GO_Biological_Process_2021,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,HRH3
870,GO_Biological_Process_2021,regulation of transforming growth factor beta production (GO:0071634),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,FN1
871,GO_Biological_Process_2021,release of cytochrome c from mitochondria (GO:0001836),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,IFI6
872,GO_Biological_Process_2021,RNA destabilization (GO:0050779),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,LIN28B
873,GO_Biological_Process_2021,sodium ion import across plasma membrane (GO:0098719),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,SLC9A4
874,GO_Biological_Process_2021,"synaptic transmission, glutamatergic (GO:0035249)",1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,GRIA2
875,GO_Biological_Process_2021,mitochondrial fission (GO:0000266),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,MTFR2
876,GO_Biological_Process_2021,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,EPO
877,GO_Biological_Process_2021,negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,POLQ
878,GO_Biological_Process_2021,negative regulation of peptide hormone secretion (GO:0090278),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,BMP8A
879,GO_Biological_Process_2021,neuron maturation (GO:0042551),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,EPHA8
880,GO_Biological_Process_2021,nitric oxide mediated signal transduction (GO:0007263),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,MAFA
881,GO_Biological_Process_2021,nucleotide biosynthetic process (GO:0009165),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,RRM2
882,GO_Biological_Process_2021,outer dynein arm assembly (GO:0036158),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,DNAH8
883,GO_Biological_Process_2021,positive regulation of cell cycle phase transition (GO:1901989),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,FAM83D
884,GO_Biological_Process_2021,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,CELF3
885,GO_Biological_Process_2021,positive regulation of nitric-oxide synthase activity (GO:0051000),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,TERT
886,GO_Biological_Process_2021,protein localization to centrosome (GO:0071539),1/18,0.6399701163154148,0.9999959186369975,0,0,1.0077933169638091,0.4498122177272404,SPAG5
887,GO_Biological_Process_2021,negative regulation of NF-kappaB transcription factor activity (GO:0032088),4/79,0.6402578744108381,0.9999959186369975,0,0,0.9134121929026388,0.4072761151544505,CDKN2A;FOXJ1;PYDC1;FOXP3
888,GO_Biological_Process_2021,regulation of dendrite development (GO:0050773),2/39,0.6417251419538458,0.9999959186369975,0,0,0.9259395635417432,0.4107423410278775,CSMD3;PACSIN1
889,GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),2/39,0.6417251419538458,0.9999959186369975,0,0,0.9259395635417432,0.4107423410278775,CEMIP;PLK1
890,GO_Biological_Process_2021,regulation of T cell differentiation (GO:0045580),2/39,0.6417251419538458,0.9999959186369975,0,0,0.9259395635417432,0.4107423410278775,IFNL1;FOXP3
891,GO_Biological_Process_2021,vesicle cytoskeletal trafficking (GO:0099518),2/39,0.6417251419538458,0.9999959186369975,0,0,0.9259395635417432,0.4107423410278775,BICDL1;KIF1A
892,GO_Biological_Process_2021,phospholipid dephosphorylation (GO:0046839),2/39,0.6417251419538458,0.9999959186369975,0,0,0.9259395635417432,0.4107423410278775,PLPP4;PLPPR5
893,GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),4/80,0.6500884357546585,0.9999959186369975,0,0,0.901345720990374,0.3881617138387927,CDKN2A;PLK1;INHBA;BRINP3
894,GO_Biological_Process_2021,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),3/60,0.6501972768613098,0.9999959186369975,0,0,0.9014354066985646,0.3880494264483602,CDH2;CEACAM6;CEACAM5
895,GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),7/139,0.6511583898544845,0.9999959186369975,0,0,0.907950398142004,0.3895128671785511,HJURP;KIF14;MKI67;ERMN;CD177;PACSIN1;AURKA
896,GO_Biological_Process_2021,bone development (GO:0060348),2/40,0.655476051953673,0.9999959186369975,0,0,0.9015249294899372,0.3807982797344538,MMP13;SULF1
897,GO_Biological_Process_2021,lymphocyte migration (GO:0072676),2/40,0.655476051953673,0.9999959186369975,0,0,0.9015249294899372,0.3807982797344538,RET;CCL11
898,GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),2/40,0.655476051953673,0.9999959186369975,0,0,0.9015249294899372,0.3807982797344538,F7;PROC
899,GO_Biological_Process_2021,activin receptor signaling pathway (GO:0032924),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,INHBA
900,GO_Biological_Process_2021,atrioventricular valve morphogenesis (GO:0003181),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,GATA4
901,GO_Biological_Process_2021,branching involved in ureteric bud morphogenesis (GO:0001658),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FOXD1
902,GO_Biological_Process_2021,cardiac muscle cell contraction (GO:0086003),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,SCN1A
903,GO_Biological_Process_2021,regulation of epithelial cell differentiation (GO:0030856),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,DSPP
904,GO_Biological_Process_2021,cellular response to copper ion (GO:0071280),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,AOC1
905,GO_Biological_Process_2021,cellular response to interleukin-7 (GO:0098761),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,H3C13
906,GO_Biological_Process_2021,regulation of leukocyte chemotaxis (GO:0002688),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,F7
907,GO_Biological_Process_2021,regulation of lymphocyte proliferation (GO:0050670),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,SOX11
908,GO_Biological_Process_2021,regulation of mitotic spindle assembly (GO:1901673),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,PLK1
909,GO_Biological_Process_2021,detection of mechanical stimulus (GO:0050982),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,CDH2
910,GO_Biological_Process_2021,DNA alkylation (GO:0006305),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,TEX15
911,GO_Biological_Process_2021,DNA methylation or demethylation (GO:0044728),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,TEX15
912,GO_Biological_Process_2021,endocardial cushion morphogenesis (GO:0003203),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,GATA5
913,GO_Biological_Process_2021,establishment of skin barrier (GO:0061436),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FLG2
914,GO_Biological_Process_2021,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FOXJ1
915,GO_Biological_Process_2021,regulation of T cell cytokine production (GO:0002724),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FOXP3
916,GO_Biological_Process_2021,regulation of water loss via skin (GO:0033561),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FLG2
917,GO_Biological_Process_2021,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,HS6ST3
918,GO_Biological_Process_2021,interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,H3C13
919,GO_Biological_Process_2021,long-term memory (GO:0007616),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,LRRN4
920,GO_Biological_Process_2021,ureteric bud development (GO:0001657),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FOXJ1
921,GO_Biological_Process_2021,negative regulation of calcium ion transport (GO:0051926),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,EPO
922,GO_Biological_Process_2021,negative regulation of immune system process (GO:0002683),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,FOXP3
923,GO_Biological_Process_2021,negative regulation of RNA metabolic process (GO:0051253),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,TERT
924,GO_Biological_Process_2021,negative regulation of striated muscle cell differentiation (GO:0051154),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,CEACAM5
925,GO_Biological_Process_2021,neuromuscular process (GO:0050905),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,CHRND
926,GO_Biological_Process_2021,nuclear membrane organization (GO:0071763),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,PLK1
927,GO_Biological_Process_2021,positive regulation of mitochondrial fission (GO:0090141),1/19,0.6598435794842474,0.9999959186369975,0,0,0.9517543859649122,0.3956942394938353,AURKA
928,GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),3/61,0.6612692013824938,0.9999959186369975,0,0,0.885846394984326,0.3663809826336551,CALY;CD177;PACSIN1
929,GO_Biological_Process_2021,O-glycan processing (GO:0016266),3/61,0.6612692013824938,0.9999959186369975,0,0,0.885846394984326,0.3663809826336551,MUC2;MUC19;MUC5AC
930,GO_Biological_Process_2021,regulation of filopodium assembly (GO:0051489),2/41,0.6688015952352505,0.9999959186369975,0,0,0.8783623279536086,0.3533369093713808,PLPPR5;NEURL1
931,GO_Biological_Process_2021,epithelial cell migration (GO:0010631),2/41,0.6688015952352505,0.9999959186369975,0,0,0.8783623279536086,0.3533369093713808,ANLN;S100P
932,GO_Biological_Process_2021,heart contraction (GO:0060047),2/41,0.6688015952352505,0.9999959186369975,0,0,0.8783623279536086,0.3533369093713808,MYH6;MYH7
933,GO_Biological_Process_2021,response to growth factor (GO:0070848),2/41,0.6688015952352505,0.9999959186369975,0,0,0.8783623279536086,0.3533369093713808,SOX2;IBSP
934,GO_Biological_Process_2021,keratinocyte differentiation (GO:0030216),2/41,0.6688015952352505,0.9999959186369975,0,0,0.8783623279536086,0.3533369093713808,IVL;S100A7
935,GO_Biological_Process_2021,positive regulation of biomineral tissue development (GO:0070169),2/41,0.6688015952352505,0.9999959186369975,0,0,0.8783623279536086,0.3533369093713808,FBN2;ISG15
936,GO_Biological_Process_2021,positive regulation of cytoskeleton organization (GO:0051495),4/82,0.6692068465433474,0.9999959186369975,0,0,0.8781409673129419,0.35271592657224,CCL11;SYNPO2L;SPAG5;CRACD
937,GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),15/296,0.6694607140938281,0.9999959186369975,0,0,0.9133608959598074,0.3665160132147544,CDKN2A;PLK1;INHBA;FOXM1;SOX2;CCNB2;CENPF;PCLAF;CKS2;BIRC5;MYBL2;PRR11;DTL;DLGAP5;CDKN3
938,GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),10/201,0.6761208637154944,0.9999959186369975,0,0,0.8960400070893789,0.3506952082038458,CDC20;PTTG1;UBE2C;UHRF1;PLK1;BUB1B;ISG15;DTL;AURKB;AURKA
939,GO_Biological_Process_2021,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4/83,0.6784924678287682,0.9999959186369975,0,0,0.8669791870630378,0.336285535187409,ANLN;PLPPR5;NEURL1;CLRN1
940,GO_Biological_Process_2021,"base-excision repair, AP site formation (GO:0006285)",1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,NEIL3
941,GO_Biological_Process_2021,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,CLDN9
942,GO_Biological_Process_2021,cardiac ventricle development (GO:0003231),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,GATA4
943,GO_Biological_Process_2021,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,SULF1
944,GO_Biological_Process_2021,cellular response to nitrogen compound (GO:1901699),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,AOC1
945,GO_Biological_Process_2021,regulation of hippo signaling (GO:0035330),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,SOX11
946,GO_Biological_Process_2021,regulation of lymphocyte differentiation (GO:0045619),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,IL4I1
947,GO_Biological_Process_2021,embryonic digestive tract development (GO:0048566),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,SOX11
948,GO_Biological_Process_2021,regulation of smooth muscle cell migration (GO:0014910),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,CCN4
949,GO_Biological_Process_2021,regulation of smooth muscle contraction (GO:0006940),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,NMU
950,GO_Biological_Process_2021,eye morphogenesis (GO:0048592),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,FBN2
951,GO_Biological_Process_2021,regulation of T cell migration (GO:2000404),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,CXCL10
952,GO_Biological_Process_2021,regulation of tissue remodeling (GO:0034103),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,IL21
953,GO_Biological_Process_2021,ganglioside metabolic process (GO:0001573),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,NEU4
954,GO_Biological_Process_2021,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,S100A14
955,GO_Biological_Process_2021,microtubule nucleation (GO:0007020),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,TPX2
956,GO_Biological_Process_2021,miRNA metabolic process (GO:0010586),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,LIN28B
957,GO_Biological_Process_2021,modulation by symbiont of entry into host (GO:0052372),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,TRIML2
958,GO_Biological_Process_2021,natural killer cell mediated immunity (GO:0002228),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,ULBP1
959,GO_Biological_Process_2021,nucleobase-containing compound biosynthetic process (GO:0034654),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,TERT
960,GO_Biological_Process_2021,organic cation transport (GO:0015695),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,SLC44A4
961,GO_Biological_Process_2021,positive regulation of epidermal cell differentiation (GO:0045606),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,ZBED2
962,GO_Biological_Process_2021,positive regulation of hormone secretion (GO:0046887),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,SOX11
963,GO_Biological_Process_2021,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,IL21
964,GO_Biological_Process_2021,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,FOXP3
965,GO_Biological_Process_2021,production of small RNA involved in gene silencing by RNA (GO:0070918),1/20,0.6786209722040802,0.9999959186369975,0,0,0.9016142898080046,0.3495491178912453,TERT
966,GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/42,0.6817068213596129,0.9999959186369975,0,0,0.8563578564940962,0.3281183034112833,CEACAM6;CEACAM5
967,GO_Biological_Process_2021,potassium ion import across plasma membrane (GO:1990573),2/42,0.6817068213596129,0.9999959186369975,0,0,0.8563578564940962,0.3281183034112833,KCNJ6;KCNJ3
968,GO_Biological_Process_2021,neuropeptide signaling pathway (GO:0007218),3/63,0.6826445578634934,0.9999959186369975,0,0,0.8562272727272727,0.3268912769733708,NMU;HCRTR2;RXFP3
969,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),3/64,0.6929486951382496,0.9999959186369975,0,0,0.8421460506706409,0.308898594955841,EPO;RTKN2;MAGEA3
970,GO_Biological_Process_2021,protein catabolic process (GO:0030163),3/64,0.6929486951382496,0.9999959186369975,0,0,0.8421460506706409,0.308898594955841,NEU4;MAGEC2;NCCRP1
971,GO_Biological_Process_2021,lipid modification (GO:0030258),2/43,0.6941975165239814,0.9999959186369975,0,0,0.8354267738862675,0.3049297307126747,PLPP4;PLPPR5
972,GO_Biological_Process_2021,substantia nigra development (GO:0021762),2/43,0.6941975165239814,0.9999959186369975,0,0,0.8354267738862675,0.3049297307126747,SYNGR3;INA
973,GO_Biological_Process_2021,natural killer cell activation (GO:0030101),2/43,0.6941975165239814,0.9999959186369975,0,0,0.8354267738862675,0.3049297307126747,IL21R;ULBP1
974,GO_Biological_Process_2021,negative regulation of proteolysis (GO:0045861),2/43,0.6941975165239814,0.9999959186369975,0,0,0.8354267738862675,0.3049297307126747,MAGEA3;CST4
975,GO_Biological_Process_2021,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),2/43,0.6941975165239814,0.9999959186369975,0,0,0.8354267738862675,0.3049297307126747,IL21;CD1A
976,GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),2/43,0.6941975165239814,0.9999959186369975,0,0,0.8354267738862675,0.3049297307126747,SLC30A8;SCT
977,GO_Biological_Process_2021,aerobic respiration (GO:0009060),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,MTFR2
978,GO_Biological_Process_2021,androgen metabolic process (GO:0008209),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,HSD17B6
979,GO_Biological_Process_2021,cellular response to inorganic substance (GO:0071241),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,AOC1
980,GO_Biological_Process_2021,regulation of lipid catabolic process (GO:0050994),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,SCT
981,GO_Biological_Process_2021,cobalamin metabolic process (GO:0009235),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,PRSS1
982,GO_Biological_Process_2021,endocardial cushion development (GO:0003197),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,GATA4
983,GO_Biological_Process_2021,epithelial cell development (GO:0002064),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,SIX3
984,GO_Biological_Process_2021,histone ubiquitination (GO:0016574),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,UHRF1
985,GO_Biological_Process_2021,sensory perception of pain (GO:0019233),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,TRPA1
986,GO_Biological_Process_2021,long-term synaptic potentiation (GO:0060291),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,SLC24A2
987,GO_Biological_Process_2021,zinc ion transport (GO:0006829),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,SLC30A8
988,GO_Biological_Process_2021,myotube differentiation (GO:0014902),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,KCNH1
989,GO_Biological_Process_2021,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,EPO
990,GO_Biological_Process_2021,negative regulation of microtubule depolymerization (GO:0007026),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,TPX2
991,GO_Biological_Process_2021,negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,LRRC15
992,GO_Biological_Process_2021,negative regulation of protein localization to plasma membrane (GO:1903077),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,LRRC15
993,GO_Biological_Process_2021,negative regulation of reproductive process (GO:2000242),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,SULF1
994,GO_Biological_Process_2021,positive regulation of immune system process (GO:0002684),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,IFNL1
995,GO_Biological_Process_2021,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/21,0.6963626935037607,0.9999959186369975,0,0,0.8564882032667877,0.3099499276927063,PAX6
996,GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",3/65,0.7029983361992995,0.9999959186369975,0,0,0.8285190615835777,0.291970741913751,HRH3;HTR1E;HTR1D
997,GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),2/44,0.7062801071017979,0.9999959186369975,0,0,0.8154924094978591,0.2835820769800989,H2BC10;H2BC11
998,GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),2/44,0.7062801071017979,0.9999959186369975,0,0,0.8154924094978591,0.2835820769800989,CEACAM5;FN1
999,GO_Biological_Process_2021,neurogenesis (GO:0022008),2/44,0.7062801071017979,0.9999959186369975,0,0,0.8154924094978591,0.2835820769800989,WDR62;ASCL1
1000,GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),3/66,0.7127948763704499,0.9999959186369975,0,0,0.8153246753246753,0.2760376191647799,GJB2;CDH2;CDH7
1001,GO_Biological_Process_2021,amino acid import (GO:0043090),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,SLC1A1
1002,GO_Biological_Process_2021,regulation of adenylate cyclase activity (GO:0045761),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,GABBR2
1003,GO_Biological_Process_2021,regulation of centrosome cycle (GO:0046605),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,AURKA
1004,GO_Biological_Process_2021,regulation of chromosome organization (GO:0033044),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,BUB1
1005,GO_Biological_Process_2021,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,MAGEA3
1006,GO_Biological_Process_2021,cellular response to osmotic stress (GO:0071470),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,EPO
1007,GO_Biological_Process_2021,glutamate metabolic process (GO:0006536),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,GAD1
1008,GO_Biological_Process_2021,tetrapyrrole metabolic process (GO:0033013),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,PRSS1
1009,GO_Biological_Process_2021,membrane lipid metabolic process (GO:0006643),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,CERKL
1010,GO_Biological_Process_2021,zinc ion transmembrane transport (GO:0071577),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,SLC30A8
1011,GO_Biological_Process_2021,natural killer cell mediated cytotoxicity (GO:0042267),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,ULBP1
1012,GO_Biological_Process_2021,negative regulation of interleukin-2 production (GO:0032703),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,FOXP3
1013,GO_Biological_Process_2021,neuronal action potential (GO:0019228),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,SCN1A
1014,GO_Biological_Process_2021,osteoclast differentiation (GO:0030316),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,EFNA2
1015,GO_Biological_Process_2021,positive regulation of dendritic spine development (GO:0060999),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,NEURL1
1016,GO_Biological_Process_2021,positive regulation of lipid catabolic process (GO:0050996),1/22,0.7131258169237722,0.9999959186369975,0,0,0.8156598392533057,0.2757724813859052,SCT
1017,GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),4/87,0.7137986512945331,0.9999959186369975,0,0,0.8250216516658079,0.2781596448087666,SLC24A2;TRPA1;TRPM8;TRPM5
1018,GO_Biological_Process_2021,cellular response to radiation (GO:0071478),2/45,0.7179615716020835,0.9999959186369975,0,0,0.7964852248484464,0.2639068033472204,GPR52;OPN5
1019,GO_Biological_Process_2021,neural crest cell development (GO:0014032),2/45,0.7179615716020835,0.9999959186369975,0,0,0.7964852248484464,0.2639068033472204,CDH2;SOX11
1020,GO_Biological_Process_2021,positive regulation of nervous system development (GO:0051962),2/45,0.7179615716020835,0.9999959186369975,0,0,0.7964852248484464,0.2639068033472204,SYNDIG1;SOX11
1021,GO_Biological_Process_2021,negative regulation of binding (GO:0051100),4/88,0.7221661105528441,0.9999959186369975,0,0,0.8151566359027688,0.2653335636763306,XIRP1;SUMO4;AURKB;AURKA
1022,GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),4/88,0.7221661105528441,0.9999959186369975,0,0,0.8151566359027688,0.2653335636763306,RET;PLPPR5;ZNF804A;PACSIN1
1023,GO_Biological_Process_2021,anion transmembrane transport (GO:0098656),3/67,0.7223400705447168,0.9999959186369975,0,0,0.8025426136363636,0.2610343998934276,SLC44A4;SLC1A1;SLC1A6
1024,GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),5/109,0.7247903818056812,0.9999959186369975,0,0,0.8228685021717809,0.2648589842811887,GRM4;CDH2;SYT1;NMU;GRM8
1025,GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),8/170,0.7265181701797211,0.9999959186369975,0,0,0.8449179773380686,0.2699443533613559,NTNG1;CDH2;CLDN9;CEACAM6;CEACAM5;GATA5;CDH7;CD177
1026,GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,SOX2
1027,GO_Biological_Process_2021,regulation of interleukin-4 production (GO:0032673),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,FOXP3
1028,GO_Biological_Process_2021,cilium-dependent cell motility (GO:0060285),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,DNAH8
1029,GO_Biological_Process_2021,cytoskeleton-dependent intracellular transport (GO:0030705),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,KIF1A
1030,GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,SIX3
1031,GO_Biological_Process_2021,DNA methylation (GO:0006306),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,TEX15
1032,GO_Biological_Process_2021,regulation of peptidase activity (GO:0052547),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,A2ML1
1033,GO_Biological_Process_2021,regulation of protein export from nucleus (GO:0046825),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,GTSE1
1034,GO_Biological_Process_2021,ERK1 and ERK2 cascade (GO:0070371),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,CDK1
1035,GO_Biological_Process_2021,response to copper ion (GO:0046688),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,AOC1
1036,GO_Biological_Process_2021,response to nutrient levels (GO:0031667),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,SCT
1037,GO_Biological_Process_2021,positive regulation of histone acetylation (GO:0035066),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,FOXP3
1038,GO_Biological_Process_2021,positive regulation of interleukin-17 production (GO:0032740),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,IL21
1039,GO_Biological_Process_2021,positive regulation of mRNA processing (GO:0050685),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,CELF3
1040,GO_Biological_Process_2021,positive regulation of natural killer cell mediated immunity (GO:0002717),1/23,0.7289642737745002,0.9999959186369975,0,0,0.7785431446955948,0.2461212766906426,IL21
1041,GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),2/46,0.7292493603476209,0.9999959186369975,0,0,0.7783420031376435,0.2457533517712916,EPO;INHBA
1042,GO_Biological_Process_2021,regulation of telomerase activity (GO:0051972),2/46,0.7292493603476209,0.9999959186369975,0,0,0.7783420031376435,0.2457533517712916,NEK2;AURKB
1043,GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),4/89,0.7303507679431319,0.9999959186369975,0,0,0.8055237381576834,0.2531200111794032,KCNG1;GRIA2;EPO;CNIH2
1044,GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),3/68,0.7316360045213004,0.9999959186369975,0,0,0.7901538461538462,0.246901071359144,IL21;IFNL1;EPO
1045,GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),5/111,0.7393677925033979,0.9999959186369975,0,0,0.8072567618654845,0.2437590842186958,AMER2;DEPDC1B;TERT;SULF1;FOXP3
1046,GO_Biological_Process_2021,regulation of DNA binding (GO:0051101),2/47,0.7401513221911248,0.9999959186369975,0,0,0.7610051468362095,0.2289869237340652,HJURP;SUMO4
1047,GO_Biological_Process_2021,regulation of T cell activation (GO:0050863),2/47,0.7401513221911248,0.9999959186369975,0,0,0.7610051468362095,0.2289869237340652,IL4I1;TIGIT
1048,GO_Biological_Process_2021,telomere organization (GO:0032200),2/47,0.7401513221911248,0.9999959186369975,0,0,0.7610051468362095,0.2289869237340652,TERT;HUS1B
1049,GO_Biological_Process_2021,positive regulation of cell-cell adhesion (GO:0022409),2/47,0.7401513221911248,0.9999959186369975,0,0,0.7610051468362095,0.2289869237340652,CEACAM6;CXCL13
1050,GO_Biological_Process_2021,apoptotic nuclear changes (GO:0030262),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,TOP2A
1051,GO_Biological_Process_2021,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,SOX11
1052,GO_Biological_Process_2021,cardiac muscle cell development (GO:0055013),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,MYH6
1053,GO_Biological_Process_2021,cardiac muscle cell differentiation (GO:0055007),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,MYH6
1054,GO_Biological_Process_2021,dorsal/ventral pattern formation (GO:0009953),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,SIX3
1055,GO_Biological_Process_2021,extracellular matrix assembly (GO:0085029),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,NTNG1
1056,GO_Biological_Process_2021,histone monoubiquitination (GO:0010390),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,UHRF1
1057,GO_Biological_Process_2021,negative regulation of ossification (GO:0030279),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,KREMEN2
1058,GO_Biological_Process_2021,negative regulation of protein depolymerization (GO:1901880),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,TPX2
1059,GO_Biological_Process_2021,negative regulation of synaptic transmission (GO:0050805),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,SLC24A2
1060,GO_Biological_Process_2021,phospholipid catabolic process (GO:0009395),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,PNLIPRP2
1061,GO_Biological_Process_2021,positive regulation of lamellipodium assembly (GO:0010592),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,CLRN1
1062,GO_Biological_Process_2021,positive regulation of protein targeting to membrane (GO:0090314),1/24,0.7439290253748087,0.9999959186369975,0,0,0.7446539887950762,0.220275831850754,CEMIP
1063,GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),6/133,0.748541513409802,0.9999959186369975,0,0,0.808360668681228,0.2341243805050925,RET;ADAMDEC1;IBSP;EPHA8;KIF14;PRSS2
1064,GO_Biological_Process_2021,cellular response to light stimulus (GO:0071482),3/70,0.7494899191083588,0.9999959186369975,0,0,0.7664857530529172,0.2210256802729649,GPR52;OPN5;AURKB
1065,GO_Biological_Process_2021,base-excision repair (GO:0006284),2/48,0.750675638214233,0.9999959186369975,0,0,0.7444220668957074,0.2134865715355532,POLQ;NEIL3
1066,GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),2/48,0.750675638214233,0.9999959186369975,0,0,0.7444220668957074,0.2134865715355532,CD80;FOXP3
1067,GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),3/71,0.7580534767482378,0.9999959186369975,0,0,0.7551737967914438,0.2091841581966825,CDKN2A;KIF14;E2F7
1068,GO_Biological_Process_2021,regulation of AMPA receptor activity (GO:2000311),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,CNIH2
1069,GO_Biological_Process_2021,regulation of calcium ion import (GO:0090279),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,PLPP4
1070,GO_Biological_Process_2021,cardiac conduction system development (GO:0003161),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,GATA4
1071,GO_Biological_Process_2021,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,CEACAM6
1072,GO_Biological_Process_2021,regulation of microtubule depolymerization (GO:0031114),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,TPX2
1073,GO_Biological_Process_2021,regulation of mitochondrial fission (GO:0090140),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,AURKA
1074,GO_Biological_Process_2021,regulation of myotube differentiation (GO:0010830),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,CEACAM5
1075,GO_Biological_Process_2021,divalent inorganic cation homeostasis (GO:0072507),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,S100A14
1076,GO_Biological_Process_2021,regulation of protein processing (GO:0070613),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,MAGEA3
1077,GO_Biological_Process_2021,fat-soluble vitamin metabolic process (GO:0006775),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,RLBP1
1078,GO_Biological_Process_2021,negative regulation of ion transport (GO:0043271),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,HRH3
1079,GO_Biological_Process_2021,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,MAGEA3
1080,GO_Biological_Process_2021,organophosphate ester transport (GO:0015748),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,SLC44A4
1081,GO_Biological_Process_2021,peripheral nervous system development (GO:0007422),1/25,0.7580682270360874,0.9999959186369975,0,0,0.7135889292196007,0.1976512089481542,ARTN
1082,GO_Biological_Process_2021,adherens junction organization (GO:0034332),2/49,0.7608307611241452,0.9999959186369975,0,0,0.728544649931397,0.1991435535568011,CDH2;CDH7
1083,GO_Biological_Process_2021,regulation of cellular protein metabolic process (GO:0032268),2/49,0.7608307611241452,0.9999959186369975,0,0,0.728544649931397,0.1991435535568011,UHRF1;INHBA
1084,GO_Biological_Process_2021,cellular defense response (GO:0006968),2/49,0.7608307611241452,0.9999959186369975,0,0,0.728544649931397,0.1991435535568011,CXCL9;CLEC5A
1085,GO_Biological_Process_2021,positive regulation of actin filament polymerization (GO:0030838),2/49,0.7608307611241452,0.9999959186369975,0,0,0.728544649931397,0.1991435535568011,CCL11;CRACD
1086,GO_Biological_Process_2021,defense response to bacterium (GO:0042742),8/176,0.760849615372105,0.9999959186369975,0,0,0.814481409001957,0.222613696378287,PGLYRP4;PGLYRP3;H2BC10;H2BC11;ISG15;S100A14;CXCL13;S100A7
1087,GO_Biological_Process_2021,cell morphogenesis involved in differentiation (GO:0000904),3/72,0.7663788785269635,0.9999959186369975,0,0,0.7441897233201581,0.1980129686743769,NTNG1;KIF14;FN1
1088,GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),5/115,0.7668054259868281,0.9999959186369975,0,0,0.7777363801953966,0.2065062682282347,CXCL10;CXCL11;CXCL9;CD80;CXCL13
1089,GO_Biological_Process_2021,hemopoiesis (GO:0030097),4/94,0.768566507476736,0.9999959186369975,0,0,0.7605702153472854,0.2002035118850332,MELK;RTKN2;TMEM190;INHBA
1090,GO_Biological_Process_2021,proteoglycan metabolic process (GO:0006029),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,SULF1
1091,GO_Biological_Process_2021,regulation of actin filament bundle assembly (GO:0032231),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,SYNPO2L
1092,GO_Biological_Process_2021,regulation of chondrocyte differentiation (GO:0032330),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,NKX3-2
1093,GO_Biological_Process_2021,regulation of myelination (GO:0031641),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,KIF14
1094,GO_Biological_Process_2021,DNA modification (GO:0006304),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,NEIL3
1095,GO_Biological_Process_2021,regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,KCNG1
1096,GO_Biological_Process_2021,endothelial cell development (GO:0001885),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,COL22A1
1097,GO_Biological_Process_2021,glial cell development (GO:0021782),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,SOX11
1098,GO_Biological_Process_2021,regulation of viral life cycle (GO:1903900),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,TRIML2
1099,GO_Biological_Process_2021,membrane depolarization during action potential (GO:0086010),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,SCN1A
1100,GO_Biological_Process_2021,metanephros development (GO:0001656),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,FOXD1
1101,GO_Biological_Process_2021,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,PYDC1
1102,GO_Biological_Process_2021,negative regulation of protein localization to membrane (GO:1905476),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,LRRC15
1103,GO_Biological_Process_2021,organelle fission (GO:0048285),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,MTFR2
1104,GO_Biological_Process_2021,positive regulation of histone methylation (GO:0031062),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,H1-5
1105,GO_Biological_Process_2021,positive regulation of interleukin-2 production (GO:0032743),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,CD80
1106,GO_Biological_Process_2021,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/26,0.7714273822142508,0.9999959186369975,0,0,0.6850090744101633,0.1777685798113873,CD1A
1107,GO_Biological_Process_2021,ion transport (GO:0006811),5/116,0.7733110061602433,0.9999959186369975,0,0,0.7706887215083936,0.1981240129340752,SLC24A2;SLC9A4;TRPA1;SLC1A1;SLC1A6
1108,GO_Biological_Process_2021,positive regulation of synaptic transmission (GO:0050806),3/73,0.7744694667613095,0.9999959186369975,0,0,0.7335194805194806,0.1874707398609863,SLC24A2;SYT1;NMU
1109,GO_Biological_Process_2021,blood circulation (GO:0008015),2/51,0.7800682732217561,0.9999959186369975,0,0,0.69873398950861,0.1735472394714496,CXCL10;EPO
1110,GO_Biological_Process_2021,inositol lipid-mediated signaling (GO:0048017),2/51,0.7800682732217561,0.9999959186369975,0,0,0.69873398950861,0.1735472394714496,MUC5AC;KCNH1
1111,GO_Biological_Process_2021,sensory perception (GO:0007600),2/51,0.7800682732217561,0.9999959186369975,0,0,0.69873398950861,0.1735472394714496,TRPA1;CLRN1
1112,GO_Biological_Process_2021,mitotic nuclear membrane organization (GO:0101024),2/51,0.7800682732217561,0.9999959186369975,0,0,0.69873398950861,0.1735472394714496,CCNB2;CDK1
1113,GO_Biological_Process_2021,mitotic nuclear membrane reassembly (GO:0007084),2/51,0.7800682732217561,0.9999959186369975,0,0,0.69873398950861,0.1735472394714496,CCNB2;CDK1
1114,GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),7/159,0.7801144119805692,0.9999959186369975,0,0,0.7876428640030734,0.195583292053101,CXCL10;CXCL11;CXCL9;CD80;S100A14;CXCL13;S100A7
1115,GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),3/74,0.7823287652788233,0.9999959186369975,0,0,0.7231498079385403,0.1775189673139051,XIRP1;AURKB;AURKA
1116,GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),4/96,0.7826149767486584,0.9999959186369975,0,0,0.7439569569173557,0.1823545870906815,SLC30A8;SYT1;CD177;PACSIN1
1117,GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,PROC
1118,GO_Biological_Process_2021,camera-type eye development (GO:0043010),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,FBN2
1119,GO_Biological_Process_2021,cellular lipid catabolic process (GO:0044242),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,PNLIPRP2
1120,GO_Biological_Process_2021,cellular senescence (GO:0090398),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,CDKN2A
1121,GO_Biological_Process_2021,entrainment of circadian clock by photoperiod (GO:0043153),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,OPN5
1122,GO_Biological_Process_2021,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,SOX11
1123,GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,CXCL13
1124,GO_Biological_Process_2021,melanosome organization (GO:0032438),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,TYRP1
1125,GO_Biological_Process_2021,monocarboxylic acid catabolic process (GO:0072329),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,AGXT
1126,GO_Biological_Process_2021,negative regulation of cation channel activity (GO:2001258),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,EPO
1127,GO_Biological_Process_2021,nucleobase-containing small molecule interconversion (GO:0015949),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,RRM2
1128,GO_Biological_Process_2021,positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,INHBA
1129,GO_Biological_Process_2021,positive regulation of muscle cell differentiation (GO:0051149),1/27,0.784049488321536,0.9999959186369975,0,0,0.6586276699706827,0.1602330061691809,CDH2
1130,GO_Biological_Process_2021,innate immune response (GO:0045087),14/302,0.7848553344913562,0.9999959186369975,0,0,0.8306741659014386,0.201235688971457,PGLYRP4;PGLYRP3;IFI6;ISG15;CXCL10;IFNL1;TRIML2;H2BC10;CLEC5A;H2BC11;PYDC1;IFNL4;IFNL3;S100A7
1131,GO_Biological_Process_2021,regulation of protein binding (GO:0043393),5/118,0.7859040638193276,0.9999959186369975,0,0,0.7569676161000694,0.182369054563421,TERT;PLK1;XIRP1;AURKB;AURKA
1132,GO_Biological_Process_2021,regulation of telomere maintenance via telomerase (GO:0032210),2/52,0.7891684589393256,0.9999959186369975,0,0,0.6847229791099001,0.1621256062238194,NEK2;AURKB
1133,GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),2/52,0.7891684589393256,0.9999959186369975,0,0,0.6847229791099001,0.1621256062238194,EPO;INHBA
1134,GO_Biological_Process_2021,negative regulation of protein-containing complex assembly (GO:0031333),2/52,0.7891684589393256,0.9999959186369975,0,0,0.6847229791099001,0.1621256062238194,KIF14;PYDC1
1135,GO_Biological_Process_2021,protein homotetramerization (GO:0051289),2/52,0.7891684589393256,0.9999959186369975,0,0,0.6847229791099001,0.1621256062238194,TDO2;TRPA1
1136,GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),8/182,0.7919981544870092,0.9999959186369975,0,0,0.7861439143441977,0.183325787128478,ORM1;IFNL1;FN1;FOXJ1;ISG15;INHBA;TIGIT;FOXP3
1137,GO_Biological_Process_2021,regulation of calcium-mediated signaling (GO:0050848),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,NEUROD2
1138,GO_Biological_Process_2021,"regulation of DNA-templated transcription, elongation (GO:0032784)",1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,ELOA2
1139,GO_Biological_Process_2021,cellular response to acid chemical (GO:0071229),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,NEURL1
1140,GO_Biological_Process_2021,cellular zinc ion homeostasis (GO:0006882),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,SLC30A8
1141,GO_Biological_Process_2021,regulation of immunoglobulin production (GO:0002637),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,IL21
1142,GO_Biological_Process_2021,regulation of muscle contraction (GO:0006937),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,TNNT1
1143,GO_Biological_Process_2021,regulation of neuron migration (GO:2001222),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,NTNG1
1144,GO_Biological_Process_2021,regulation of postsynapse organization (GO:0099175),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,KIF1A
1145,GO_Biological_Process_2021,glycerophospholipid catabolic process (GO:0046475),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,PNLIPRP2
1146,GO_Biological_Process_2021,keratan sulfate biosynthetic process (GO:0018146),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,ACAN
1147,GO_Biological_Process_2021,leukocyte cell-cell adhesion (GO:0007159),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,CD177
1148,GO_Biological_Process_2021,sulfur compound transport (GO:0072348),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,SLC44A4
1149,GO_Biological_Process_2021,ventricular septum morphogenesis (GO:0060412),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,SOX11
1150,GO_Biological_Process_2021,negative regulation of oxidative stress-induced cell death (GO:1903202),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,GATA4
1151,GO_Biological_Process_2021,neutral amino acid transport (GO:0015804),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,SLC1A1
1152,GO_Biological_Process_2021,photoperiodism (GO:0009648),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,OPN5
1153,GO_Biological_Process_2021,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,FN1
1154,GO_Biological_Process_2021,positive regulation of monooxygenase activity (GO:0032770),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,TERT
1155,GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,EPHA8
1156,GO_Biological_Process_2021,positive regulation of synapse assembly (GO:0051965),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,SYNDIG1
1157,GO_Biological_Process_2021,protein localization to cell surface (GO:0034394),1/28,0.7959751747732817,0.9999959186369975,0,0,0.6342004436378302,0.1447164749028609,CD177
1158,GO_Biological_Process_2021,actomyosin structure organization (GO:0031032),3/76,0.7973683723464816,0.9999959186369975,0,0,0.7032627646326276,0.159245771362608,SYNPO2L;TNNT1;MYH6
1159,GO_Biological_Process_2021,regulation of BMP signaling pathway (GO:0030510),3/76,0.7973683723464816,0.9999959186369975,0,0,0.7032627646326276,0.159245771362608,FOXD1;SOX11;SULF1
1160,GO_Biological_Process_2021,positive regulation of growth (GO:0045927),3/76,0.7973683723464816,0.9999959186369975,0,0,0.7032627646326276,0.159245771362608,H1-5;SLC44A4;PRSS2
1161,GO_Biological_Process_2021,bicellular tight junction assembly (GO:0070830),2/53,0.797934959261069,0.9999959186369975,0,0,0.671261420099375,0.1515226250666736,CLDN25;CLDN9
1162,GO_Biological_Process_2021,cardiac muscle tissue development (GO:0048738),2/53,0.797934959261069,0.9999959186369975,0,0,0.671261420099375,0.1515226250666736,GATA5;GATA4
1163,GO_Biological_Process_2021,regulation of DNA replication (GO:0006275),2/53,0.797934959261069,0.9999959186369975,0,0,0.671261420099375,0.1515226250666736,CCNA2;ESCO2
1164,GO_Biological_Process_2021,epidermal cell differentiation (GO:0009913),2/53,0.797934959261069,0.9999959186369975,0,0,0.671261420099375,0.1515226250666736,IVL;S100A7
1165,GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity (GO:2000117),2/53,0.797934959261069,0.9999959186369975,0,0,0.671261420099375,0.1515226250666736,IFI6;MAGEA3
1166,GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),5/120,0.7979473231614351,0.9999959186369975,0,0,0.7437237665320345,0.1678678955211211,CXCL10;CXCL11;CXCL9;CD80;CXCL13
1167,GO_Biological_Process_2021,response to UV (GO:0009411),4/99,0.8024058899402665,0.9999959186369975,0,0,0.7203486423064029,0.1585780557712699,PCLAF;DTL;IVL;AURKB
1168,GO_Biological_Process_2021,cellular response to UV (GO:0034644),3/77,0.8045564563427682,0.9999959186369975,0,0,0.6937223587223588,0.1508597356677738,MMP1;OPN5;AURKB
1169,GO_Biological_Process_2021,double-strand break repair (GO:0006302),7/164,0.8060797390773323,0.9999959186369975,0,0,0.7623552931331071,0.1643429199153872,POLQ;BRIP1;EME1;CDCA5;HUS1B;AUNIP;TRIP13
1170,GO_Biological_Process_2021,regulation of proteolysis (GO:0030162),2/54,0.8063768618249645,0.9999959186369975,0,0,0.6583176133584853,0.1416726332036637,PLK1;CST4
1171,GO_Biological_Process_2021,nuclear membrane reassembly (GO:0031468),2/54,0.8063768618249645,0.9999959186369975,0,0,0.6583176133584853,0.1416726332036637,CCNB2;CDK1
1172,GO_Biological_Process_2021,neuron development (GO:0048666),6/143,0.8069000427121902,0.9999959186369975,0,0,0.7489570094950395,0.1606928315658221,CNTNAP2;SLC44A4;EPHA8;GPRIN1;BICDL1;ASCL1
1173,GO_Biological_Process_2021,beta-catenin-TCF complex assembly (GO:1904837),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,TERT
1174,GO_Biological_Process_2021,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,AUNIP
1175,GO_Biological_Process_2021,determination of bilateral symmetry (GO:0009855),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,FOXJ1
1176,GO_Biological_Process_2021,regulation of protein targeting to membrane (GO:0090313),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,CEMIP
1177,GO_Biological_Process_2021,regulation of T cell mediated cytotoxicity (GO:0001914),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,CD1A
1178,GO_Biological_Process_2021,response to zinc ion (GO:0010043),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,SLC30A8
1179,GO_Biological_Process_2021,lipid catabolic process (GO:0016042),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,PNLIPRP2
1180,GO_Biological_Process_2021,telomere maintenance via telomerase (GO:0007004),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,TERT
1181,GO_Biological_Process_2021,mismatch repair (GO:0006298),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,EXO1
1182,GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,INHBA
1183,GO_Biological_Process_2021,negative regulation of wound healing (GO:0061045),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,PROC
1184,GO_Biological_Process_2021,positive regulation of dephosphorylation (GO:0035306),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,CDCA2
1185,GO_Biological_Process_2021,positive regulation of leukocyte migration (GO:0002687),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,F7
1186,GO_Biological_Process_2021,positive regulation of viral genome replication (GO:0045070),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,TOP2A
1187,GO_Biological_Process_2021,production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,0.8072428331602853,0.9999959186369975,0,0,0.6115180191858958,0.1309448105427672,LIN28B
1188,GO_Biological_Process_2021,epithelium development (GO:0060429),5/122,0.8094511917465141,0.9999959186369975,0,0,0.7309326981458129,0.1545182967335828,KRT3;CDK1;FOXJ1;SOX11;ACTL8
1189,GO_Biological_Process_2021,central nervous system development (GO:0007417),12/268,0.8095290840963076,0.9999959186369975,0,0,0.800913725939505,0.1692351350786824,DMBX1;CNTNAP2;ACAN;CDH2;SCT;SIX3;FOXJ1;SOX11;PAX6;MNX1;HAPLN1;NKX2-2
1190,GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),7/165,0.8109796472941964,0.9999959186369975,0,0,0.757489836459392,0.1587034537678137,NTNG1;RET;CDH2;PLPPR5;ZNF804A;KIF1A;CSMD3
1191,GO_Biological_Process_2021,triglyceride metabolic process (GO:0006641),2/55,0.8145032676780045,0.9999959186369975,0,0,0.6458622521549877,0.1325159753691714,PNLIPRP2;FABP6
1192,GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/55,0.8145032676780045,0.9999959186369975,0,0,0.6458622521549877,0.1325159753691714,IFI6;MAGEA3
1193,GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),16/351,0.8173142035468227,0.9999959186369975,0,0,0.8155871974076261,0.1645297722491962,COL11A1;COL22A1;KIF14;ERMN;ADAMTS14;KIF18A;KIF18B;H3C13;P4HA3;COL9A1;XIRP1;COL10A1;KIF2C;FSD1;MYH6;CLRN1
1194,GO_Biological_Process_2021,cardiac muscle cell action potential (GO:0086001),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,SCN1A
1195,GO_Biological_Process_2021,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,IL21
1196,GO_Biological_Process_2021,regulation of type I interferon-mediated signaling pathway (GO:0060338),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,ISG15
1197,GO_Biological_Process_2021,RNA-dependent DNA biosynthetic process (GO:0006278),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,TERT
1198,GO_Biological_Process_2021,ion homeostasis (GO:0050801),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,SLC30A8
1199,GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,SYNDIG1
1200,GO_Biological_Process_2021,maintenance of blood-brain barrier (GO:0035633),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,SLC1A1
1201,GO_Biological_Process_2021,microtubule polymerization (GO:0046785),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,TPX2
1202,GO_Biological_Process_2021,zinc ion homeostasis (GO:0055069),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,SLC30A8
1203,GO_Biological_Process_2021,morphogenesis of an epithelium (GO:0002009),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,FLG2
1204,GO_Biological_Process_2021,mRNA splice site selection (GO:0006376),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,CELF3
1205,GO_Biological_Process_2021,ncRNA catabolic process (GO:0034661),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,LIN28B
1206,GO_Biological_Process_2021,"negative regulation of gene expression, epigenetic (GO:0045814)",1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,H3C13
1207,GO_Biological_Process_2021,negative regulation of interleukin-1 production (GO:0032692),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,PYDC1
1208,GO_Biological_Process_2021,plasma membrane invagination (GO:0099024),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,AURKB
1209,GO_Biological_Process_2021,positive regulation of B cell proliferation (GO:0030890),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,IL21
1210,GO_Biological_Process_2021,positive regulation of small GTPase mediated signal transduction (GO:0051057),1/30,0.8178887406251768,0.9999959186369975,0,0,0.5903998998685775,0.1186874811230034,EPO
1211,GO_Biological_Process_2021,recombinational repair (GO:0000725),3/79,0.8182894477281856,0.9999959186369975,0,0,0.6753947368421053,0.1354430910945229,POLQ;HUS1B;AUNIP
1212,GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),4/102,0.8207103911909592,0.9999959186369975,0,0,0.6981857347124473,0.1379510165596231,H1-5;SLC44A4;SYT1;PRSS2
1213,GO_Biological_Process_2021,blood vessel morphogenesis (GO:0048514),2/56,0.8223232622037403,0.9999959186369975,0,0,0.6338682006256938,0.1239983738489891,CDH2;SLC1A1
1214,GO_Biological_Process_2021,tight junction assembly (GO:0120192),2/56,0.8223232622037403,0.9999959186369975,0,0,0.6338682006256938,0.1239983738489891,CLDN25;CLDN9
1215,GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),2/56,0.8223232622037403,0.9999959186369975,0,0,0.6338682006256938,0.1239983738489891,ORM1;PYDC1
1216,GO_Biological_Process_2021,skin development (GO:0043588),3/80,0.8248427223767255,0.9999959186369975,0,0,0.6665879574970484,0.1283598771381256,FLG2;IVL;S100A7
1217,GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),3/80,0.8248427223767255,0.9999959186369975,0,0,0.6665879574970484,0.1283598771381256,RET;IBSP;PRSS2
1218,GO_Biological_Process_2021,regulation of cellular pH (GO:0030641),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,SLC9A4
1219,GO_Biological_Process_2021,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,SCN1A
1220,GO_Biological_Process_2021,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,SOX11
1221,GO_Biological_Process_2021,steroid hormone biosynthetic process (GO:0120178),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,HSD17B6
1222,GO_Biological_Process_2021,organelle transport along microtubule (GO:0072384),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,BICDL1
1223,GO_Biological_Process_2021,positive regulation of Rho protein signal transduction (GO:0035025),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,SYNPO2L
1224,GO_Biological_Process_2021,positive regulation of RNA splicing (GO:0033120),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,CELF3
1225,GO_Biological_Process_2021,protein acetylation (GO:0006473),1/31,0.8279471759619101,0.9999959186369975,0,0,0.5706896551724138,0.1077495875362053,ESCO2
1226,GO_Biological_Process_2021,regulation of bone mineralization (GO:0030500),2/57,0.8298458890204856,0.9999959186369975,0,0,0.6223102964247379,0.1160703737768697,FBN2;ISG15
1227,GO_Biological_Process_2021,renal system development (GO:0072001),2/57,0.8298458890204856,0.9999959186369975,0,0,0.6223102964247379,0.1160703737768697,CENPF;SULF1
1228,GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),2/57,0.8298458890204856,0.9999959186369975,0,0,0.6223102964247379,0.1160703737768697,CNTNAP2;SYNDIG1
1229,GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),2/57,0.8298458890204856,0.9999959186369975,0,0,0.6223102964247379,0.1160703737768697,UBE2C;UBE2T
1230,GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),12/274,0.8317708497975566,0.9999959186369975,0,0,0.7823203028246374,0.1441020674987055,KCNG1;SLC24A2;KCNF1;KCNG3;SLC9A4;SLC30A8;TRPA1;TRPM8;TRPM5;LRRC52;SCN1A;KCNH1
1231,GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),6/148,0.8318379873386141,0.9999959186369975,0,0,0.7223926971124834,0.1330051980042702,RET;EPHA8;PLK1;NEK2;MAGEC2;AURKB
1232,GO_Biological_Process_2021,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/58,0.8370801273191468,0.9999959186369975,0,0,0.6111651745166732,0.1086868530926466,H2BC11;PYDC1
1233,GO_Biological_Process_2021,muscle organ development (GO:0007517),2/58,0.8370801273191468,0.9999959186369975,0,0,0.6111651745166732,0.1086868530926466,CXCL10;MYH6
1234,GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),3/82,0.8373442290810011,0.9999959186369975,0,0,0.6496432681242807,0.1153246909585936,CDH2;CDH7;CD177
1235,GO_Biological_Process_2021,axonemal dynein complex assembly (GO:0070286),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,DNAH8
1236,GO_Biological_Process_2021,regulation of cell morphogenesis (GO:0022604),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,NTNG1
1237,GO_Biological_Process_2021,regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,KIF1A
1238,GO_Biological_Process_2021,chondrocyte differentiation (GO:0002062),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,SULF1
1239,GO_Biological_Process_2021,regulation of NMDA receptor activity (GO:2000310),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,GRIA2
1240,GO_Biological_Process_2021,response to amino acid (GO:0043200),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,NEURL1
1241,GO_Biological_Process_2021,RNA biosynthetic process (GO:0032774),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,TERT
1242,GO_Biological_Process_2021,membrane depolarization (GO:0051899),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,SCN1A
1243,GO_Biological_Process_2021,negative regulation of cell-matrix adhesion (GO:0001953),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,CDKN2A
1244,GO_Biological_Process_2021,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,TPX2
1245,GO_Biological_Process_2021,positive regulation of lamellipodium organization (GO:1902745),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,CLRN1
1246,GO_Biological_Process_2021,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.837450529785889,0.9999959186369975,0,0,0.5522510391663251,0.0979655160512441,IFNL1
1247,GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),3/83,0.8433011584493884,0.9999959186369975,0,0,0.6414886363636364,0.1093296387539375,FBN2;CCN4;SOX11
1248,GO_Biological_Process_2021,muscle contraction (GO:0006936),5/129,0.8456435848343523,0.9999959186369975,0,0,0.6894133027792467,0.11558517476701,CHRND;SMPX;TNNT1;MYH6;MYH7
1249,GO_Biological_Process_2021,apoptotic mitochondrial changes (GO:0008637),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,IFI6
1250,GO_Biological_Process_2021,regulation of histone acetylation (GO:0035065),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,FOXP3
1251,GO_Biological_Process_2021,signal transduction by p53 class mediator (GO:0072331),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,E2F7
1252,GO_Biological_Process_2021,keratan sulfate metabolic process (GO:0042339),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,ACAN
1253,GO_Biological_Process_2021,muscle cell development (GO:0055001),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,MYH6
1254,GO_Biological_Process_2021,phosphatidylcholine biosynthetic process (GO:0006656),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,SLC44A4
1255,GO_Biological_Process_2021,positive regulation of histone modification (GO:0031058),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,FOXP3
1256,GO_Biological_Process_2021,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.8464294081426126,0.9999959186369975,0,0,0.534964836660617,0.0891938705988548,IFNL1
1257,GO_Biological_Process_2021,response to calcium ion (GO:0051592),4/107,0.8480924787816017,0.9999959186369975,0,0,0.6641165401909944,0.1094235562094278,NEUROD2;SYT1;SYT13;KCNH1
1258,GO_Biological_Process_2021,apical junction assembly (GO:0043297),2/60,0.8507189114799142,0.9999959186369975,0,0,0.5900278743462056,0.0953918767087802,CLDN25;CLDN9
1259,GO_Biological_Process_2021,Notch signaling pathway (GO:0007219),2/60,0.8507189114799142,0.9999959186369975,0,0,0.5900278743462056,0.0953918767087802,ASCL1;DLGAP5
1260,GO_Biological_Process_2021,peptidyl-threonine phosphorylation (GO:0018107),2/60,0.8507189114799142,0.9999959186369975,0,0,0.5900278743462056,0.0953918767087802,SBK1;CDK1
1261,GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),5/131,0.8548773819636456,0.9999959186369975,0,0,0.6783979529881169,0.106370922062865,NEUROD2;AOC1;SYT1;SYT13;KCNH1
1262,GO_Biological_Process_2021,regulation of activated T cell proliferation (GO:0046006),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,FOXP3
1263,GO_Biological_Process_2021,autophagosome maturation (GO:0097352),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,LIX1
1264,GO_Biological_Process_2021,axoneme assembly (GO:0035082),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,FOXJ1
1265,GO_Biological_Process_2021,cell-substrate junction assembly (GO:0007044),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,FN1
1266,GO_Biological_Process_2021,cellular response to amino acid stimulus (GO:0071230),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,NEURL1
1267,GO_Biological_Process_2021,regulation of keratinocyte differentiation (GO:0045616),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,ZBED2
1268,GO_Biological_Process_2021,regulation of lamellipodium assembly (GO:0010591),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,CLRN1
1269,GO_Biological_Process_2021,striated muscle tissue development (GO:0014706),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,GATA5
1270,GO_Biological_Process_2021,organelle disassembly (GO:1903008),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,CDK1
1271,GO_Biological_Process_2021,positive regulation of DNA binding (GO:0043388),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,SUMO4
1272,GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,TERT
1273,GO_Biological_Process_2021,positive regulation of protein dephosphorylation (GO:0035307),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,CDCA2
1274,GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.8549127313324073,0.9999959186369975,0,0,0.5187262827916186,0.0813133969465335,PLK1
1275,GO_Biological_Process_2021,"regulation of DNA-templated transcription, initiation (GO:2000142)",2/61,0.8571409209636264,0.9999959186369975,0,0,0.5799966132483566,0.0894081823715172,CDKN2A;CDK1
1276,GO_Biological_Process_2021,negative regulation of response to stimulus (GO:0048585),2/61,0.8571409209636264,0.9999959186369975,0,0,0.5799966132483566,0.0894081823715172,TERT;FOXP3
1277,GO_Biological_Process_2021,positive regulation of DNA biosynthetic process (GO:2000573),2/61,0.8571409209636264,0.9999959186369975,0,0,0.5799966132483566,0.0894081823715172,NEK2;AURKB
1278,GO_Biological_Process_2021,regulation of Ras protein signal transduction (GO:0046578),3/86,0.8600493584453711,0.9999959186369975,0,0,0.6182037239868565,0.093203792213668,EPO;KIF14;FOXM1
1279,GO_Biological_Process_2021,regulation of blood circulation (GO:1903522),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,MYH6
1280,GO_Biological_Process_2021,regulation of muscle cell differentiation (GO:0051147),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,CDH2
1281,GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,EPHA8
1282,GO_Biological_Process_2021,regulation of postsynaptic membrane potential (GO:0060078),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,GABRA5
1283,GO_Biological_Process_2021,oxoacid metabolic process (GO:0043436),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,AGXT
1284,GO_Biological_Process_2021,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,FAM83D
1285,GO_Biological_Process_2021,positive regulation of immunoglobulin production (GO:0002639),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,IL21
1286,GO_Biological_Process_2021,positive regulation of reproductive process (GO:2000243),1/35,0.8629278259849438,0.9999959186369975,0,0,0.5034429379737376,0.0742196839210933,INHBA
1287,GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),2/62,0.8633094397231604,0.9999959186369975,0,0,0.570299727520436,0.0838238454986994,ORM1;PYDC1
1288,GO_Biological_Process_2021,sodium ion transmembrane transport (GO:0035725),3/87,0.8652725862702755,0.9999959186369975,0,0,0.6108116883116883,0.0883909827427179,SLC24A2;SLC9A4;SCN1A
1289,GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),6/156,0.866297380042486,0.9999959186369975,0,0,0.6835733819507749,0.0981112603048273,TPX2;BRIP1;EXO1;CDK1;AURKB;AURKA
1290,GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),6/156,0.866297380042486,0.9999959186369975,0,0,0.6835733819507749,0.0981112603048273,SBK1;PLK1;CDK1;TTK;CLSPN;AURKA
1291,GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),2/63,0.8692328637723343,0.9999959186369975,0,0,0.5609207724721192,0.0786098053159049,HOXB9;GATA4
1292,GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),2/63,0.8692328637723343,0.9999959186369975,0,0,0.5609207724721192,0.0786098053159049,PNLIPRP2;IL4I1
1293,GO_Biological_Process_2021,positive regulation of Ras protein signal transduction (GO:0046579),2/63,0.8692328637723343,0.9999959186369975,0,0,0.5609207724721192,0.0786098053159049,SYNPO2L;EPO
1294,GO_Biological_Process_2021,regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,H3C13
1295,GO_Biological_Process_2021,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,CDH7
1296,GO_Biological_Process_2021,regulation of embryonic development (GO:0045995),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,CDK1
1297,GO_Biological_Process_2021,regulation of microtubule-based process (GO:0032886),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,AURKA
1298,GO_Biological_Process_2021,regulation of sodium ion transport (GO:0002028),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,NKAIN1
1299,GO_Biological_Process_2021,transition metal ion transport (GO:0000041),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,SLC30A8
1300,GO_Biological_Process_2021,platelet aggregation (GO:0070527),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,FN1
1301,GO_Biological_Process_2021,positive regulation of interferon-beta production (GO:0032728),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,ISG15
1302,GO_Biological_Process_2021,positive regulation of T cell mediated immunity (GO:0002711),1/36,0.870500513375205,0.9999959186369975,0,0,0.4890329271454498,0.0678224753477048,CD1A
1303,GO_Biological_Process_2021,protein secretion (GO:0009306),2/64,0.8749194352642545,0.9999959186369975,0,0,0.5518443643608449,0.0737393593334188,SLC30A8;MAFA
1304,GO_Biological_Process_2021,diterpenoid metabolic process (GO:0016101),2/64,0.8749194352642545,0.9999959186369975,0,0,0.5518443643608449,0.0737393593334188,CLPS;RLBP1
1305,GO_Biological_Process_2021,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/64,0.8749194352642545,0.9999959186369975,0,0,0.5518443643608449,0.0737393593334188,CDKN2A;CDK1
1306,GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/89,0.8752061454650245,0.9999959186369975,0,0,0.5965433403805497,0.0795167370356327,SOX2;IFI6;MAGEA3
1307,GO_Biological_Process_2021,regulation of erythrocyte differentiation (GO:0045646),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,INHBA
1308,GO_Biological_Process_2021,regulation of intracellular pH (GO:0051453),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,SLC9A4
1309,GO_Biological_Process_2021,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,H3C13
1310,GO_Biological_Process_2021,regulation of transport (GO:0051049),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,SLC30A8
1311,GO_Biological_Process_2021,negative regulation of endothelial cell proliferation (GO:0001937),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,SULF1
1312,GO_Biological_Process_2021,negative regulation of stress-activated MAPK cascade (GO:0032873),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,FOXM1
1313,GO_Biological_Process_2021,neural crest cell migration (GO:0001755),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,FN1
1314,GO_Biological_Process_2021,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.8776551919015805,0.9999959186369975,0,0,0.4754234724742892,0.0620434679311416,INHBA
1315,GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),3/90,0.8799251931441703,0.9999959186369975,0,0,0.5896551724137931,0.0754277361320291,IL4I1;TDO2;GAD1
1316,GO_Biological_Process_2021,BMP signaling pathway (GO:0030509),2/65,0.8803772332374091,0.9999959186369975,0,0,0.5430560961896111,0.069187947475632,BMP8A;AMH
1317,GO_Biological_Process_2021,cellular response to type I interferon (GO:0071357),2/65,0.8803772332374091,0.9999959186369975,0,0,0.5430560961896111,0.069187947475632,IFI6;ISG15
1318,GO_Biological_Process_2021,type I interferon signaling pathway (GO:0060337),2/65,0.8803772332374091,0.9999959186369975,0,0,0.5430560961896111,0.069187947475632,IFI6;ISG15
1319,GO_Biological_Process_2021,protein autoubiquitination (GO:0051865),2/65,0.8803772332374091,0.9999959186369975,0,0,0.5430560961896111,0.069187947475632,UHRF1;UBE2T
1320,GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),4/114,0.8804214059138608,0.9999959186369975,0,0,0.6216229630242369,0.0791665536128954,RET;CENPE;EPHA8;EEF1A2
1321,GO_Biological_Process_2021,regulation of apoptotic signaling pathway (GO:2001233),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,GATA4
1322,GO_Biological_Process_2021,regulation of cell communication (GO:0010646),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,IGFBPL1
1323,GO_Biological_Process_2021,connective tissue development (GO:0061448),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,SULF1
1324,GO_Biological_Process_2021,negative regulation of G0 to G1 transition (GO:0070317),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,RRM2
1325,GO_Biological_Process_2021,negative regulation of innate immune response (GO:0045824),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,ISG15
1326,GO_Biological_Process_2021,positive regulation of insulin secretion (GO:0032024),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,SLC30A8
1327,GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.8844149156748199,0.9999959186369975,0,0,0.4625496640015696,0.056814496415064,IL21
1328,GO_Biological_Process_2021,positive regulation of supramolecular fiber organization (GO:1902905),3/91,0.8844848450834721,0.9999959186369975,0,0,0.5829235537190083,0.0715538075819749,CCL11;SYNPO2L;CRACD
1329,GO_Biological_Process_2021,positive regulation of transport (GO:0051050),3/91,0.8844848450834721,0.9999959186369975,0,0,0.5829235537190083,0.0715538075819749,SPAG5;CALY;SYNGR3
1330,GO_Biological_Process_2021,calcium ion transport (GO:0006816),4/115,0.8845156654424255,0.9999959186369975,0,0,0.6159899663084376,0.0755912422672775,SLC24A2;TRPA1;TRPM8;TRPM5
1331,GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),4/115,0.8845156654424255,0.9999959186369975,0,0,0.6159899663084376,0.0755912422672775,UHRF1;CD80;INHBA;DTL
1332,GO_Biological_Process_2021,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),2/66,0.8856141672896584,0.9999959186369975,0,0,0.5345424613987284,0.0649329576751372,AURKB;AURKA
1333,GO_Biological_Process_2021,positive regulation of T cell proliferation (GO:0042102),2/66,0.8856141672896584,0.9999959186369975,0,0,0.5345424613987284,0.0649329576751372,IL21;CD80
1334,GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),3/92,0.88888937207505,0.9999959186369975,0,0,0.5763432073544433,0.0678831392510333,CDKN2A;E2F7;AURKA
1335,GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),3/92,0.88888937207505,0.9999959186369975,0,0,0.5763432073544433,0.0678831392510333,TCL1A;SYNPO2L;MMP1
1336,GO_Biological_Process_2021,regulation of viral genome replication (GO:0045069),2/67,0.8906379709525422,0.9999959186369975,0,0,0.5262907846014113,0.0609535522963262,ISG15;IFNL3
1337,GO_Biological_Process_2021,peptidyl-threonine modification (GO:0018210),2/67,0.8906379709525422,0.9999959186369975,0,0,0.5262907846014113,0.0609535522963262,SBK1;CDK1
1338,GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),2/67,0.8906379709525422,0.9999959186369975,0,0,0.5262907846014113,0.0609535522963262,SCT;DTL
1339,GO_Biological_Process_2021,regulation of cellular component biogenesis (GO:0044087),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,HJURP
1340,GO_Biological_Process_2021,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,KCNJ3
1341,GO_Biological_Process_2021,regulation of intracellular transport (GO:0032386),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,SPAG5
1342,GO_Biological_Process_2021,regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,TERT
1343,GO_Biological_Process_2021,DNA recombination (GO:0006310),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,EXO1
1344,GO_Biological_Process_2021,endothelial cell migration (GO:0043542),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,S100P
1345,GO_Biological_Process_2021,regulation of viral entry into host cell (GO:0046596),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,TRIML2
1346,GO_Biological_Process_2021,replication fork processing (GO:0031297),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,EME1
1347,GO_Biological_Process_2021,response to peptide (GO:1901652),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,MMP13
1348,GO_Biological_Process_2021,membrane protein proteolysis (GO:0033619),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,RET
1349,GO_Biological_Process_2021,negative regulation of protein secretion (GO:0050709),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,BMP8A
1350,GO_Biological_Process_2021,negative regulation of secretion by cell (GO:1903531),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,HRH3
1351,GO_Biological_Process_2021,odontogenesis (GO:0042476),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,INHBA
1352,GO_Biological_Process_2021,organophosphate biosynthetic process (GO:0090407),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,ITPKA
1353,GO_Biological_Process_2021,positive regulation of intracellular transport (GO:0032388),1/39,0.8908014682768508,0.9999959186369975,0,0,0.4503534243958353,0.0520760306685816,SPAG5
1354,GO_Biological_Process_2021,heart development (GO:0007507),6/164,0.8946801506075593,0.9999959186369975,0,0,0.6486851366788595,0.0721915190103556,SYNPO2L;FN1;GATA5;GATA4;MYH6;MYH7
1355,GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),4/118,0.8960734828123135,0.9999959186369975,0,0,0.5996839231837555,0.0658050303694452,TCL1A;MMP1;ISG15;CXCL13
1356,GO_Biological_Process_2021,carboxylic acid metabolic process (GO:0019752),1/40,0.8968354329968865,0.9999959186369975,0,0,0.4387826329750104,0.0477759244626102,AGXT
1357,GO_Biological_Process_2021,sulfur compound catabolic process (GO:0044273),1/40,0.8968354329968865,0.9999959186369975,0,0,0.4387826329750104,0.0477759244626102,ACAN
1358,GO_Biological_Process_2021,synaptic vesicle exocytosis (GO:0016079),1/40,0.8968354329968865,0.9999959186369975,0,0,0.4387826329750104,0.0477759244626102,SYT1
1359,GO_Biological_Process_2021,negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.8968354329968865,0.9999959186369975,0,0,0.4387826329750104,0.0477759244626102,CDKN2A
1360,GO_Biological_Process_2021,positive regulation of cation channel activity (GO:2001259),1/40,0.8968354329968865,0.9999959186369975,0,0,0.4387826329750104,0.0477759244626102,LRRC52
1361,GO_Biological_Process_2021,positive regulation of double-strand break repair (GO:2000781),1/40,0.8968354329968865,0.9999959186369975,0,0,0.4387826329750104,0.0477759244626102,FOXM1
1362,GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),3/94,0.8972499057870806,0.9999959186369975,0,0,0.5636163836163837,0.0611077696154422,CCN4;SOX11;GATA4
1363,GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),6/165,0.897838652395013,0.9999959186369975,0,0,0.6445709568118884,0.0694621254877911,CXCL10;CXCL11;CXCL9;HTR1E;HTR1D;GRM8
1364,GO_Biological_Process_2021,cell chemotaxis (GO:0060326),2/69,0.9000762169674736,0.9999959186369975,0,0,0.5105263871378801,0.0537460910440558,HOXB9;CCR8
1365,GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),2/69,0.9000762169674736,0.9999959186369975,0,0,0.5105263871378801,0.0537460910440558,IL21;IFNL4
1366,GO_Biological_Process_2021,positive regulation of protein polymerization (GO:0032273),2/69,0.9000762169674736,0.9999959186369975,0,0,0.5105263871378801,0.0537460910440558,CCL11;CRACD
1367,GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),6/166,0.9009157131815996,0.9999959186369975,0,0,0.6405082041932544,0.0668329150915692,SOX2;RET;GRM4;EPHA8;FN1;FAM83D
1368,GO_Biological_Process_2021,ciliary basal body-plasma membrane docking (GO:0097711),3/95,0.9012142112304772,0.9999959186369975,0,0,0.5574604743083004,0.0579827468265942,PLK1;CDK1;NEK2
1369,GO_Biological_Process_2021,DNA metabolic process (GO:0006259),11/277,0.9024761287896322,0.9999959186369975,0,0,0.7055447685146933,0.0723980930027121,TOP2A;POLQ;NEIL3;ORC6;TERT;EXO1;UHRF1;UBE2T;CDK1;HUS1B;MCM10
1370,GO_Biological_Process_2021,acylglycerol metabolic process (GO:0006639),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,PNLIPRP2
1371,GO_Biological_Process_2021,regulation of cell development (GO:0060284),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,ASCL1
1372,GO_Biological_Process_2021,carbohydrate catabolic process (GO:0016052),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,NEU4
1373,GO_Biological_Process_2021,regulation of G0 to G1 transition (GO:0070316),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,RRM2
1374,GO_Biological_Process_2021,regulation of mitochondrial membrane potential (GO:0051881),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,TCL1A
1375,GO_Biological_Process_2021,regulation of protein dephosphorylation (GO:0035304),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,CDCA2
1376,GO_Biological_Process_2021,import into cell (GO:0098657),1/41,0.90253625871445,0.9999959186369975,0,0,0.4277903811252269,0.0438683694088356,SLC1A6
1377,GO_Biological_Process_2021,carbohydrate homeostasis (GO:0033500),2/70,0.9045052111865434,0.9999959186369975,0,0,0.50299193246781,0.050483898304127,SLC30A8;PAX6
1378,GO_Biological_Process_2021,kidney development (GO:0001822),2/70,0.9045052111865434,0.9999959186369975,0,0,0.50299193246781,0.050483898304127,CENPF;SULF1
1379,GO_Biological_Process_2021,negative regulation of viral process (GO:0048525),2/70,0.9045052111865434,0.9999959186369975,0,0,0.50299193246781,0.050483898304127,ISG15;IFNL3
1380,GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),6/168,0.9068316161608538,0.9999959186369975,0,0,0.6325331712751949,0.0618607923895681,ANLN;CENPE;CENPF;CALY;CENPA;DLGAP5
1381,GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,SLC24A2
1382,GO_Biological_Process_2021,regulation of double-strand break repair (GO:2000779),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,FOXM1
1383,GO_Biological_Process_2021,cellular respiration (GO:0045333),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,MTFR2
1384,GO_Biological_Process_2021,determination of left/right symmetry (GO:0007368),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,FOXJ1
1385,GO_Biological_Process_2021,monocyte chemotaxis (GO:0002548),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,CCL11
1386,GO_Biological_Process_2021,nucleic acid-templated transcription (GO:0097659),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,TERT
1387,GO_Biological_Process_2021,phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,ITPKA
1388,GO_Biological_Process_2021,positive regulation of ATPase activity (GO:0032781),1/42,0.9079223223741892,0.9999959186369975,0,0,0.4173343366827498,0.040313016257357,UHRF1
1389,GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),3/97,0.908731219347832,0.9999959186369975,0,0,0.545541586073501,0.0522115576560222,SLC24A2;CCL11;S100A14
1390,GO_Biological_Process_2021,double-strand break repair via homologous recombination (GO:0000724),3/97,0.908731219347832,0.9999959186369975,0,0,0.545541586073501,0.0522115576560222,POLQ;HUS1B;AUNIP
1391,GO_Biological_Process_2021,protein tetramerization (GO:0051262),2/71,0.9087501744996688,0.9999959186369975,0,0,0.4956758677881767,0.0474287742144155,TDO2;TRPA1
1392,GO_Biological_Process_2021,regulation of endopeptidase activity (GO:0052548),2/71,0.9087501744996688,0.9999959186369975,0,0,0.4956758677881767,0.0474287742144155,A2ML1;SERPINB7
1393,GO_Biological_Process_2021,cellular response to BMP stimulus (GO:0071773),2/71,0.9087501744996688,0.9999959186369975,0,0,0.4956758677881767,0.0474287742144155,BMP8A;AMH
1394,GO_Biological_Process_2021,gland development (GO:0048732),2/71,0.9087501744996688,0.9999959186369975,0,0,0.4956758677881767,0.0474287742144155,SOX2;SIX3
1395,GO_Biological_Process_2021,phosphatidylinositol-mediated signaling (GO:0048015),2/71,0.9087501744996688,0.9999959186369975,0,0,0.4956758677881767,0.0474287742144155,MUC5AC;KCNH1
1396,GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),6/169,0.9096735022227882,0.9999959186369975,0,0,0.6286190446896444,0.0595110711552262,SBK1;PLK1;CDK1;TTK;CLSPN;AURKA
1397,GO_Biological_Process_2021,negative regulation of epithelial cell proliferation (GO:0050680),2/72,0.9128179113710428,0.9999959186369975,0,0,0.4885688335279616,0.0445666911358913,SOX2;SULF1
1398,GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),2/72,0.9128179113710428,0.9999959186369975,0,0,0.4885688335279616,0.0445666911358913,NEURL1;SOX11
1399,GO_Biological_Process_2021,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/43,0.9130109881421716,0.9999959186369975,0,0,0.4073761991184859,0.0370742337344477,EME1
1400,GO_Biological_Process_2021,heart looping (GO:0001947),1/43,0.9130109881421716,0.9999959186369975,0,0,0.4073761991184859,0.0370742337344477,GATA4
1401,GO_Biological_Process_2021,negative regulation of type I interferon production (GO:0032480),1/43,0.9130109881421716,0.9999959186369975,0,0,0.4073761991184859,0.0370742337344477,ISG15
1402,GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.9130109881421716,0.9999959186369975,0,0,0.4073761991184859,0.0370742337344477,IL4I1
1403,GO_Biological_Process_2021,neuron projection development (GO:0031175),6/171,0.915132713163935,0.9999959186369975,0,0,0.6209331233943813,0.0550681883109189,CNTNAP2;EPHA8;GPRIN1;BICDL1;MNX1;PACSIN1
1404,GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),5/148,0.9161760109411876,0.9999959186369975,0,0,0.5972078922898595,0.0522836286080911,KISS1;CCKBR;CCR8;CXCL13;HCRTR2
1405,GO_Biological_Process_2021,regulation of actin filament polymerization (GO:0030833),2/73,0.9167150361660644,0.9999959186369975,0,0,0.4816619974159215,0.0418846585823248,CCL11;CRACD
1406,GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),2/73,0.9167150361660644,0.9999959186369975,0,0,0.4816619974159215,0.0418846585823248,H2BC11;S100A7
1407,GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),2/73,0.9167150361660644,0.9999959186369975,0,0,0.4816619974159215,0.0418846585823248,S100A14;S100A7
1408,GO_Biological_Process_2021,response to amyloid-beta (GO:1904645),1/44,0.9178186630654644,0.9999959186369975,0,0,0.3978812307432575,0.0341204810690061,MMP13
1409,GO_Biological_Process_2021,metal ion homeostasis (GO:0055065),1/44,0.9178186630654644,0.9999959186369975,0,0,0.3978812307432575,0.0341204810690061,S100A14
1410,GO_Biological_Process_2021,positive regulation of cell-matrix adhesion (GO:0001954),1/44,0.9178186630654644,0.9999959186369975,0,0,0.3978812307432575,0.0341204810690061,CEACAM6
1411,GO_Biological_Process_2021,positive regulation of stress fiber assembly (GO:0051496),1/44,0.9178186630654644,0.9999959186369975,0,0,0.3978812307432575,0.0341204810690061,SYNPO2L
1412,GO_Biological_Process_2021,protein K63-linked ubiquitination (GO:0070534),1/44,0.9178186630654644,0.9999959186369975,0,0,0.3978812307432575,0.0341204810690061,UBE2T
1413,GO_Biological_Process_2021,cellular response to lipid (GO:0071396),8/219,0.9209506577068468,0.9999959186369975,0,0,0.6470081585838257,0.0532803576495624,RET;STRA8;CXCL10;CXCL11;CXCL9;CD80;CXCL13;BRINP3
1414,GO_Biological_Process_2021,action potential (GO:0001508),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,SCN1A
1415,GO_Biological_Process_2021,amino acid transmembrane transport (GO:0003333),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,SLC1A6
1416,GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,TERT
1417,GO_Biological_Process_2021,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,IFNL1
1418,GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,F7
1419,GO_Biological_Process_2021,positive regulation of Notch signaling pathway (GO:0045747),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,GATA5
1420,GO_Biological_Process_2021,positive regulation of RNA metabolic process (GO:0051254),1/45,0.9223608497946332,0.9999959186369975,0,0,0.3888178518396304,0.0314237746203669,LIN28B
1421,GO_Biological_Process_2021,neuron differentiation (GO:0030182),6/174,0.922782607766402,0.9999959186369975,0,0,0.6097473629378826,0.0490002737428827,NEUROD2;LHX2;SOX11;PAX6;INHBA;ASCL1
1422,GO_Biological_Process_2021,proteolysis (GO:0006508),11/287,0.9239129515048408,0.9999959186369975,0,0,0.6796165790731008,0.0537831027294031,RET;F7;ACAN;PRSS1;PROC;MMP1;PRSS48;KLK4;PRSS33;PRSS2;CPA6
1423,GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),2/75,0.9240229598464904,0.9999959186369975,0,0,0.468416010351735,0.0370134646221114,FN1;ISG15
1424,GO_Biological_Process_2021,positive regulation of immune response (GO:0050778),2/75,0.9240229598464904,0.9999959186369975,0,0,0.468416010351735,0.0370134646221114,IFNL1;CD177
1425,GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),2/75,0.9240229598464904,0.9999959186369975,0,0,0.468416010351735,0.0370134646221114,IL21;CD80
1426,GO_Biological_Process_2021,positive regulation of T cell activation (GO:0050870),2/75,0.9240229598464904,0.9999959186369975,0,0,0.468416010351735,0.0370134646221114,IL21;CD80
1427,GO_Biological_Process_2021,protein O-linked glycosylation (GO:0006493),3/102,0.9253049199998624,0.9999959186369975,0,0,0.5178512396694215,0.0402018028644289,MUC2;MUC19;MUC5AC
1428,GO_Biological_Process_2021,cell junction assembly (GO:0034329),3/102,0.9253049199998624,0.9999959186369975,0,0,0.5178512396694215,0.0402018028644289,CDH2;FN1;CDH7
1429,GO_Biological_Process_2021,regulation of protein catabolic process (GO:0042176),3/102,0.9253049199998624,0.9999959186369975,0,0,0.5178512396694215,0.0402018028644289,EEF1A2;FAM83D;DTL
1430,GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),3/102,0.9253049199998624,0.9999959186369975,0,0,0.5178512396694215,0.0402018028644289,UHRF1;PLK1;INHBA
1431,GO_Biological_Process_2021,regulation of B cell proliferation (GO:0030888),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,IL21
1432,GO_Biological_Process_2021,regulation of cellular protein localization (GO:1903827),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,SUMO4
1433,GO_Biological_Process_2021,regulation of double-strand break repair via homologous recombination (GO:0010569),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,POLQ
1434,GO_Biological_Process_2021,regulation of fibroblast proliferation (GO:0048145),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,FN1
1435,GO_Biological_Process_2021,spliceosomal complex assembly (GO:0000245),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,CELF3
1436,GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,ORM1
1437,GO_Biological_Process_2021,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,GTSE1
1438,GO_Biological_Process_2021,positive regulation of organelle assembly (GO:1902117),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,SPAG5
1439,GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.9266521964659492,0.9999959186369975,0,0,0.3801572897761645,0.0289592328961285,CCN4
1440,GO_Biological_Process_2021,phospholipid metabolic process (GO:0006644),2/76,0.9274460425810132,0.9999959186369975,0,0,0.4620615165574294,0.0348027789918958,PNLIPRP2;PLPPR5
1441,GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),4/128,0.9275682854641968,0.9999959186369975,0,0,0.5510287945052688,0.0414312291279445,CNTNAP2;EPHA8;GPRIN1;BICDL1
1442,GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),6/177,0.9298212237044756,0.9999959186369975,0,0,0.5989540853044187,0.0435816625015226,CDC20;NEUROD2;FOXD1;NEURL1;PACSIN1;AURKA
1443,GO_Biological_Process_2021,regulation of cellular metabolic process (GO:0031323),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,FOXM1
1444,GO_Biological_Process_2021,determination of heart left/right asymmetry (GO:0061371),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,GATA4
1445,GO_Biological_Process_2021,embryonic heart tube morphogenesis (GO:0003143),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,GATA4
1446,GO_Biological_Process_2021,epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,FAM83A
1447,GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,FAM83D
1448,GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,SYNDIG1
1449,GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,NEU4
1450,GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.9307065435995424,0.9999959186369975,0,0,0.3718732738893711,0.026704687234771,ITPKA
1451,GO_Biological_Process_2021,phosphatidylcholine metabolic process (GO:0046470),2/77,0.9307230840018048,0.9999959186369975,0,0,0.4558764759309718,0.0327289610549229,PNLIPRP2;SLC44A4
1452,GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),2/77,0.9307230840018048,0.9999959186369975,0,0,0.4558764759309718,0.0327289610549229,EPO;FN1
1453,GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),5/154,0.9315980226232928,0.9999959186369975,0,0,0.5729758804904586,0.040597554844545,TPX2;CENPE;TCL1A;KIF14;CLSPN
1454,GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),12/314,0.9330658286192184,0.9999959186369975,0,0,0.6772448874293588,0.0469192039484448,FAM111B;BRIP1;ORC6;TERT;EXO1;EEF1A2;PCLAF;CDK1;MCM10;CLSPN;INHBA;GAL3ST2
1455,GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.9338597623977772,0.9999959186369975,0,0,0.4498541995315264,0.030783072728351,RTKN2;GATA4
1456,GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.9338597623977772,0.9999959186369975,0,0,0.4498541995315264,0.030783072728351,CXCL10;SULF1
1457,GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),2/78,0.9338597623977772,0.9999959186369975,0,0,0.4498541995315264,0.030783072728351,CDKN2A;PLK1
1458,GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),3/105,0.9338761427693356,0.9999959186369975,0,0,0.5025401069518717,0.0343795019232862,UHRF1;CDK1;INHBA
1459,GO_Biological_Process_2021,regulation of immune response (GO:0050776),6/179,0.9341933105455836,0.9999959186369975,0,0,0.5919665298422919,0.0402962814284715,IL4I1;IFNL1;CXCL13;FOXP3;ULBP1;CD1A
1460,GO_Biological_Process_2021,cognition (GO:0050890),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,HRH3
1461,GO_Biological_Process_2021,regulation of protein metabolic process (GO:0051246),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,FAM83D
1462,GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,ITPKA
1463,GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,ORM1
1464,GO_Biological_Process_2021,nucleus organization (GO:0006997),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,CEP55
1465,GO_Biological_Process_2021,positive regulation of DNA repair (GO:0045739),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,FOXM1
1466,GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.9345369688724392,0.9999959186369975,0,0,0.3639417693169093,0.0246403473283169,CALY
1467,GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/79,0.9368615746972248,0.9999959186369975,0,0,0.4439883458957028,0.0289568045285934,CDC20;PLK1
1468,GO_Biological_Process_2021,regulation of cellular localization (GO:0060341),1/49,0.9381558288122128,0.9999959186369975,0,0,0.3563407441016334,0.0227485133674492,SPAG5
1469,GO_Biological_Process_2021,regulation of interferon-beta production (GO:0032648),1/49,0.9381558288122128,0.9999959186369975,0,0,0.3563407441016334,0.0227485133674492,ISG15
1470,GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.9381558288122128,0.9999959186369975,0,0,0.3563407441016334,0.0227485133674492,CCN4
1471,GO_Biological_Process_2021,regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.9381558288122128,0.9999959186369975,0,0,0.3563407441016334,0.0227485133674492,FOXM1
1472,GO_Biological_Process_2021,oligosaccharide metabolic process (GO:0009311),1/49,0.9381558288122128,0.9999959186369975,0,0,0.3563407441016334,0.0227485133674492,NEU4
1473,GO_Biological_Process_2021,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/49,0.9381558288122128,0.9999959186369975,0,0,0.3563407441016334,0.0227485133674492,CD177
1474,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/80,0.9397338389783122,0.9999959186369975,0,0,0.4382728987633619,0.0272424271034249,TERT;IFI6
1475,GO_Biological_Process_2021,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/50,0.9415747987254022,0.9999959186369975,0,0,0.3490499648135116,0.0210133271649981,PSCA
1476,GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),4/134,0.9420541083877446,0.9999959186369975,0,0,0.5254287114159726,0.0313641881150503,IL21;IFNL1;EPO;CD80
1477,GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),5/159,0.942459083696565,0.9999959186369975,0,0,0.5542249189790174,0.0328449056341519,MELK;EPHA8;NEK2;AURKB;AURKA
1478,GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),2/81,0.9424816976338491,0.9999959186369975,0,0,0.432702146495131,0.0256327467445222,CCKBR;TRHR
1479,GO_Biological_Process_2021,regulation of axonogenesis (GO:0050770),1/51,0.9448049100400656,0.9999959186369975,0,0,0.3420508166969147,0.0194205566937444,CDH2
1480,GO_Biological_Process_2021,regulation of interleukin-12 production (GO:0032655),1/51,0.9448049100400656,0.9999959186369975,0,0,0.3420508166969147,0.0194205566937444,TIGIT
1481,GO_Biological_Process_2021,regulation of protein modification process (GO:0031399),1/51,0.9448049100400656,0.9999959186369975,0,0,0.3420508166969147,0.0194205566937444,FN1
1482,GO_Biological_Process_2021,mesenchymal cell differentiation (GO:0048762),1/51,0.9448049100400656,0.9999959186369975,0,0,0.3420508166969147,0.0194205566937444,FAM83D
1483,GO_Biological_Process_2021,negative regulation of protein ubiquitination (GO:0031397),1/51,0.9448049100400656,0.9999959186369975,0,0,0.3420508166969147,0.0194205566937444,ISG15
1484,GO_Biological_Process_2021,positive regulation of actin filament bundle assembly (GO:0032233),1/51,0.9448049100400656,0.9999959186369975,0,0,0.3420508166969147,0.0194205566937444,SYNPO2L
1485,GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),16/409,0.944865959336498,0.9999959186369975,0,0,0.6930483086020071,0.0393042967272372,H2BC9;UHRF1;UBE2C;H2BC3;PLK1;SUMO4;ISG15;H2BC17;NEUROD2;H2BC13;H2BC14;TRIML2;UBE2T;H2BC10;H2BC11;MKRN3
1486,GO_Biological_Process_2021,ephrin receptor signaling pathway (GO:0048013),2/82,0.945110120531601,0.9999959186369975,0,0,0.4272706630336058,0.0241210647828509,EFNA2;EPHA8
1487,GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),2/82,0.945110120531601,0.9999959186369975,0,0,0.4272706630336058,0.0241210647828509,PLK1;MAGEC2
1488,GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),2/83,0.9476239082559104,0.9999959186369975,0,0,0.4219732902748343,0.0227011404450502,ORM1;PYDC1
1489,GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),2/83,0.9476239082559104,0.9999959186369975,0,0,0.4219732902748343,0.0227011404450502,NEURL1;MAGEA1
1490,GO_Biological_Process_2021,cartilage development (GO:0051216),1/52,0.947856586221954,0.9999959186369975,0,0,0.3353261449770471,0.0179574086949507,SULF1
1491,GO_Biological_Process_2021,regulation of exocytosis (GO:0017157),1/52,0.947856586221954,0.9999959186369975,0,0,0.3353261449770471,0.0179574086949507,SYT1
1492,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.947856586221954,0.9999959186369975,0,0,0.3353261449770471,0.0179574086949507,RTKN2
1493,GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.947856586221954,0.9999959186369975,0,0,0.3353261449770471,0.0179574086949507,NEU4
1494,GO_Biological_Process_2021,positive regulation of developmental growth (GO:0048639),1/52,0.947856586221954,0.9999959186369975,0,0,0.3353261449770471,0.0179574086949507,SYT1
1495,GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),3/111,0.9483594628013812,0.9999959186369975,0,0,0.474469696969697,0.0251571749516309,SLC24A2;SLC30A8;CCL11
1496,GO_Biological_Process_2021,heart morphogenesis (GO:0003007),1/53,0.9507396756200102,0.9999959186369975,0,0,0.3288601144771744,0.0166123658638554,SYNPO2L
1497,GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),1/53,0.9507396756200102,0.9999959186369975,0,0,0.3288601144771744,0.0166123658638554,IL21
1498,GO_Biological_Process_2021,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.9507396756200102,0.9999959186369975,0,0,0.3288601144771744,0.0166123658638554,RTKN2
1499,GO_Biological_Process_2021,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.9534634836184362,0.9999959186369975,0,0,0.3226380851282402,0.0153750443098281,CELF3
1500,GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),1/54,0.9534634836184362,0.9999959186369975,0,0,0.3226380851282402,0.0153750443098281,CXCL13
1501,GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),1/54,0.9534634836184362,0.9999959186369975,0,0,0.3226380851282402,0.0153750443098281,H3C13
1502,GO_Biological_Process_2021,cytoplasmic microtubule organization (GO:0031122),1/54,0.9534634836184362,0.9999959186369975,0,0,0.3226380851282402,0.0153750443098281,FSD1
1503,GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),4/140,0.9538495741008534,0.9999959186369975,0,0,0.5020874591874966,0.0237232805365616,NTNG1;CNTNAP2;MNX1;PACSIN1
1504,GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),3/114,0.9544382712350092,0.9999959186369975,0,0,0.4615724815724816,0.0215241906868339,TPX2;KIF14;CLSPN
1505,GO_Biological_Process_2021,response to lipid (GO:0033993),3/114,0.9544382712350092,0.9999959186369975,0,0,0.4615724815724816,0.0215241906868339,S100A14;ASCL1;S100A7
1506,GO_Biological_Process_2021,histone modification (GO:0016570),3/114,0.9544382712350092,0.9999959186369975,0,0,0.4615724815724816,0.0215241906868339,CCNA2;UHRF1;AURKB
1507,GO_Biological_Process_2021,regulation of neuron death (GO:1901214),2/86,0.95452300488111,0.9999959186369975,0,0,0.4068379395354872,0.0189356757183902,GRM4;KIF14
1508,GO_Biological_Process_2021,glucose homeostasis (GO:0042593),2/86,0.95452300488111,0.9999959186369975,0,0,0.4068379395354872,0.0189356757183902,SLC30A8;PAX6
1509,GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),2/86,0.95452300488111,0.9999959186369975,0,0,0.4068379395354872,0.0189356757183902,CDKN2A;INHBA
1510,GO_Biological_Process_2021,protein sumoylation (GO:0016925),1/55,0.9560368023970855,0.9999959186369975,0,0,0.3166465013107481,0.0142360690278471,SUMO4
1511,GO_Biological_Process_2021,regulation of cardiac conduction (GO:1903779),1/55,0.9560368023970855,0.9999959186369975,0,0,0.3166465013107481,0.0142360690278471,CORIN
1512,GO_Biological_Process_2021,regulation of gene silencing by RNA (GO:0060966),1/55,0.9560368023970855,0.9999959186369975,0,0,0.3166465013107481,0.0142360690278471,H3C13
1513,GO_Biological_Process_2021,regulation of posttranscriptional gene silencing (GO:0060147),1/55,0.9560368023970855,0.9999959186369975,0,0,0.3166465013107481,0.0142360690278471,H3C13
1514,GO_Biological_Process_2021,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/55,0.9560368023970855,0.9999959186369975,0,0,0.3166465013107481,0.0142360690278471,ISG15
1515,GO_Biological_Process_2021,cellular response to lectin (GO:1990858),3/115,0.9563111871964614,0.9999959186369975,0,0,0.457426948051948,0.0204341351245832,MUC2;MUC19;MUC5AC
1516,GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),3/115,0.9563111871964614,0.9999959186369975,0,0,0.457426948051948,0.0204341351245832,MUC2;MUC19;MUC5AC
1517,GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),2/87,0.9566230013099302,0.9999959186369975,0,0,0.4020302398888711,0.0178283940888411,CXCL10;SULF1
1518,GO_Biological_Process_2021,chromatin organization (GO:0006325),4/142,0.957261589974734,0.9999959186369975,0,0,0.49475808046841,0.0216103309547552,SOX2;H1-5;H3C13;FOXP3
1519,GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),3/116,0.9581118118734911,0.9999959186369975,0,0,0.4533547868061142,0.019399411275897,TCL1A;MMP1;HJURP
1520,GO_Biological_Process_2021,protein-containing complex disassembly (GO:0032984),1/56,0.9584679393310248,0.9999959186369975,0,0,0.3108727932684375,0.0131869645758395,LIX1
1521,GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),4/143,0.958878806711144,0.9999959186369975,0,0,0.4911724851238209,0.0206246208380112,CDKN2A;PYDC1;FOXJ1;FOXP3
1522,GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),3/117,0.9598426662165044,0.9999959186369975,0,0,0.4493540669856459,0.018417179645031,RET;PLPPR5;ZNF804A
1523,GO_Biological_Process_2021,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),2/89,0.960547731065396,0.9999959186369975,0,0,0.3927464060885088,0.0158086728223641,KIF14;NCCRP1
1524,GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),2/89,0.960547731065396,0.9999959186369975,0,0,0.3927464060885088,0.0158086728223641,CCR8;MAFA
1525,GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),2/89,0.960547731065396,0.9999959186369975,0,0,0.3927464060885088,0.0158086728223641,IL21;CCN4
1526,GO_Biological_Process_2021,carboxylic acid transport (GO:0046942),1/57,0.9607647433898804,0.9999959186369975,0,0,0.3053052890847809,0.0122200591140464,SLC1A1
1527,GO_Biological_Process_2021,regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.9607647433898804,0.9999959186369975,0,0,0.3053052890847809,0.0122200591140464,FOXM1
1528,GO_Biological_Process_2021,negative regulation of cell cycle G2/M phase transition (GO:1902750),1/57,0.9607647433898804,0.9999959186369975,0,0,0.3053052890847809,0.0122200591140464,AURKA
1529,GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),1/57,0.9607647433898804,0.9999959186369975,0,0,0.3053052890847809,0.0122200591140464,PLK1
1530,GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),3/118,0.9615061993685032,0.9999959186369975,0,0,0.4454229249011858,0.0174847501426855,CXCL10;CXCL11;CXCL9
1531,GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),32/764,0.9615248493493812,0.9999959186369975,0,0,0.7414550519661417,0.0290908925229305,IL21;CXCL9;EPO;UHRF1;RTKN2;KIF14;TTK;FOXM1;FGF5;TCL1A;ESM1;IFNL1;SIX3;PRAME;E2F7;KCNH1;CDKN2A;TNFRSF9;H2AC4;FN1;SOX11;INHBA;NCCRP1;FOXP3;CXCL10;CXCL11;CCKBR;FABP6;CEACAM6;NEURL1;BIRC5;CDKN3
1532,GO_Biological_Process_2021,sodium ion transport (GO:0006814),2/90,0.9623800482158692,0.9999959186369975,0,0,0.3882627363553794,0.0148882630247049,SLC24A2;SCN1A
1533,GO_Biological_Process_2021,positive regulation of binding (GO:0051099),2/90,0.9623800482158692,0.9999959186369975,0,0,0.3882627363553794,0.0148882630247049,TERT;SUMO4
1534,GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),1/58,0.9629346308960904,0.9999959186369975,0,0,0.2999331359251122,0.0113283996138239,PLPP4
1535,GO_Biological_Process_2021,positive regulation of mitochondrion organization (GO:0010822),1/58,0.9629346308960904,0.9999959186369975,0,0,0.2999331359251122,0.0113283996138239,AURKA
1536,GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.9629346308960904,0.9999959186369975,0,0,0.2999331359251122,0.0113283996138239,TERT
1537,GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),3/119,0.963104789444557,0.9999959186369975,0,0,0.4415595611285266,0.0165995739629704,MUC2;MUC19;MUC5AC
1538,GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),7/221,0.9634291578472398,0.9999959186369975,0,0,0.5575968688177911,0.0207740071955798,RET;F7;LRRC15;CEMIP;CCL11;CEACAM6;GTSE1
1539,GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),9/269,0.9640658871656428,0.9999959186369975,0,0,0.5896955421178456,0.0215802851939879,RET;F7;LRRC15;CEMIP;CCL11;CEACAM6;FN1;CCN4;GTSE1
1540,GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),3/120,0.9646407446942074,0.9999959186369975,0,0,0.4377622377622377,0.0157592357959353,KISS1;CCL11;PACSIN1
1541,GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),4/147,0.964797405799443,0.9999959186369975,0,0,0.4773315856118404,0.0171061997482302,KISS1;CCKBR;CCR8;CXCL13
1542,GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.9649846089213476,0.9999959186369975,0,0,0.2947462294261218,0.0105056773102079,UBE2C
1543,GO_Biological_Process_2021,regulation of secretion by cell (GO:1903530),1/59,0.9649846089213476,0.9999959186369975,0,0,0.2947462294261218,0.0105056773102079,SYT1
1544,GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),1/59,0.9649846089213476,0.9999959186369975,0,0,0.2947462294261218,0.0105056773102079,S100A7
1545,GO_Biological_Process_2021,negative regulation of autophagy (GO:0010507),1/59,0.9649846089213476,0.9999959186369975,0,0,0.2947462294261218,0.0105056773102079,MAGEA3
1546,GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),2/92,0.9658025009862776,0.9999959186369975,0,0,0.3795943082046624,0.0132083316613047,CCL11;SULF1
1547,GO_Biological_Process_2021,retinoid metabolic process (GO:0001523),2/92,0.9658025009862776,0.9999959186369975,0,0,0.3795943082046624,0.0132083316613047,CLPS;RLBP1
1548,GO_Biological_Process_2021,protein homooligomerization (GO:0051260),3/121,0.9661163046784564,0.9999959186369975,0,0,0.4340292758089368,0.0149614465167677,POLQ;TDO2;TRPA1
1549,GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),18/474,0.9665966064296074,0.9999959186369975,0,0,0.670907106475867,0.0227934184373634,IL21;EPO;RTKN2;FN1;KIF14;SOX11;TTK;NCCRP1;FOXM1;FGF5;TCL1A;ESM1;TERT;CCKBR;CEACAM6;BIRC5;CCN4;PRAME
1550,GO_Biological_Process_2021,cellular protein catabolic process (GO:0044257),1/60,0.9669212979052388,0.9999959186369975,0,0,0.2897351502660801,0.0097461616119053,MAGEC2
1551,GO_Biological_Process_2021,response to organic cyclic compound (GO:0014070),1/60,0.9669212979052388,0.9999959186369975,0,0,0.2897351502660801,0.0097461616119053,SLC1A1
1552,GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),2/93,0.9673994001564508,0.9999959186369975,0,0,0.3754029803076124,0.0124422958083703,SOX2;UHRF1
1553,GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),2/93,0.9673994001564508,0.9999959186369975,0,0,0.3754029803076124,0.0124422958083703,MYH6;CORIN
1554,GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),4/150,0.9687055996886684,0.9999959186369975,0,0,0.4674486145561968,0.0148623099078556,IL21;CCN4;ISG15;FOXP3
1555,GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),3/123,0.9688948609920386,0.9999959186369975,0,0,0.42675,0.0134849481729603,CDH2;KIF1A;CXCL13
1556,GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),2/94,0.9689243763464904,0.9999959186369975,0,0,0.3713027682344114,0.0117215505721534,RET;EPHA8
1557,GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),2/94,0.9689243763464904,0.9999959186369975,0,0,0.3713027682344114,0.0117215505721534,PSCA;FOXM1
1558,GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),11/321,0.9694622137408796,0.9999959186369975,0,0,0.6039731773602741,0.0187314912820666,CDC20;PTTG1;UBE2C;PLK1;KIF14;CDK1;BUB1B;PRAME;NCCRP1;AURKB;AURKA
1559,GO_Biological_Process_2021,generation of neurons (GO:0048699),6/202,0.9695895890965038,0.9999959186369975,0,0,0.5218592450653917,0.0161162664939473,NEUROD2;ARTN;LHX2;SIX3;SOX11;ASCL1
1560,GO_Biological_Process_2021,DNA repair (GO:0006281),10/298,0.969606216755341,0.9999959186369975,0,0,0.5911672766087221,0.0182465269770446,POLQ;NEIL3;BRIP1;EME1;EXO1;CDCA5;UBE2T;CDK1;HUS1B;TRIP13
1561,GO_Biological_Process_2021,double-strand break repair via nonhomologous end joining (GO:0006303),1/62,0.9704794853966908,0.9999959186369975,0,0,0.2802058849781321,0.0083963734837182,POLQ
1562,GO_Biological_Process_2021,negative regulation of kinase activity (GO:0033673),1/62,0.9704794853966908,0.9999959186369975,0,0,0.2802058849781321,0.0083963734837182,PYDC1
1563,GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),3/125,0.9714570478790772,0.9999959186369975,0,0,0.419709388971684,0.0121540382110328,CDKN2A;FN1;INHBA
1564,GO_Biological_Process_2021,amyloid fibril formation (GO:1990000),1/63,0.9721124781467204,0.9999959186369975,0,0,0.2756717990749956,0.0077970358194069,H3C13
1565,GO_Biological_Process_2021,COPII vesicle coating (GO:0048208),1/63,0.9721124781467204,0.9999959186369975,0,0,0.2756717990749956,0.0077970358194069,CNIH2
1566,GO_Biological_Process_2021,vesicle coating (GO:0006901),1/63,0.9721124781467204,0.9999959186369975,0,0,0.2756717990749956,0.0077970358194069,CNIH2
1567,GO_Biological_Process_2021,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.9721124781467204,0.9999959186369975,0,0,0.2756717990749956,0.0077970358194069,CNIH2
1568,GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.9721124781467204,0.9999959186369975,0,0,0.2756717990749956,0.0077970358194069,SERPINB7
1569,GO_Biological_Process_2021,negative regulation of peptidase activity (GO:0010466),1/63,0.9721124781467204,0.9999959186369975,0,0,0.2756717990749956,0.0077970358194069,SERPINB7
1570,GO_Biological_Process_2021,synapse organization (GO:0050808),3/126,0.9726619073943018,0.9999959186369975,0,0,0.4162749445676275,0.0115386134578835,NTNG1;CDH2;CBLN2
1571,GO_Biological_Process_2021,regulated exocytosis (GO:0045055),5/180,0.9730177724340824,0.9999959186369975,0,0,0.4871714806141036,0.0133255680685776,ORM1;SYT1;FN1;SYT13;SYNGR3
1572,GO_Biological_Process_2021,glycosaminoglycan biosynthetic process (GO:0006024),2/97,0.9730978417839756,0.9999959186369975,0,0,0.3595200535398442,0.0098043437625339,ACAN;CEMIP
1573,GO_Biological_Process_2021,plasma membrane organization (GO:0007009),1/64,0.9736552078615502,0.9999959186369975,0,0,0.2712816524068793,0.0072426867921112,PACSIN1
1574,GO_Biological_Process_2021,pre-replicative complex assembly (GO:0036388),1/64,0.9736552078615502,0.9999959186369975,0,0,0.2712816524068793,0.0072426867921112,ORC6
1575,GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),2/98,0.9743646205282332,0.9999959186369975,0,0,0.3557561307901907,0.0092388770254048,GRM4;KIF14
1576,GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),2/98,0.9743646205282332,0.9999959186369975,0,0,0.3557561307901907,0.0092388770254048,IL21;CCN4
1577,GO_Biological_Process_2021,regulation of cell-matrix adhesion (GO:0001952),1/65,0.9751126592851248,0.9999959186369975,0,0,0.2670286978221415,0.0067297284523117,CDKN2A
1578,GO_Biological_Process_2021,organic anion transport (GO:0015711),2/99,0.9755736562185534,0.9999959186369975,0,0,0.3520698146951693,0.0087065511997159,SLC44A4;SLCO5A1
1579,GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),8/258,0.975854263712127,0.9999959186369975,0,0,0.5449351598173516,0.0133193180832976,FBN2;NEUROD2;CDH2;CCN4;GATA5;SOX11;ASCL1;BRINP3
1580,GO_Biological_Process_2021,regulation of protein localization (GO:0032880),1/66,0.976489542479256,0.9999959186369975,0,0,0.2629066033784727,0.0062548735489234,TRIML2
1581,GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),1/66,0.976489542479256,0.9999959186369975,0,0,0.2629066033784727,0.0062548735489234,FAM83A
1582,GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.9777903072481908,0.9999959186369975,0,0,0.2589094208876423,0.0058151163904505,IFI6
1583,GO_Biological_Process_2021,regulation of gene silencing by miRNA (GO:0060964),1/67,0.9777903072481908,0.9999959186369975,0,0,0.2589094208876423,0.0058151163904505,H3C13
1584,GO_Biological_Process_2021,transcription elongation from RNA polymerase II promoter (GO:0006368),1/67,0.9777903072481908,0.9999959186369975,0,0,0.2589094208876423,0.0058151163904505,ELOA2
1585,GO_Biological_Process_2021,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.9777903072481908,0.9999959186369975,0,0,0.2589094208876423,0.0058151163904505,SULF1
1586,GO_Biological_Process_2021,nervous system development (GO:0007399),16/447,0.9781190838676892,0.9999959186369975,0,0,0.6306465142786399,0.0139523312270753,FN1;PAX6;WDR62;INHBA;ASCL1;HAPLN1;FGF5;DMBX1;NEUROD2;ACAN;GBX2;CDH2;ARTN;NEURL1;LY6H;MNX1
1587,GO_Biological_Process_2021,regulation of cell death (GO:0010941),2/102,0.9788788900476364,0.9999959186369975,0,0,0.3414532243415077,0.0072891221444349,CCN4;SOX11
1588,GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),1/68,0.9790191581631452,0.9999959186369975,0,0,0.2550315572771351,0.0054077063624152,H3C13
1589,GO_Biological_Process_2021,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.9790191581631452,0.9999959186369975,0,0,0.2550315572771351,0.0054077063624152,FBN2
1590,GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),4/161,0.9798300804624112,0.9999959186369975,0,0,0.4344424288438244,0.0088522465598203,FGF5;RET;F7;CD80
1591,GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),3/133,0.9798391659020274,0.9999959186369975,0,0,0.3937132867132867,0.0080186944189258,BMP8A;INHBA;AMH
1592,GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),2/103,0.9798810485389118,0.9999959186369975,0,0,0.3380545138982563,0.0068706516251272,AOC1;NEURL1
1593,GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.9801800675658392,0.9999959186369975,0,0,0.2512677484787018,0.0050301244791911,TERT
1594,GO_Biological_Process_2021,"DNA-templated transcription, elongation (GO:0006354)",1/69,0.9801800675658392,0.9999959186369975,0,0,0.2512677484787018,0.0050301244791911,ELOA2
1595,GO_Biological_Process_2021,RNA 3'-end processing (GO:0031123),1/69,0.9801800675658392,0.9999959186369975,0,0,0.2512677484787018,0.0050301244791911,LIN28B
1596,GO_Biological_Process_2021,synapse assembly (GO:0007416),1/69,0.9801800675658392,0.9999959186369975,0,0,0.2512677484787018,0.0050301244791911,CDH2
1597,GO_Biological_Process_2021,negative regulation of cellular catabolic process (GO:0031330),1/69,0.9801800675658392,0.9999959186369975,0,0,0.2512677484787018,0.0050301244791911,MAGEA3
1598,GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),2/104,0.980837033480367,0.9999959186369975,0,0,0.3347224448362451,0.0064765298809669,SLC24A2;CCL11
1599,GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),2/104,0.980837033480367,0.9999959186369975,0,0,0.3347224448362451,0.0064765298809669,SLC30A8;BMP8A
1600,GO_Biological_Process_2021,COPII-coated vesicle budding (GO:0090114),1/70,0.981276788580564,0.9999959186369975,0,0,0.2476130355874694,0.0046800621268255,CNIH2
1601,GO_Biological_Process_2021,wound healing (GO:0042060),1/70,0.981276788580564,0.9999959186369975,0,0,0.2476130355874694,0.0046800621268255,GATA4
1602,GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.981276788580564,0.9999959186369975,0,0,0.2476130355874694,0.0046800621268255,FN1
1603,GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),2/105,0.981748883691896,0.9999959186369975,0,0,0.3314550761443701,0.0061053105516721,FOXJ1;CXCL13
1604,GO_Biological_Process_2021,nucleotide-excision repair (GO:0006289),2/105,0.981748883691896,0.9999959186369975,0,0,0.3314550761443701,0.0061053105516721,BRIP1;HUS1B
1605,GO_Biological_Process_2021,regulation of cell growth (GO:0001558),6/217,0.982137830431966,0.9999959186369975,0,0,0.4843714222761776,0.0087301282080731,H1-5;SLC44A4;CDKN2A;KIF14;INHBA;PRSS2
1606,GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),5/191,0.9821748717565832,0.9999959186369975,0,0,0.4580909571655209,0.0082391824233704,SOX2;SIX3;PRAME;ASCL1;NKX3-2
1607,GO_Biological_Process_2021,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.9823128671921968,0.9999959186369975,0,0,0.2440627430645579,0.0043554019956985,PLPP4
1608,GO_Biological_Process_2021,regulation of TOR signaling (GO:0032006),1/71,0.9823128671921968,0.9999959186369975,0,0,0.2440627430645579,0.0043554019956985,FAM83D
1609,GO_Biological_Process_2021,response to metal ion (GO:0010038),1/71,0.9823128671921968,0.9999959186369975,0,0,0.2440627430645579,0.0043554019956985,SLC30A8
1610,GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.9823128671921968,0.9999959186369975,0,0,0.2440627430645579,0.0043554019956985,EFNA2
1611,GO_Biological_Process_2021,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.9823128671921968,0.9999959186369975,0,0,0.2440627430645579,0.0043554019956985,KIF14
1612,GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),3/136,0.9823298393122588,0.9999959186369975,0,0,0.384771018455229,0.0068597522690056,SLC24A2;CCL11;HCRTR2
1613,GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),2/106,0.9826185535825144,0.9999959186369975,0,0,0.3282505414658003,0.005755636016049,EPO;FN1
1614,GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),2/106,0.9826185535825144,0.9999959186369975,0,0,0.3282505414658003,0.005755636016049,CCNA2;CDKN2A
1615,GO_Biological_Process_2021,peptidyl-lysine modification (GO:0018205),2/106,0.9826185535825144,0.9999959186369975,0,0,0.3282505414658003,0.005755636016049,SUMO4;IVL
1616,GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.9826185535825144,0.9999959186369975,0,0,0.3282505414658003,0.005755636016049,TCL1A;CEMIP
1617,GO_Biological_Process_2021,cell junction organization (GO:0034330),1/72,0.9832916537025244,0.9999959186369975,0,0,0.2406124587817285,0.0040542008946585,CBLN2
1618,GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.9832916537025244,0.9999959186369975,0,0,0.2406124587817285,0.0040542008946585,INHBA
1619,GO_Biological_Process_2021,Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.9832916537025244,0.9999959186369975,0,0,0.2406124587817285,0.0040542008946585,PLPP4
1620,GO_Biological_Process_2021,negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.9832916537025244,0.9999959186369975,0,0,0.2406124587817285,0.0040542008946585,TPX2
1621,GO_Biological_Process_2021,positive regulation of protein secretion (GO:0050714),1/72,0.9832916537025244,0.9999959186369975,0,0,0.2406124587817285,0.0040542008946585,SLC30A8
1622,GO_Biological_Process_2021,positive regulation of secretion by cell (GO:1903532),1/72,0.9832916537025244,0.9999959186369975,0,0,0.2406124587817285,0.0040542008946585,SOX11
1623,GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.9842163133298112,0.9999959186369975,0,0,0.2372580157289776,0.0037746743069524,IQGAP3
1624,GO_Biological_Process_2021,regulation of Rho protein signal transduction (GO:0035023),1/73,0.9842163133298112,0.9999959186369975,0,0,0.2372580157289776,0.0037746743069524,SYNPO2L
1625,GO_Biological_Process_2021,insulin receptor signaling pathway (GO:0008286),1/73,0.9842163133298112,0.9999959186369975,0,0,0.2372580157289776,0.0037746743069524,IRS4
1626,GO_Biological_Process_2021,ubiquitin-dependent ERAD pathway (GO:0030433),1/73,0.9842163133298112,0.9999959186369975,0,0,0.2372580157289776,0.0037746743069524,NCCRP1
1627,GO_Biological_Process_2021,negative regulation of cell adhesion (GO:0007162),1/73,0.9842163133298112,0.9999959186369975,0,0,0.2372580157289776,0.0037746743069524,ADAMDEC1
1628,GO_Biological_Process_2021,proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.9850898368628432,0.9999959186369975,0,0,0.2339954752256171,0.0035151822923658,ISG15
1629,GO_Biological_Process_2021,regulation of stress fiber assembly (GO:0051492),1/74,0.9850898368628432,0.9999959186369975,0,0,0.2339954752256171,0.0035151822923658,SYNPO2L
1630,GO_Biological_Process_2021,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.9850898368628432,0.9999959186369975,0,0,0.2339954752256171,0.0035151822923658,PLPP4
1631,GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),2/110,0.9857117461018768,0.9999959186369975,0,0,0.3160258350994046,0.0045480269851466,ORM1;FOXJ1
1632,GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),2/110,0.9857117461018768,0.9999959186369975,0,0,0.3160258350994046,0.0045480269851466,CENPE;PYDC1
1633,GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),2/110,0.9857117461018768,0.9999959186369975,0,0,0.3160258350994046,0.0045480269851466,TCL1A;CCL11
1634,GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),10/323,0.9857478228919994,0.9999959186369975,0,0,0.5432186817651684,0.0077977492546326,RET;STRA8;CXCL10;AOC1;CXCL11;CXCL9;CD80;NEURL1;CXCL13;BRINP3
1635,GO_Biological_Process_2021,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.9859150496627744,0.9999959186369975,0,0,0.2308211114926178,0.0032742169985625,FGF5
1636,GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.9859150496627744,0.9999959186369975,0,0,0.2308211114926178,0.0032742169985625,EPO
1637,GO_Biological_Process_2021,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.9859150496627744,0.9999959186369975,0,0,0.2308211114926178,0.0032742169985625,HORMAD1
1638,GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),5/198,0.9863858888216248,0.9999959186369975,0,0,0.441311097898204,0.0060493305558943,IGFBPL1;CD80;SULF1;FOXP3;CD177
1639,GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.9866946213985432,0.9999959186369975,0,0,0.2277313974591651,0.0030503910702806,NTNG1
1640,GO_Biological_Process_2021,establishment of protein localization to organelle (GO:0072594),1/76,0.9866946213985432,0.9999959186369975,0,0,0.2277313974591651,0.0030503910702806,LAMP5
1641,GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),1/76,0.9866946213985432,0.9999959186369975,0,0,0.2277313974591651,0.0030503910702806,PRSS1
1642,GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.9874310740776396,0.9999959186369975,0,0,0.2247229916897506,0.0028424274225698,CCL11
1643,GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.9874310740776396,0.9999959186369975,0,0,0.2247229916897506,0.0028424274225698,ORM1
1644,GO_Biological_Process_2021,positive regulation of type I interferon production (GO:0032481),1/77,0.9874310740776396,0.9999959186369975,0,0,0.2247229916897506,0.0028424274225698,ISG15
1645,GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),11/354,0.9884948139852352,0.9999959186369975,0,0,0.5448958233214793,0.0063054705691731,CDC20;PTTG1;UBE2C;UHRF1;PLK1;KIF14;BUB1B;PRAME;DTL;AURKB;AURKA
1646,GO_Biological_Process_2021,axon development (GO:0061564),1/79,0.9887840223879129,0.9999959186369975,0,0,0.2189375959793382,0.0024694739916081,NTNG1
1647,GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.9887840223879129,0.9999959186369975,0,0,0.2189375959793382,0.0024694739916081,PLK1
1648,GO_Biological_Process_2021,axon guidance (GO:0007411),5/203,0.9887982161462704,0.9999959186369975,0,0,0.4300518849699177,0.0048445329099944,RET;EFNA2;EPHA8;ARTN;TUBB3
1649,GO_Biological_Process_2021,inflammatory response (GO:0006954),6/230,0.9889156993276011,0.9999959186369975,0,0,0.4559431566610236,0.0050820287278199,CXCL10;ORM1;CXCL11;CXCL9;CCL11;CXCL13
1650,GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),2/116,0.9893710666006325,0.9999959186369975,0,0,0.2992972895453893,0.0031982381583559,CERKL;NEU4
1651,GO_Biological_Process_2021,tumor necrosis factor-mediated signaling pathway (GO:0033209),2/116,0.9893710666006325,0.9999959186369975,0,0,0.2992972895453893,0.0031982381583559,TNFRSF9;PYDC1
1652,GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.9894048963601446,0.9999959186369975,0,0,0.2161547474097728,0.0023024006911295,RTKN2
1653,GO_Biological_Process_2021,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.9894048963601446,0.9999959186369975,0,0,0.2161547474097728,0.0023024006911295,LRRC15
1654,GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),1/80,0.9894048963601446,0.9999959186369975,0,0,0.2161547474097728,0.0023024006911295,CCL11
1655,GO_Biological_Process_2021,negative regulation of cellular component organization (GO:0051129),1/80,0.9894048963601446,0.9999959186369975,0,0,0.2161547474097728,0.0023024006911295,CRACD
1656,GO_Biological_Process_2021,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.9894048963601446,0.9999959186369975,0,0,0.2161547474097728,0.0023024006911295,SULF1
1657,GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),12/381,0.9895112303239648,0.9999959186369975,0,0,0.5522791799870336,0.0058233225293822,COMP;TCL1A;PROC;CEACAM5;PLK1;CLEC5A;KIF14;IFI6;CDK1;BIRC5;PRAME;ASCL1
1658,GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.9899914220751326,0.9999959186369975,0,0,0.2134414700544464,0.0021470078458048,ORM1
1659,GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),5/207,0.9904303702628336,0.9999959186369975,0,0,0.4214458331079009,0.004052502125025,RET;FGF5;F7;CD80;GATA4
1660,GO_Biological_Process_2021,"regulation of gene expression, epigenetic (GO:0040029)",1/82,0.9905454981206688,0.9999959186369975,0,0,0.2107951872017207,0.0020024445384596,H3C13
1661,GO_Biological_Process_2021,protein ubiquitination (GO:0016567),18/525,0.9906709681771136,0.9999959186369975,0,0,0.6017506067133859,0.0056400999927842,H2BC9;UHRF1;UBE2C;H2BC3;PLK1;ISG15;H2BC17;NEUROD2;H2BC13;H2BC14;TRIML2;UBE2T;H2BC10;H2BC11;NEURL1;MKRN3;PRAME;DTL
1662,GO_Biological_Process_2021,glycoprotein biosynthetic process (GO:0009101),1/83,0.9910689181198072,0.9999959186369975,0,0,0.2082134478332079,0.0018679251191416,GAL3ST2
1663,GO_Biological_Process_2021,actin filament organization (GO:0007015),3/152,0.9913606864140212,0.9999959186369975,0,0,0.3431604636973764,0.0029775514568172,XIRP1;ERMN;CLRN1
1664,GO_Biological_Process_2021,vascular transport (GO:0010232),1/84,0.9915633767872586,0.9999959186369975,0,0,0.2056939190518881,0.001742723824933,SLC1A1
1665,GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),3/153,0.9917437752281636,0.9999959186369975,0,0,0.3408545454545454,0.0028258533004812,DEPDC1B;TERT;SULF1
1666,GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),6/238,0.9917916284390156,0.9999959186369975,0,0,0.4400323767013485,0.0036268549814791,CCL11;PSCA;FN1;GATA4;FAM83D;S100A7
1667,GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.9920304752057244,0.9999959186369975,0,0,0.2032343790510759,0.0016261699652516,PROC
1668,GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.9920304752057244,0.9999959186369975,0,0,0.2032343790510759,0.0016261699652516,DTL
1669,GO_Biological_Process_2021,axonogenesis (GO:0007409),6/240,0.9923912178723684,0.9999959186369975,0,0,0.4362246686768108,0.0033318301833791,NTNG1;RET;EFNA2;EPHA8;ARTN;TUBB3
1670,GO_Biological_Process_2021,response to interleukin-1 (GO:0070555),1/86,0.9924717260882604,0.9999959186369975,0,0,0.2008327105796946,0.0015176434683475,CCL11
1671,GO_Biological_Process_2021,transport across blood-brain barrier (GO:0150104),1/86,0.9924717260882604,0.9999959186369975,0,0,0.2008327105796946,0.0015176434683475,SLC1A1
1672,GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.9924717260882604,0.9999959186369975,0,0,0.2008327105796946,0.0015176434683475,PLK1
1673,GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),2/123,0.9924936027948038,0.9999959186369975,0,0,0.2818774817783983,0.0021238656412048,IBSP;SLC1A1
1674,GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.9924936027948038,0.9999959186369975,0,0,0.2818774817783983,0.0021238656412048,CCL11;SOX11
1675,GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),4/185,0.992546486753006,0.9999959186369975,0,0,0.3763541944208446,0.0028156673648227,F7;PROC;PROZ;CNIH2
1676,GO_Biological_Process_2021,ERAD pathway (GO:0036503),1/87,0.992888558333066,0.9999959186369975,0,0,0.1984868948634617,0.0014165708964175,NCCRP1
1677,GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.992888558333066,0.9999959186369975,0,0,0.1984868948634617,0.0014165708964175,EPO
1678,GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),10/345,0.9929577172693292,0.9999959186369975,0,0,0.5069437806393468,0.0035826713831002,IL21;FOXD1;TERT;ZBED2;GATA5;FOXJ1;SOX11;TRPM8;INHBA;NKX6-1
1679,GO_Biological_Process_2021,platelet degranulation (GO:0002576),2/125,0.9932070184285704,0.9999959186369975,0,0,0.2772645710108327,0.0018898793712579,ORM1;FN1
1680,GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.9932823220551752,0.9999959186369975,0,0,0.1961950059453032,0.001322421655592,SLC30A8
1681,GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),3/158,0.9934257237100425,0.9999959186369975,0,0,0.3297712609970674,0.0021751653114312,SLC44A4;INHBA;GAL3ST2
1682,GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),2/126,0.9935383811569622,0.9999959186369975,0,0,0.2750139169669802,0.0017828012221164,CDKN2A;INHBA
1683,GO_Biological_Process_2021,negative regulation of growth (GO:0045926),2/126,0.9935383811569622,0.9999959186369975,0,0,0.2750139169669802,0.0017828012221164,CDKN2A;INHBA
1684,GO_Biological_Process_2021,regulation of type I interferon production (GO:0032479),1/89,0.9936542929161384,0.9999959186369975,0,0,0.1939552054116482,0.0012347046142972,ISG15
1685,GO_Biological_Process_2021,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.9940056758369922,0.9999959186369975,0,0,0.1917657374742551,0.0011529650797382,CELF3
1686,GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.9940056758369922,0.9999959186369975,0,0,0.1917657374742551,0.0011529650797382,PYDC1
1687,GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),1/90,0.9940056758369922,0.9999959186369975,0,0,0.1917657374742551,0.0011529650797382,TRIML2
1688,GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.9940056758369922,0.9999959186369975,0,0,0.1917657374742551,0.0011529650797382,POLQ
1689,GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),7/274,0.9942266768385588,0.9999959186369975,0,0,0.4456450422373493,0.0025803085094136,SOX2;RET;CCL11;GRM4;EPHA8;GATA4;S100A7
1690,GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),19/566,0.99424464439239,0.9999959186369975,0,0,0.5879942254632784,0.0033938917851847,ADAMDEC1;CDKN2A;EPO;H2AC4;SOX11;TEX15;INHBA;FOXM1;FOXP3;TEX19;ORC6;IFNL1;FABP6;NEURL1;CCN4;PRAME;E2F7;CDKN3;APOBEC3B
1691,GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.9943376095195392,0.9999959186369975,0,0,0.1896249243799153,0.0010767818314791,IQGAP3
1692,GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.9943376095195392,0.9999959186369975,0,0,0.1896249243799153,0.0010767818314791,S100A14
1693,GO_Biological_Process_2021,DNA-dependent DNA replication (GO:0006261),2/129,0.9944402696259588,0.9999959186369975,0,0,0.2684746150600385,0.001496811271922,ORC6;MCM10
1694,GO_Biological_Process_2021,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.9946511693856906,0.9999959186369975,0,0,0.1875311621228136,0.0010057646578402,FGF5
1695,GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.9946511693856906,0.9999959186369975,0,0,0.1875311621228136,0.0010057646578402,CD80
1696,GO_Biological_Process_2021,T cell activation (GO:0042110),1/92,0.9946511693856906,0.9999959186369975,0,0,0.1875311621228136,0.0010057646578402,FOXP3
1697,GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),11/379,0.9947813045032706,0.9999959186369975,0,0,0.5071941192865106,0.0026538224507159,SOX2;IFNL1;CDKN2A;FABP6;H2AC4;NEURL1;SOX11;INHBA;FOXP3;E2F7;CDKN3
1698,GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),4/194,0.9949265057659052,0.9999959186369975,0,0,0.3583544849384608,0.0018227371560967,TCL1A;CCL11;TNFRSF9;PYDC1
1699,GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),4/194,0.9949265057659052,0.9999959186369975,0,0,0.3583544849384608,0.0018227371560967,TERT;GATA5;SOX11;AURKA
1700,GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.9949473716208034,0.9999959186369975,0,0,0.1854829164365185,0.0009395518545135672,TCL1A
1701,GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),2/131,0.9949716759451258,0.9999959186369975,0,0,0.2642840546648923,0.0013322581965123,TERT;EPO
1702,GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),6/252,0.9952021529064976,0.9999959186369975,0,0,0.4146786135135736,0.0019943527152013,F7;DEPDC1B;ESM1;TERT;CD80;SULF1
1703,GO_Biological_Process_2021,negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.995227176280213,0.9999959186369975,0,0,0.1834787190445524,0.0008778080642569835,CST4
1704,GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),3/165,0.995233976224306,0.9999959186369975,0,0,0.3154040404040404,0.0015068167769017,SOX2;AMER2;KREMEN2
1705,GO_Biological_Process_2021,regulation of cell motility (GO:2000145),2/133,0.995453142285898,0.9999959186369975,0,0,0.2602214503123461,0.0011858879884388,FGF5;KIF14
1706,GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),21/621,0.9954800172505172,0.9999959186369975,0,0,0.591862292051756,0.0026812715760441,IL21;CXCL9;CCL11;EPO;MMP1;TNFRSF9;CD80;FN1;IFI6;ISG15;CXCL13;SOX2;CXCL10;CXCL11;IFNL1;H3C13;IL21R;PYDC1;BIRC5;IL17C;IFNL3
1707,GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.9957411703975064,0.9999959186369975,0,0,0.1795969051485337,0.0007665059863792726,SLC30A8
1708,GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),21/625,0.995936501854424,0.9999959186369975,0,0,0.5878141410926541,0.0023934478578355,IL21;SLC44A4;SPAG5;EPO;RTKN2;FN1;KIF14;SOX11;TTK;NCCRP1;FOXM1;H1-5;FGF5;TCL1A;ESM1;IBSP;CCKBR;CEACAM6;BIRC5;PRAME;PRSS2
1709,GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.9959770262740024,0.9999959186369975,0,0,0.1777166515426497,0.0007163913998585585,F7
1710,GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.9959770262740024,0.9999959186369975,0,0,0.1777166515426497,0.0007163913998585585,TRPM8
1711,GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),15/485,0.9960093828469588,0.9999959186369975,0,0,0.5405291770963705,0.0021613604609523,PLK1;KIF14;IFI6;GATA4;ASCL1;COMP;TCL1A;PROC;CEACAM6;CEACAM5;CLEC5A;CDK1;BIRC5;PRAME;MAGEA3
1712,GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),4/200,0.996085951374554,0.9999959186369975,0,0,0.347273031141483,0.0013619105643716,SOX2;TRIML2;PRDM13;ASCL1
1713,GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.9961998225615364,0.9999959186369975,0,0,0.1758751660523509,0.0006696300018289828,TCL1A
1714,GO_Biological_Process_2021,RNA splicing (GO:0008380),1/98,0.9961998225615364,0.9999959186369975,0,0,0.1758751660523509,0.0006696300018289828,CELF3
1715,GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.9961998225615364,0.9999959186369975,0,0,0.1758751660523509,0.0006696300018289828,KIF14
1716,GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),14/464,0.9963679559296732,0.9999959186369975,0,0,0.527003367003367,0.0019175839407175,FOXD1;CDKN2A;SUMO4;ASCL1;FOXM1;FOXP3;DMBX1;CENPF;IFNL1;SIX3;MAEL;DEPDC1;BIRC5;PRAME
1717,GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),3/172,0.996555066385194,0.9999959186369975,0,0,0.3022270037654653,0.0010429494435921,CCL11;GATA4;S100A7
1718,GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),4/203,0.996565093111328,0.9999959186369975,0,0,0.3419828898816192,0.0011767014732028,CXCL10;GATA4;SULF1;CXCL13
1719,GO_Biological_Process_2021,cell-matrix adhesion (GO:0007160),1/100,0.9966090863151922,0.9999959186369975,0,0,0.1723038002529835,0.0005852601593079575,FN1
1720,GO_Biological_Process_2021,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/100,0.9966090863151922,0.9999959186369975,0,0,0.1723038002529835,0.0005852601593079575,SOX11
1721,GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),2/139,0.9966417644794122,0.9999959186369975,0,0,0.2487453343675623,0.0008367512089817896,IL21;CCN4
1722,GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.9967968812404416,0.9999959186369975,0,0,0.1705716878402904,0.0005472382764035186,SUMO4
1723,GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.9967968812404416,0.9999959186369975,0,0,0.1705716878402904,0.0005472382764035186,CEMIP
1724,GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),2/140,0.9968076307124092,0.9999959186369975,0,0,0.246929668680646,0.0007895516322957814,RET;EPHA8
1725,GO_Biological_Process_2021,regulation of small GTPase mediated signal transduction (GO:0051056),2/141,0.9969654284566478,0.9999959186369975,0,0,0.2451401276798724,0.0007450262459048773,DEPDC1B;FOXM1
1726,GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),2/141,0.9969654284566478,0.9999959186369975,0,0,0.2451401276798724,0.0007450262459048773,LIN28B;TRIML2
1727,GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.9969742755479764,0.9999959186369975,0,0,0.1688738746832941,0.0005117403956587537,CCR8
1728,GO_Biological_Process_2021,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.9969742755479764,0.9999959186369975,0,0,0.1688738746832941,0.0005117403956587537,PLK1
1729,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.9969742755479764,0.9999959186369975,0,0,0.1688738746832941,0.0005117403956587537,IFI6
1730,GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.9969742755479764,0.9999959186369975,0,0,0.1688738746832941,0.0005117403956587537,GATA4
1731,GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),2/142,0.997115541929148,0.9999959186369975,0,0,0.2433761515505384,0.0007030227125005384,CCNA2;CDKN2A
1732,GO_Biological_Process_2021,protein localization to organelle (GO:0033365),2/142,0.997115541929148,0.9999959186369975,0,0,0.2433761515505384,0.0007030227125005384,LAMP5;ISG15
1733,GO_Biological_Process_2021,protein phosphorylation (GO:0006468),15/496,0.9971362908979108,0.9999959186369975,0,0,0.5278525131466308,0.0015137846018383,RET;CCL11;EPHA8;PLK1;TTK;AURKB;AURKA;CCNA2;MELK;SBK1;CCNE1;CDK1;BIRC5;NEK2;CLSPN
1734,GO_Biological_Process_2021,chromatin remodeling (GO:0006338),1/103,0.9971418446854442,0.9999959186369975,0,0,0.1672093519803565,0.0004785945730891508,FOXP3
1735,GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.9972583378071148,0.9999959186369975,0,0,0.2416371963592092,0.0006633973875387994,CENPF;SLC44A4
1736,GO_Biological_Process_2021,translational elongation (GO:0006414),1/104,0.997300132417692,0.9999959186369975,0,0,0.1655771501066023,0.0004476409378549685,EEF1A2
1737,GO_Biological_Process_2021,phosphorylation (GO:0016310),11/400,0.9973928875500684,0.9999959186369975,0,0,0.4792696592182453,0.0012511415383593,RET;CERKL;CCL11;MELK;CCNE1;PLK1;CDK1;BIRC5;NEK2;AURKB;AURKA
1738,GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),3/178,0.9973974342986291,0.9999959186369975,0,0,0.2917714285714285,0.0007603441651951438,IFNL1;SCT;FOXP3
1739,GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.9975908898118364,0.9999959186369975,0,0,0.162406015037594,0.0003917260307191672,F7
1740,GO_Biological_Process_2021,protein localization to nucleus (GO:0034504),1/106,0.9975908898118364,0.9999959186369975,0,0,0.162406015037594,0.0003917260307191672,PLK1
1741,GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),2/148,0.9978742336614934,0.9999959186369975,0,0,0.2332997399624252,0.0004964686092792535,CEMIP;GTSE1
1742,GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),4/214,0.997881647817063,0.9999959186369975,0,0,0.3238788509034186,0.0006868171882720098,PROC;TNNT1;KREMEN2;FOXP3
1743,GO_Biological_Process_2021,regulation of protein ubiquitination (GO:0031396),1/109,0.9979693651686716,0.9999959186369975,0,0,0.1578695301472071,0.0003209012937758415,ISG15
1744,GO_Biological_Process_2021,regulation of cell migration (GO:0030334),11/408,0.9980116449139996,0.9999959186369975,0,0,0.4694088447237062,0.0009342806127412814,RET;FGF5;NTNG1;F7;LRRC15;CEMIP;CCL11;CEACAM6;KIF14;SULF1;GTSE1
1745,GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),2/150,0.9980804198241912,0.9999959186369975,0,0,0.2301224930652723,0.0004421630953555186,AOC1;SLC1A1
1746,GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.9982883519884816,0.9999959186369975,0,0,0.1535782606563006,0.0002630971536135768,IQGAP3
1747,GO_Biological_Process_2021,dephosphorylation (GO:0016311),2/153,0.9983532338776115,0.9999959186369975,0,0,0.2255144329958917,0.0003716756438596176,PLPP4;PLPPR5
1748,GO_Biological_Process_2021,sulfur compound biosynthetic process (GO:0044272),1/113,0.9983831206890312,0.9999959186369975,0,0,0.1521989240342235,0.00024628645285667525,ACAN
1749,GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),1/113,0.9983831206890312,0.9999959186369975,0,0,0.1521989240342235,0.00024628645285667525,TRPM8
1750,GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),8/335,0.9983860359741876,0.9999959186369975,0,0,0.4148967366260316,0.0006701693675599505,IL21;ORM1;IFNL1;CD80;GATA4;ISG15;SULF1;TIGIT
1751,GO_Biological_Process_2021,"transcription, DNA-templated (GO:0006351)",4/221,0.9984479088731716,0.9999959186369975,0,0,0.3133137372475187,0.0004866692467793827,ELOA2;TRIP13;NKX3-2;PAX1
1752,GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),22/684,0.9984707823696892,0.9999959186369975,0,0,0.5605892496317888,0.0008579191037244288,FOXD3;DMRT1;EPO;UHRF1;CBX2;PLK1;FOXJ1;SOX11;PAX6;ASCL1;FOXM1;HOXB13;FOXP3;AURKB;H1-5;SOX2;RIPPLY3;MAGEA1;ZBED2;NKX6-1;E2F7;E2F8
1753,GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),1/114,0.9984726374316892,0.9999959186369975,0,0,0.1508440004497052,0.0002305696064920168,SULF1
1754,GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),2/155,0.9985134521619464,0.9999959186369975,0,0,0.2225427864152018,0.0003310666322251078,TRIML2;RTKN2
1755,GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),3/191,0.9985911189593136,0.9999959186369975,0,0,0.2714071566731141,0.0003826500148585411,SOX2;AMER2;KREMEN2
1756,GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.9986370621508006,0.9999959186369975,0,0,0.148204844945948,0.00020213177044312285,GATA4
1757,GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.9987837646565412,0.9999959186369975,0,0,0.1456559169807808,0.0001772596908303547,PROC
1758,GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),9/371,0.9988464773289618,0.9999959186369975,0,0,0.4212202167523508,0.0004861675260946728,FGF5;CENPE;TCL1A;CEMIP;CD80;PLK1;BMP8A;TTK;INHBA
1759,GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",33/948,0.9988832173614768,0.9999959186369975,0,0,0.6061038762065267,0.0006772645351562387,UHRF1;EPO;SUMO4;FOXM1;HOXB13;ASCL1;AURKB;DMBX1;SOX2;IFNL1;SIX3;ZBED2;MAEL;MAGEA1;PRAME;NKX6-1;E2F7;E2F8;FOXD3;FOXD1;DMRT1;CDKN2A;CBX2;PLK1;FOXJ1;SOX11;PAX6;FOXP3;H1-5;CENPF;RIPPLY3;DEPDC1;BIRC5
1760,GO_Biological_Process_2021,macroautophagy (GO:0016236),1/120,0.9989146533823796,0.9999959186369975,0,0,0.1431926672665436,0.0001554980770144744,LIX1
1761,GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),1/121,0.9989747071970464,0.9999959186369975,0,0,0.141991833030853,0.0001456578882434779,CCL11
1762,GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),8/350,0.9990868170026196,0.9999959186369975,0,0,0.3963790755427381,0.0003621320038740728,TOP2A;POLQ;EXO1;UBE2T;PCLAF;CDK1;MCM10;DTL
1763,GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.999135618722288,0.9999959186369975,0,0,0.1385064848833606,0.00011977418511716706,ORM1
1764,GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.999183420519448,0.9999959186369975,0,0,0.1373821790293308,0.00011222929669805129,SUMO4
1765,GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),5/267,0.9992065901502786,0.9999959186369975,0,0,0.3238886803209166,0.0002570784669650536,NEURL1;MAGEA1;GATA4;PRAME;SULF1
1766,GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.9992285713044864,0.9999959186369975,0,0,0.1362758620689655,0.00010516768040656542,FN1
1767,GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.9992285713044864,0.9999959186369975,0,0,0.1362758620689655,0.00010516768040656542,ITPKA
1768,GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),9/384,0.999288438230451,0.9999959186369975,0,0,0.4063327239488117,0.00028923374812558293,FGF5;FOXD1;FN1;ZNF804A;GATA5;SOX11;PAX6;INHBA;AMH
1769,GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),3/206,0.9993120922465586,0.9999959186369975,0,0,0.2511509180474697,0.00017282811552690375,IL21;PROC;CCN4
1770,GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),1/129,0.999349546829256,0.9999959186369975,0,0,0.1330606284029038,8.657786812379486e-05,IRS4
1771,GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.999349546829256,0.9999959186369975,0,0,0.1330606284029038,8.657786812379486e-05,IFNL1
1772,GO_Biological_Process_2021,Golgi organization (GO:0007030),1/130,0.9993854836108368,0.9999959186369975,0,0,0.1320221162368632,8.115469215841553e-05,CDK1
1773,GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),12/468,0.999387719869566,0.9999959186369975,0,0,0.4448116165758116,0.0002724327257015311,SOX2;CCNA2;ZNF280A;SOX11;GATA4;MYBL2;ESCO2;MAFA;FOXP3;MYT1;ZNF730;ZNF695
1774,GO_Biological_Process_2021,mitochondrion organization (GO:0007005),2/175,0.9994688970485918,0.9999959186369975,0,0,0.19660529313866,0.00010444538953147532,TERT;MTFR2
1775,GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),3/212,0.9994846506411352,0.9999959186369975,0,0,0.2438625489343192,0.00012570680248736056,CERKL;ITPKA;PLPPR5
1776,GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.9994980596025962,0.9999959186369975,0,0,0.2805706164131178,0.0001408650825982561,NEUROD2;TRIML2;RTKN2;NKX6-1
1777,GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),3/214,0.9995320433317167,0.9999959186369975,0,0,0.2415252046531667,0.00011304978333936632,CCL11;FOXJ1;CXCL13
1778,GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),1/136,0.99956289971591,0.9999959186369975,0,0,0.1261141359144988,5.513657562047546e-05,PACSIN1
1779,GO_Biological_Process_2021,ribonucleoprotein complex assembly (GO:0022618),1/136,0.99956289971591,0.9999959186369975,0,0,0.1261141359144988,5.513657562047546e-05,CELF3
1780,GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.99956289971591,0.9999959186369975,0,0,0.1261141359144988,5.513657562047546e-05,SCT
1781,GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.99956289971591,0.9999959186369975,0,0,0.1261141359144988,5.513657562047546e-05,CENPF
1782,GO_Biological_Process_2021,protein stabilization (GO:0050821),2/179,0.9995680752688352,0.9999959186369975,0,0,0.1921211841315291,8.299981693452846e-05,H1-5;GTSE1
1783,GO_Biological_Process_2021,RNA processing (GO:0006396),2/179,0.9995680752688352,0.9999959186369975,0,0,0.1921211841315291,8.299981693452846e-05,LIN28B;CELF3
1784,GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.9995869990807976,0.9999959186369975,0,0,0.1251801537311839,5.17101974715999e-05,SCT
1785,GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),6/314,0.9996127048149116,0.9999959186369975,0,0,0.3301033515254117,0.00012787220237012685,TRIML2;UBE2C;UBE2T;MKRN3;PRAME;DTL
1786,GO_Biological_Process_2021,protein dephosphorylation (GO:0006470),1/139,0.9996312595889968,0.9999959186369975,0,0,0.1233527972855677,4.549354934008968e-05,PPP2R2C
1787,GO_Biological_Process_2021,post-translational protein modification (GO:0043687),7/345,0.9996360735344098,0.9999959186369975,0,0,0.3506915950416792,0.00012764918156256964,PROC;CDH2;FN1;DMP1;ESCO2;DTL;MATN3
1788,GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),10/430,0.9996462861631176,0.9999959186369975,0,0,0.4024964056986015,0.00014239373279274848,SOX2;ZNF280A;SOX11;GATA4;MYBL2;MAFA;FOXP3;MYT1;ZNF730;ZNF695
1789,GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),1/140,0.9996515648475964,0.9999959186369975,0,0,0.1224588387366332,4.26763995490967e-05,PACSIN1
1790,GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),13/511,0.9996594256069804,0.9999959186369975,0,0,0.440637780479717,0.0001500955054222179,RET;EPO;CD80;SOX11;GATA4;PAX6;HOXC13;INHBA;FOXM1;FOXP3;SOX2;IFNL1;LHX2
1791,GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.9997059644640456,0.9999959186369975,0,0,0.1198525088826972,3.524607873859452e-05,AGXT
1792,GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),1/144,0.9997221224994312,0.9999959186369975,0,0,0.1190080337085781,3.30742504624164e-05,SULF1
1793,GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),6/322,0.999723342382158,0.9999959186369975,0,0,0.3216078372546531,8.898756824614948e-05,TERT;H3C13;GATA5;SOX11;FOXP3;AURKA
1794,GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),10/437,0.9997273109326222,0.9999959186369975,0,0,0.3957481182144839,0.00010793090172977613,TPX2;DEPDC1B;BRIP1;EXO1;CDK1;SUMO4;GATA4;FAM83D;AURKB;AURKA
1795,GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),14/547,0.999757884810385,0.9999959186369975,0,0,0.442935236726811,0.0001072543333029125,FOXD1;CDKN2A;SUMO4;ASCL1;FOXM1;FOXP3;DMBX1;CENPF;IFNL1;SIX3;MAEL;DEPDC1;BIRC5;PRAME
1796,GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),1/149,0.9997904097726468,0.9999959186369975,0,0,0.1149568352381419,2.4096354501784404e-05,CCL11
1797,GO_Biological_Process_2021,apoptotic process (GO:0006915),3/231,0.9997943406723672,0.9999959186369975,0,0,0.2233133971291866,4.593120635740899e-05,MELK;ESPL1;IFI6
1798,GO_Biological_Process_2021,regulation of autophagy (GO:0010506),3/231,0.9997943406723672,0.9999959186369975,0,0,0.2233133971291866,4.593120635740899e-05,TRIML2;EEF1A2;MAGEA3
1799,GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),2/194,0.9998010495303026,0.9999959186369975,0,0,0.176969800181653,3.521172767943468e-05,CXCL10;BIRC5
1800,GO_Biological_Process_2021,response to cytokine (GO:0034097),1/150,0.9998018782141008,0.9999959186369975,0,0,0.11417922264583,2.2623632694450173e-05,ISG15
1801,GO_Biological_Process_2021,protein deubiquitination (GO:0016579),4/267,0.9998082256140554,0.9999959186369975,0,0,0.2578770192051536,4.945894963874704e-05,CDC20;CCNA2;CDK1;CLSPN
1802,GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),1/152,0.9998229389942777,0.9999959186369975,0,0,0.1126548959748079,1.9948555288610476e-05,PYDC1
1803,GO_Biological_Process_2021,cellular response to interleukin-1 (GO:0071347),1/155,0.9998503419178476,0.9999959186369975,0,0,0.1104426426567987,1.6529871033111764e-05,CCL11
1804,GO_Biological_Process_2021,organelle assembly (GO:0070925),9/425,0.9998506491373732,0.9999959186369975,0,0,0.3654747046828857,5.458803889952859e-05,CENPE;ANLN;CENPF;CNGA2;FOXJ1;NEK2;CENPA;DLGAP5;MYH6
1805,GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.9998584803865478,0.9999959186369975,0,0,0.1097242550201978,1.5529233028237917e-05,PRAME
1806,GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),4/276,0.9998730533192932,0.9999959186369975,0,0,0.2492238933790076,3.1640154366040053e-05,CDC20;CCNA2;CDK1;CLSPN
1807,GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),1/158,0.9998734252410186,0.9999959186369975,0,0,0.1083149340515796,1.3710804410849772e-05,IBSP
1808,GO_Biological_Process_2021,cellular response to starvation (GO:0009267),1/158,0.9998734252410186,0.9999959186369975,0,0,0.1083149340515796,1.3710804410849772e-05,AOC1
1809,GO_Biological_Process_2021,membrane organization (GO:0061024),3/242,0.999879068520222,0.9999959186369975,0,0,0.2129098516546215,2.5749060387298572e-05,SYT1;KIF20A;CEP55
1810,GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),2/205,0.9998869592045022,0.9999959186369975,0,0,0.1672818709368554,1.8910744626006617e-05,KIF14;PRAME
1811,GO_Biological_Process_2021,cilium assembly (GO:0060271),5/314,0.9998981603120622,0.9999959186369975,0,0,0.2739314198808071,2.78985109289442e-05,PLK1;CDK1;CNGA2;FOXJ1;NEK2
1812,GO_Biological_Process_2021,peptide biosynthetic process (GO:0043043),1/162,0.9998986431304488,0.9999959186369975,0,0,0.1056013346710103,1.0703963171952267e-05,EEF1A2
1813,GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),13/546,0.9998993069817343,0.9999959186369975,0,0,0.4109196688297158,4.137882503354233e-05,RET;EPO;EPHA8;CD80;RTKN2;FN1;SOX11;FGF5;SOX2;F7;NEUROD2;GRM4;TRIML2
1814,GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.9999208142433316,0.9999959186369975,0,0,0.1616452575580641,1.2800508847259245e-05,PROC;SCT
1815,GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),2/214,0.999928411023519,0.9999959186369975,0,0,0.1601031652185834,1.1462032011826358e-05,FGF5;CDCA2
1816,GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),3/253,0.9999284900182376,0.9999959186369975,0,0,0.2034218181818181,1.4547210649843377e-05,SOX2;AMER2;KREMEN2
1817,GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),3/253,0.9999284900182376,0.9999959186369975,0,0,0.2034218181818181,1.4547210649843377e-05,RET;FGF5;EPHA8
1818,GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),8/417,0.9999337456966292,0.9999959186369975,0,0,0.3302497460115439,2.188119172998248e-05,PROC;CDH2;MMP1;EEF1A2;FN1;DMP1;MAGEC2;MATN3
1819,GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.9999381044669656,0.9999959186369975,0,0,0.0999626347816803,6.187432052499282e-06,TRIML2
1820,GO_Biological_Process_2021,organelle organization (GO:0006996),8/420,0.9999409984656836,0.9999959186369975,0,0,0.3277918162876269,1.9340790671093432e-05,KISS1;CCL11;TERT;KIF4A;CDCA8;MTFR2;CEP55;PACSIN1
1821,GO_Biological_Process_2021,cellular protein localization (GO:0034613),5/329,0.9999466545780208,0.9999959186369975,0,0,0.2610385886797544,1.3925585102359673e-05,CNTNAP2;SYNDIG1;FOXJ1;CD177;PACSIN1
1822,GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),10/481,0.9999468037782572,0.9999959186369975,0,0,0.3579233221251624,1.904067486116964e-05,FLG2;AOC1;ORM1;CALML5;CEACAM6;CLEC5A;S100P;PRSS2;CD177;S100A7
1823,GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),10/482,0.9999486945383312,0.9999959186369975,0,0,0.357145626250252,1.832399130222357e-05,SOX2;CXCL10;TCL1A;CCL11;IFNL1;MMP1;CD80;FN1;BIRC5;IFNL3
1824,GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),10/482,0.9999486945383312,0.9999959186369975,0,0,0.357145626250252,1.832399130222357e-05,FGF5;IL21;FOXD1;FN1;ZNF804A;GATA5;SOX11;PAX6;INHBA;AMH
1825,GO_Biological_Process_2021,cellular component assembly (GO:0022607),3/261,0.9999508413429006,0.9999959186369975,0,0,0.197029598308668,9.685948537755109e-06,FOXJ1;TRIP13;HORMAD1
1826,GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),10/485,0.9999539450493372,0.9999959186369975,0,0,0.3548321856792026,1.6342155126487675e-05,FLG2;AOC1;ORM1;CALML5;CEACAM6;CLEC5A;S100P;PRSS2;CD177;S100A7
1827,GO_Biological_Process_2021,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.9999551199098042,0.9999959186369975,0,0,0.0965238821976571,4.3320977522723125e-06,SLC44A4
1828,GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/224,0.9999564031299232,0.9999959186369975,0,0,0.1528094852345533,6.662160499988181e-06,TRIML2;SUMO4
1829,GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),10/488,0.9999586163636472,0.9999959186369975,0,0,0.3525477841111371,1.4590011190604774e-05,FLG2;AOC1;ORM1;CALML5;CEACAM6;CLEC5A;S100P;PRSS2;CD177;S100A7
1830,GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.999961668504562,0.9999959186369975,0,0,0.0948909549929533,3.637381922006754e-06,TYRP1
1831,GO_Biological_Process_2021,MAPK cascade (GO:0000165),4/303,0.9999620696621004,0.9999959186369975,0,0,0.2263900596772377,8.587214319659353e-06,RET;FGF5;ARTN;CDK1
1832,GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),3/267,0.9999626437616724,0.9999959186369975,0,0,0.1924896694214876,7.190824278434297e-06,TERT;FN1;CNIH2
1833,GO_Biological_Process_2021,cilium organization (GO:0044782),2/228,0.9999640611841512,0.9999959186369975,0,0,0.1500727415945279,5.393533543282127e-06,CNGA2;FOXJ1
1834,GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),1/189,0.999975727659346,0.9999959186369975,0,0,0.0903048615669768,2.1919369644986673e-06,CCL11
1835,GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),4/320,0.9999810563608216,0.9999959186369975,0,0,0.2140150424436484,4.054262144192582e-06,ELOA2;TRIP13;NKX3-2;PAX1
1836,GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.9999817795373774,0.9999959186369975,0,0,0.0874838625180084,1.5940109689396934e-06,PACSIN1
1837,GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),3/286,0.999983305946482,0.9999959186369975,0,0,0.17938323160938,2.9946582652822818e-06,TOP2A;MELK;NEURL1
1838,GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.9999841055765386,0.9999959186369975,0,0,0.0861378020580946,1.3691215826729631e-06,RTKN2
1839,GO_Biological_Process_2021,ncRNA processing (GO:0034470),1/201,0.999986061729256,0.9999959186369975,0,0,0.0848321234119782,1.18242134437121e-06,LIN28B
1840,GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),6/404,0.9999885190602548,0.9999959186369975,0,0,0.2542200519461482,2.9187018532043835e-06,RET;FGF5;EFNA2;EPHA8;IRS4;SULF1
1841,GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),17/742,0.9999910521979124,0.9999959186369975,0,0,0.392359179526259,3.5107679924625057e-06,TOP2A;PLK1;KIF14;IFI6;ASCL1;COMP;CXCL10;TCL1A;MELK;PROC;GRM4;CEACAM5;CLEC5A;NEURL1;CDK1;BIRC5;PRAME
1842,GO_Biological_Process_2021,translation (GO:0006412),1/214,0.999991514529167,0.9999959186369975,0,0,0.0795991922496868,6.754394898790797e-07,EEF1A2
1843,GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),23/908,0.9999916304184135,0.9999959186369975,0,0,0.4334337727558066,3.627674504436094e-06,FOXD3;ONECUT2;DMRT1;UHRF1;GATA5;FOXJ1;GATA4;SOX11;PAX6;INHBA;FOXM1;ASCL1;HOXC11;FOXP3;SOX2;IL4I1;CXCL10;TERT;MYBL2;NKX6-1;DLGAP5;E2F7;E2F8
1844,GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),2/266,0.999992011423274,0.9999959186369975,0,0,0.12820989183387,1.0242186489789822e-06,FGF5;FN1
1845,GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),3/310,0.9999922726006438,0.9999959186369975,0,0,0.1651465798045602,1.2761585051553508e-06,TOP2A;MELK;NEURL1
1846,GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",64/2244,0.9999930925097256,0.9999959186369975,0,0,0.4723525620082824,3.2627819969535218e-06,RET;HMX3;ONECUT2;EPO;CD80;TCF24;SUMO4;HOXC13;FOXM1;HOXC11;DMBX1;SOX2;ZNF280A;SALL3;SALL4;SIX3;MAEL;MYBL2;PITX1;NKX3-2;FOXD3;FOXD1;SOX11;PAX6;MYT1;FOXP3;POU5F2;PAX1;HOXB9;CCNE1;ZFP42;DEPDC1;BIRC5;HMX2;GATA5;GATA4;HOXB13;ASCL1;NEUROD2;STRA8;BRIP1;IFNL1;GBX2;SOHLH1;PRAME;NKX6-1;E2F7;E2F8;NKX2-2;RRM2;DMRT1;CDKN2A;ELOA2;FOXJ1;INHBA;MAFA;CENPF;TLX3;LHX2;TLX1;ZSCAN4;ZNF730;SIM2;ZNF695
1847,GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),60/2206,0.9999931192087932,0.9999959186369975,0,0,0.4490326938834229,3.089710841432826e-06,HMX3;ONECUT2;EPO;TCF24;HOXC13;FOXM1;HOXC11;DMBX1;SOX2;IL4I1;SALL3;SALL4;SIX3;MAGEA1;MYBL2;PITX1;NKX3-2;FOXD3;FOXD1;SOX11;PAX6;MYT1;FOXP3;POU5F2;PAX1;RIPPLY3;HOXB9;ZFP42;HMX2;UHRF1;GATA5;GATA4;HOXB13;ASCL1;AURKB;NEUROD2;STRA8;BRIP1;GBX2;SOHLH1;ZBED2;NKX6-1;E2F7;E2F8;NKX2-2;DMRT1;CDKN2A;CBX2;PLK1;FOXJ1;INHBA;MAFA;H1-5;CXCL10;TLX3;LHX2;TLX1;CDK1;ZSCAN4;SIM2
1848,GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",32/1183,0.9999934934053408,0.9999959186369975,0,0,0.4606654709378683,2.997373244175307e-06,RET;ONECUT2;UHRF1;EPO;CD80;GATA5;GATA4;HOXC13;FOXM1;ASCL1;HOXC11;SOX2;IL4I1;IFNL1;MYBL2;NKX6-1;E2F7;E2F8;FOXD3;DMRT1;FOXJ1;SOX11;PAX6;INHBA;H1-1;FOXP3;H1-3;H1-5;H1-4;CXCL10;H1-6;LHX2
1849,GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),2/278,0.9999939672662796,0.9999959186369975,0,0,0.1225565691268807,7.393533773991853e-07,CNGA2;FOXJ1
1850,GO_Biological_Process_2021,regulation of gene expression (GO:0010468),24/1079,0.9999942191372696,0.9999959186369975,0,0,0.3761671549486315,2.1745769719139e-06,FOXD1;FN1;ZNF804A;GATA5;GATA4;SOX11;PRDM13;PAX6;INHBA;ASCL1;MAFA;FOXP3;MYT1;AURKA;FGF5;SOX2;TERT;TRIML2;ZNF280A;CCN4;MYBL2;AMH;ZNF730;ZNF695
1851,GO_Biological_Process_2021,cellular protein modification process (GO:0006464),19/1025,0.9999943125761304,0.9999959186369975,0,0,0.3117173343701628,1.7728736495889376e-06,RET;CCL11;GAD1;PLK1;FN1;ISG15;DMP1;AURKB;AURKA;PROC;MELK;CDH2;CCNE1;CDK1;BIRC5;NEK2;DTL;IVL;MATN3
1852,GO_Biological_Process_2021,protein transport (GO:0015031),2/369,0.9999957811994749,0.9999959186369975,0,0,0.0917174626980179,3.8693849600423675e-07,CENPF;SYNDIG1
1853,GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.9999958436448396,0.9999959186369975,0,0,0.0473965389432785,1.969972586112835e-07,EEF1A2
1854,GO_Biological_Process_2021,intracellular protein transport (GO:0006886),1/336,0.9999959186369975,0.9999959186369975,0,0,0.0502803586423598,2.0521281428715098e-07,SYNDIG1
